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ABSTRACT
PORE FORMING PROTEIN ASSEMBLY AND THE USE IN NANOPORE SENSING: A
STUDY ON E. COLI PROTEINS CLYA AND OMPG
SEPTEMBER 2017
MONIFA AKILAH VERNA FAHIE, B.A. CLARK UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Min Chen

Pore forming proteins are typically the proteins that form channels in
membranes. They have several roles ranging from molecule transport to triggering the
death of a cell. This work focuses on two E. coli pore forming proteins that have vastly
differing roles in nature. Outer membrane protein G (OmpG) is an innocuous β-barrel
porin while Cytolysin A (ClyA) is an α-helical pore forming toxin.
For OmpG we probed its potential to be a nanopore sensor for protein detection
and quantification. A small high affinity ligand, biotin, was covalently attached to loop 6
of OmpG and used to capture biotin-binding proteins. OmpG specifically interacted with
target proteins and with a high sensitivity. In addition, we found that OmpG could
discriminate among eight target proteins, four avidin homologues and four antibody
homologues. Our work was the first revelation that a “noisy” nanopore sensor could not
only discriminate among homologous proteins but could maintain this sensitivity and
specificity in a serum sample.
Unlike OmpG which is a monomeric pore, the ClyA pore is an oligomer which
allowed us to probe its assembly. We found an alternative mechanism of assembly of
the ClyA pore from its soluble monomer. Our results revealed an off-pathway
oligomerization of ClyA. These oligomers are stable in solution but are less efficient at
converting into transmembrane pores in the membrane than monomeric ClyA.
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INTRODUCTION
I.1 Pore forming proteins (PFPs)
Pore-forming proteins (PFPs) are a class of membrane proteins that form a hole
across the lipid bilayer.1–5 These proteins create channels that typically allow the passage
of water soluble molecules through the membrane.

PFPs are involved in cellular

processes such as moving various cargo across the bilayer,6–8 signaling pathways,4,9–12
and inducing lytic death in a target cell.1,13–15 PFPs can make the lipid bilayer permeable
to either specific molecules such as a polypeptide,16 an anion17 or they can be unspecific
allowing molecules equal to or smaller than its exclusion limit to pass through the
membrane.18
In this dissertation we will focus on two large classes of PFPs which are (i) the
membrane porins which can be found in gram negative,19 mitochondria6,20–22 and
chloroplasts6,22–24 and (ii) pore forming toxins (PFTs). In the first class, known membrane
porins typically have beta-barrel structure6,8 and create water-filled channels in the
membrane.

On the other hand, PFTs are proteins that can convert from a soluble

monomer into a membrane bound oligomer.2–4,12,14,15,25–27

PFTs are implicated in

infectious disease as a large class of virulence factors,25 as well as in immunity.11,12 These
proteins are produced as soluble monomers in a wide range of organisms for example
bacteria28, amoebae,29 humans,30 and plants.9 These monomers are secreted from the
organism and then interact specifically with a target cell membrane by binding to a receptor
such as lipid domains or cholesterol31–34 a protein receptor35–37 or sugar moiety.26,38 Then
they assemble into a membrane bound pore.14,25,26

Once bound to the target cell

membrane PFTs can trigger cell death through lysis15 or deliver harmful molecules into
the cell.37,39 Because of their significance in a variety of cellular functions, PFPs hold great
interest in our fundamental understanding of biological processes and networks. Thus,

1

there is motivation to study PFPs so that we may better understand and develop ways to
manipulate a biological outcome.

I.2 Fundamental research on PFPs
Like all proteins, PFP function depends on their structure. A protein’s structure
depends on the correct folding mechanisms. The study of protein folding is filled with
many questions regarding protein regulation. Our understanding of membrane protein
folding, in particular, has been lagging behind that of soluble proteins.40 Membrane
proteins are difficult to study in vitro as they are unstable because of their insolubility in
aqueous solution and our lack of suitable detergent or lipid mimics to reconstitute them
into a native-like membrane environment.40 Despite this difficulty we have gained some
insight into PFP folding and thermodynamics from studies on bacterial outer membrane
proteins.8,41–43
On the other hand, pore forming toxins (PFTs) represent a unique class of PFPs
whose cytotoxic function relies on the assembly into quaternary structures. They undergo
significant conformational changes from a soluble protein to a transmembrane pore.25
Because PFTs are initially soluble, they are less difficult to isolate than membrane porins
and their assembly mechanisms can be easily probed. They are classified as either PFTs or β-PFTs depending on their predominant secondary structures.14 The classical
model of PFT assembly includes (i) binding of monomers to membrane, (ii) oligomerization
on the membrane, (iii) formation of a pre-pore complex and (iv) membrane insertion of a
transmembrane-spanning domain (Figure I.1).2,14,25,26

2

Figure I.1. Schematic of the classical assembly mechanism for a pore forming toxin
(PFT). Reprinted by permission from Macmillan Publishers Ltd: Nature Publishing Group H.
Bayley, “Membrane-protein structure: Piercing insights,” Nature, vol. 459, pp. 4–5, 2009.,
copyright (2009)

Although the route of toxin assembly is specific for PFTs, protein complex formation is not
unique to them. Many other proteins such as secretion systems (types I to VI),44 and
photosystems I45 and II46 are examples of membrane spanning multi-protein complexes.
Thus, studying assembly of PFTs which can form either homo-oligomeric or heterooligomeric complexes would have wide appeal to many other biological questions that
focus on multi-protein complex formation and function.
Some knowledge of PFTs and their assembly has been elucidated while studying
infectious diseases,15 signaling pathways4,9,11,12,47 and this fundamental knowledge has
been exploited in protein engineering and nanopore sensing.48 To paint a complete
picture of PFTs, studying their kinetics of assembly and their thermodynamics is essential.
Studying the kinetics of alpha hemolysin (αHL) assembly revealed that its conversion from
monomer to oligomer is too rapid for detecting intermediate states.49 However atomic
force microscopy characterization of MACPF/CDC pores has shown pre-pore,
3

intermediate pore called arcs and pore states.50 Thus, studying PFT assembly may be
limited to larger pores with slow kinetics. One such toxin is the E. coli PFT, Cytolysin A
(ClyA) which was recently studied with more direct assays via FRET and cross-linking
experiments.51 ClyA converts from monomer to oligomer in the presence of detergent
DDM within minutes.51–54 which is slow enough to study the oligomerization process. A
model for ClyA assembly was proposed highlighting that oligomerization is a concerted
cooperative process.51 This model for ClyA can be extended to other PFTs and can
explain the quick assembly kinetics of small toxins.

I.3 Applied research on PFPs
One application of PFPs that has seen a boom is in nanopore technology.
Nanopore technology is a field of research focusing on developing sensors based on
biological or solid state pores. Solid state nanopores are holes of nm size that are typically
fabricated on silica, graphene, borosilicate glass and other materials.55–57

Biological

nanopores are mainly based on membrane pore-forming proteins, although there is
increasing success and progress with using nucleic acid based nanopores.[15]–[22] PFP
nanopores have been used to detect various molecules ranging from metal ions,66,67
neurotransmitters,68

peptides,69–71

proteins,72–77

nucleosomes,78

to

even

microorganisms.79–83 In fact, the most significant progress has been in the sequencing of
single stranded DNA.48,57,84–104
The principle behind nanopore detection and analysis is based on monitoring the
changes in ionic flow through the nanopore when an analyte binds.100,105,106 because of
this, analytes can be characterized by their size, their charge and their concentration.107,108
Analytes can bind directly in the lumen of the nanopore,92,94,98,107,109,110 or via an adaptor
molecule in the lumen,89,90,111 they can bind to either prevent or promote oligomerization
of the nanopore,112 or they can bind to an non-lumen site on the nanopore.73 In addition,

4

nanopores can be used to detect analytes indirectly72 and study enzyme kinetics.109
Although there has been much progress in nanopore sensing especially in the sub-field of
DNA sequencing, there are some limitations. The most commonly used protein-based
nanopores such as αHL or ClyA range from 1–7 nm in diameter. This means that
molecules larger than these diameters cannot enter their lumen. Solid-state nanopores
(ss-nanopores) have an advantage to PFPs in their tunable sizes, however, ss-nanopore
fabrication lacks the size and shape precision of a biologically produced protein
nanopore.55–57,75,91,95,99,100 In addition, we would need to designate unique ss-nanopores
to detect a specific subset of molecules. This is because analytes that are very small will
not generate a noticeable change in the ionic current of a large nanopore. To alleviate
the nanopore size limitation, researchers have used alternative approaches where large
analytes were detected by specifically binding to native receptor sites113 or engineered
sites114–117 on the nanopore surface where binding altered the ionic flow of the nanopore.
Another big area for nanopores is geared towards protein analytes118–120 i.e.
protein/peptide translocation48,121–125 as well as protein folding/aggregation analysis.126–132
Protein translocation across the lipid bilayers is ubiquitously found in nature for example
in secretion systems133 or across mitochondria and chloroplasts23 and the use of
nanopores is a suitable in vitro platform to probe these mechanisms.77 Furthermore,
nanopores have the potential to be used as analytical tools in protein/peptide sequencing
however unlike nucleic acid which have four building blocks, proteins have 20 different
amino acids. Currently, nanopores cannot resolve individual amino acids but many works
have proven the feasibility of translocating unfolded proteins through nanopores.74,134–138
The current challenges of protein sequencing using nanopores are quite similar to the
early challenges of DNA sequencing. Challenges such as low capture rate due to the
heterogeneity of charge on proteins, difficulty of peptide unfolding, rapid protein/peptide
translocation120,136 are all barriers to protein/peptide sequencing.
5

Researchers have

started to address these challenges by adding tags to polypeptide chains to enhance
capture rate,135–138 coupling nanopores with unfoldase enzymes,135,136 engineering binding
sites in the nanopore,76,123,139,140 and using chaotropic agents to denature proteins.127,128,131
However, amino acid resolution via nanopores is still a distant dream. Thus, nanopore
protein analysis/sequencing research will be thriving for the next several years.
In order to advance nanopore sequencing technology, the next steps will require
improving computer software analytical tools.141 In addition, nanopores with asymmetric
properties i.e. geometric asymmetry as well as functional group asymmetry in the lumen
could also improve the resolution of molecule detection.142,143 Solid state nanopores,
monomeric protein nanopores and even DNA origami pores have an advantage over
oligomeric nanopores based on PFTs to introduce geometric143 or functional group
asymmetry.142 We currently do not have a large repertoire of monomeric nanopores
whose stability rivals that of αHL nor do we have the precision to repeatedly synthesize
an asymmetric solid-state one. However, this limitation will drive researchers to design
and engineer new strategies to fill the gap. The nanopore field has many avenues to
explore with both solid state and protein nanopores and vibrant research is needed to
pinpoint limitations so that we can engineer schemes to overcome them.
In addition to nanopore technology another application for PFPs is in drug
development. We can exploit the cytotoxic behavior of PFTs for therapeutic purposes.
Malignant cells that resist cell death such as in some cancers144–146 could undergo death
if attacked by a specific and potent PFT147–153 or peptide154 (Figure I.2a). Furthermore,
PFTs can potentially be used as delivery vehicles to increase the uptake of drugs into a
cell,147 (Figure I.2b) or in delivery vehicles such as outer membrane vesicles155,156 and can
enhance vaccine efficacy.157

Although there is great potential for PFTs in drug

development, the progress has been relatively slow. One major setback in developing
PFTs as cytocidal drugs are due to low toxin specificity which is why some researchers
6

have proposed to attach the toxin to an antibody to increase specificity.149 However these
large immunotoxins may not survive oral delivery and may be cleared very quickly from
the blood. Some research has successfully targeted PFTs to tumor cells in mice models
using engineered bacteria,150–153 however this method is limited to areas where the
bacteria can be safely injected.

It also raises an ethical and safety concern about

administering genetically modified organisms (GMOs) into the human populace. Other
limitations are related to toxin potency. For example, PFTs that can efficiently lyse its
target cell would be an unlikely candidate to exploit as a drug delivery vehicle. Research
on toxin assembly, stability and combinational methods will improve our engineering
efforts to create specific and efficacious PFT drugs.

Figure I.2. PFTs as drugs to induce cell death or as drug delivery vehicles. (a) A PFT is
used to induce cell death by lysis in the malignant cell such as a cancer cell that has become
‘immortal’. (b) A PFT is used as a delivery mechanism to allow beneficial drugs to enter the cell
to alleviate the malignancy.

I.4 Pore forming protein research using OmpG and ClyA

I.4.1 Outer membrane protein G (OmpG) as a nanopore sensor
One monomeric nanopore that has been recently introduced in the nanopore field
is outer membrane protein G (OmpG).117,158–162 OmpG is a 33 kDa monomeric protein
found in the outer membrane of E. coli.18,163 It belongs to the family of bacterial outer
7

membrane proteins (Omps) which are typically beta barrels and have various functions
ranging from enzymatic activity to iron transport.8 OmpG, in particular, was found to be
involved in the uptake of polar molecules such as maltose,18,163,164 and unlike other typical
trimeric Omps it is a monomer.165–169 OmpG’s 14 beta strands are connected by seven
long loops which face the exterior of the bacterial cell and seven short turns which face
the periplasm170 (Figure I.3).

Figure I.3. Side and top views of the OmpG porin structure. OmpG consists of 14 beta
strands, seven periplasmic turns and seven long extracellular loops.

Reconstituted in an artificial planar bilayer, OmpG generates a noisy ionic current
fluctuating

rapidly

applied.158,159,164,166,171

between

high

and

low

current

states

when

voltage

is

Many structural studies on OmpG under various conditions

advanced the understanding of its gating mechanism which is largely due to the movement
of its longest loop L6.168,172–174 Because of this gating property of OmpG, it was deemed
undesirable for use as a nanopore sensor.158 Thus in an attempt to make it more suitable
for nanopore sensing researchers stabilized loop 6,158,175 or shortened it.176 Thereafter
8

ADP was successful detected by Chen et al using a cyclodextrin adaptor in the lumen.158
Because OmpG is its widest at the periplasmic side with 1.5 nm and narrows to 0.8 nm
near the extracellular loop side,159 thus it is limited to detecting small molecules such as
ADP. But the paradigm in nanopore sensing is shifting toward the detection and analysis
of proteins. Thus, as will be shown in the following chapters of this dissertation, we
exploited this intrinsic gating property to engineer an OmpG nanopore sensor for protein
analytes. To do this we covalently attached a high affinity ligand biotin to loop 6 of OmpG
which was used to capture biotin-binding proteins. After attaching the biotin ligand, OmpG
gained the ability to specifically and sensitively interact with various proteins and generate
individual signals for each that could be used to distinguish one from the other.117,160–162
This was the first report of a single nanopore sensor that would distinguish more than five
protein analytes.

I.4.2 Cytolysin A as a model for studying oligomeric protein assembly
Another protein that has been recently probed in nanopore sensing is the PFT
Cytolysin A (ClyA) also known as hemolysin E (HlyE) or silent hemolysin locus A
(SheA).177

It is an -PFT and currently is the only one whose monomeric178 and

oligomeric179 structures are known (Figure I.4). ClyA is found in several bacterial strains
such as Escherichia coli, Salmonella enterica and Shigella flexneri177 and may be involved
in the pathogenicity of these strains.15,180–182

The ClyA toxin is exported to the

periplasm[138],[139] and studies have found that it is secreted into the extracellular
environment via outer membrane vesicles (OMVs).184–186 Subsequent studies have taken
advantage of ClyA secretion into OMVs to engineer particles for cancer therapeutics 150–
153

and vaccines.155–157 ClyA has also been exploited in nanopore sensing and was shown

to detect DNA,86,187 distinguish between homologous proteins,110,188 trap proteins and
reveal conformational changes 189–191 or study protein-ligand interactions.192
9

Figure I.4. The structures of the inactive and active ClyA α-PFT. The soluble ClyA
monomer (a) is expressed in the bacteria and the transmembrane oligomeric pore (b) is
bound to the target cell and induces them to lyse.

Although, ClyA has now been deemed a bona fide nanopore, our interest in ClyA
stems from its ability to assemble into large dodecameric pores on the time scale of
minutes.51–53

Also ClyA tends to assemble into a large distribution of oligomers as

suggested in one study.189 Unlike αHL,49 the conversion of the ClyA monomer into the
oligomer is a slow process. This is advantageous as we can study the steps in PFT
oligomerization using ClyA as a model.4,7,9 In this dissertation, we have shown that ClyA
can undergo an off-pathway assembly into the cytotoxic transmembrane pore through a
soluble protein conglomerate. We have shown that ClyA forms multimeric intermediates
in the absence of membrane or detergent.53,193 By revealing this off-pathway folding
conglomerate we have sampled a small subset of folding mechanisms in the protein
folding landscape of ClyA.
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CHAPTER 1
RESOLVED SINGLE-MOLECULE DETECTION OF INDIVIDUAL SPECIES WITHIN A
MIXTURE OF ANTI-BIOTIN ANTIBODIES USING AN ENGINEERED MONOMERIC
NANOPORE
Reprinted (adapted) with permission from M. Fahie, C. Chisholm, and M. Chen,
“Resolved Single-Molecule Detection of Individual Species within a Mixture of anti-Biotin
Antibodies Using an Engineered Monomeric Nanopore,” ACS Nano, vol. 9, no. 2, pp.
1089–1098, Jan. 2015. Copyright 2015 American Chemical Society.
1.1 Summary
Oligomeric protein nanopores with rigid structures have been engineered for the
purpose of sensing a wide range of analytes including small molecules and biological
species such as proteins and DNA. We chose a monomeric β-barrel porin, OmpG, as
the platform from which to derive the nanopore sensor. OmpG is decorated with seven
flexible loops that move dynamically to create a distinct gating pattern when ionic current
passes through the pore. Biotin was chemically tethered to the most flexible one of
these loops. The gating characteristic of the loop’s movement in and out of the porin was
substantially altered by analyte protein binding. The gating characteristics of the pore
with bound targets were remarkably sensitive to molecular identity – even providing the
ability to distinguish between homologues within an antibody mixture. A total of five
gating parameters were analyzed for each analyte to create a unique fingerprint for each
biotin binding protein. Our exploitation of gating noise as a molecular identifier may open
new possibilities for more sophisticated sensor design while OmpG’s monomeric
structure greatly simplifies nanopore production.
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1.2 Introduction
Protein nanopores have become powerful single-molecule analytical tools that
enable the study of fundamental problems in chemistry and biology,1,2 including protein
folding3 and unfolding,4–8 enzymatic activity,9–11 chemical reactions12,13 and stability of
complex formation.14 Beyond basic research, nanopores also hold tremendous promise
in biotech applications such as DNA sequencing11,15–17 and biosensing.1

Molecular

detection using a single nanopore works by observing modulations in ionic current
flowing through the pore during an applied potential. Typically, binding (or translocation)
of an analyte within (or through) the pore’s lumen partially blocks the flow of current and
provides information about a molecule’s size, concentration and affinity.18 Protein
nanopores based on protein toxins, especially α-hemolysin (αHL), have been used to
detect metal ions,19,20 organic molecules,21–23 oligonucleotides11,17,24 and measure the
size of polymers.25,26
Although αHL works well for small analyte detection, molecules larger than 27Å
in diameter cannot fit in the pore’s lumen. Direct protein detection with nanopores is
therefore problematic, though some strategies have been developed to transmit the
binding signal from solution to the pore’s interior.27–30 For example, binding of a kinase
was performed using an αHL pore modified with an inhibitor peptide attached to its stem
side.28 The binding of lethal factor to the PA63 pores of the anthrax toxin orients the Nterminal leader sequence towards the pore’s lumen.31,32 In both cases, analyte docking
to the binding site on the sensor pore manifest as a current blockage.28,32 In addition to
direct current blockade, target analytes may also be detected indirectly through current
modulation. A common strategy involves a nanopore-permeable molecule, e.g. a small
chemical ligand or ligand-modified polymer whose partitioning into or translocation
through the nanopore was altered after analyte binding. Following this scheme, the
detection of streptavidin or avidin was demonstrated by tethering biotin via a PEG
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polymer to αHL30 or monitoring the translocation of biotinylated poly nucleic acids
through αHL.33–35
Another strategy is to use larger nanopores for analyte detect. For example, the
bacterial toxin ClyA, with a 70Å diameter, was modified at one end with an aptamer
specific to thrombin.36 So far, ClyA represents the largest protein pore for sensing.
Although there are many proteins that form larger pores in nature,37 e.g. perfringolysin O
(~15 nm in diameter),38 their application as sensors has yet to be realized. Synthetic
nanopores do not have the size limitation and are more robust39–41 and have been
applied to identify proteins either during translocation40–42 or via capture by specific
receptors immobilized on the wall of the pore.39,43–45 However, synthetic nanopores lack
the well-controlled geometry common to their protein pore counterparts.
Unlike other multimeric proteinaceous nanopores such as αHL and ClyA,27,36
outer membrane protein G (OmpG) from Escherichia coli (E. coli) is monomeric.46 Thus,
complex and asymmetric alterations by chemical or genetic modifications are
straightforward, making OmpG an attractive nanopore platform for developing nanoporebased sensing technology. OmpG is composed of 14 β-strands connected by seven
flexible loops on the extracellular side and seven short turns on the periplasmic side.47–49
The extracellular opening is 8 Å in diameter and the periplasmic side is 14 Å.50 Wildtype OmpG spontaneously gates during an applied potential as revealed by planar
bilayer studies.46,50 Pore gating is attributed to loop 6 which flops in and out of the pore,
intermittently blocking the current.50,51 To reduce gating, a disulfide bond or lipid anchor
was introduced into OmpG’s structure which effectively pinned the flexible loop 6 in
place.50,51 The resulting quiet OmpG was used to sense ADP in the presence of a
cyclodextrin adapter.50
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So far, a rigid and stable structure is usually sought for protein pores for
sensing.2,52 The protein pores with demonstrated sensing applications include αHL,30
MspA,53 ClyA,36 aerolysin54 and phi29 DNA packaging motor55 all of which are homooligomers that possess a rigid structure.

Two monomeric outer membrane porins,

OmpG50 and FhuA56 with flexible loops have also been used for sensing purposes.
However in both cases the flexible loops were considered as the major obstacle for
sensing. These loops were either fixed or removed to stabilize a single open
conformation by protein engineering.50,56 Here, we directly exploit loop dynamics instead
of pore blockage to detect protein interactions.

Our results demonstrate that the

flexibility of OmpG’s structure represents a unique feature, which can be used for
resolving subtle differences between the surface properties of highly homologous protein
analytes. This capability has not been demonstrated with other nanopores.
1.3 Materials and Methods
The DNA oligos and all chemicals were purchased from Fisher Scientific unless
stated otherwise. Streptavidin (Z7041) was purchased from Promega. The biotinmaleimide

reagents,

Maleimide-PEG2-Biotin

and

Maleimide-PEG11-Biotin

were

purchased from Piercenet (Thermo Scientific). Mouse anti-biotin monoclonal antibody
(MS-1048-P1) was purchased from Thermo Scientific. Goat anti-biotin polyclonal
antibody (B3640) was from Sigma Aldrich. Mouse anti-His6 (BSM-0287M) and mouse
anti-GAPDH (BSM-0978M) antibodies were obtained from Bioss antibodies. LB media
and

DL-dithiothreitol

(DTT)

were

purchased

from

Boston

BioProducts.

Diphytanoylphosphatidylcholine (DPhPC) were from Avanti polar lipids. Octyl-glucoside
(OG) and tris(2-carboxyethyl)phosphine (TCEP) were purchased from GoldBio
Technology.
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1.3.1 Construction of OmpG D224C mutant
Single cysteine was introduced to replace the aspartic acid 224 by mutagenesis
PCR based on the plasmid pT7-OmpG wt.50 The primers for D224C were
5’-GGGACTGGCAGTGTGATATTGAACGTGAAG

(forward)

and

5’-

GTTCAATATCACACTGCCAGTCCCAGTTAC (reverse). These two primers were used
in a pair with the primer SC47: 5’-CAGAAGTGGTCCTGCAACTTTATC (reverse) and
SC46: 5’-ATAAAGTTGCAGGACCACTTCTG (forward) which annealed to the middle of
the plasmid. The two PCR products were mixed in a 1:1 molar ratio and subjected to
DpnI digestion for three hours to degrade the parental plasmid. E. coli DH5α cells were
then co-transformed with the PCR mixture and colonies containing the desired mutant
construct pT7-OmpG D224C was identified by DNA sequencing.

1.3.2 Cloning, expression and purification of OmpG D224C
The OmpG D224C was prepared by following an established protocol.50 The
pT7-OmpG D224C was transformed into the BL21(pLys) E. coli cells and cells were
grown in LB medium at 37°C until the OD600 reached 0.6. IPTG (0.5 mM) was added to
the culture to induce the protein expression. Cells were harvested 3 hours after induction
and lysed in lysis buffer (50 mM Tris·HCl, pH 8.0, 150 mM NaCl, 200 µg/ml lysozyme, 1
mM EDTA, 1mM TCEP). Cells were sonicated on ice to break the bacterial membranes.
DNAase I (5ul, 2,000 U/µl) and 2 mM MgCl2 were then added to the mixture to decrease
the viscosity. The lysate was centrifuged at 13,000 rpm for 30 min. The pellet was
washed once with 30 ml 50 mM Tris·HCl, pH8.0, 1.5 M Urea, 1mM TCEP. Then the
OmpG-containing inclusion body was dissolved in 50 ml 50 mM Tris·HCl, pH 8.0, 3 mM
Tris(2-carboxyethyl)phosphine (TCEP), 8 M Urea and passed through a 0.45 µm filter
before FPLC purification. All OmpG proteins were purified using a 5ml Q-ionic exchange
column (GE Healthcare).
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1.3.3 Biotinylation and refolding of OmpG proteins
The purified OmpG D224C was incubated with 10 mM freshly prepared DLdithiothreitol (DTT) for 30 min on ice to reduce the thiols. The DTT was then removed
using a desalting column equilibrated with buffer 50 mM HEPES, pH7.0, 150 mM NaCl,
8M Urea. To label the OmpG D224C with biotin, the protein was incubated with
maleimide-PEG-biotin in a molar ratio 1:20 (protein to biotin) at room temperature
(~23°C) for 2 hours and then at 4 °C overnight. DTT (10 mM) was added to quench the
reaction. The reaction mixture was passed through the desalting column once again to
remove the unreacted chemicals. The biotin labelled OmpG was then diluted with the
refolding buffer 50 mM Tris·HCl, pH 9.0, 3.25% OG until the final concentration of urea
reached 3.0 M. Samples were then incubated at 37 °C for 3 days. The biotinylation and
refolding efficiency was determined by SDS-PAGE (Figure 1.1).

Figure 1.1 SDS-PAGE analysis of OmpG variants. The refolded OmpG variants were either
pre-heated at 95ºC for 15 min or directly loaded on a 12.5% SDS-PAGE. Heating denatures the
OmpG protein which migrates slower in SDS-PAGE. To determine the labelling efficiency, the
OmpG-PEG11-biotin and OmpG-PEG2-biotin were incubated with streptavidin for 5 minutes
which forms an SDS-resistant complex with biotin. Consequentlys, OmpG shifts to highermolecular weight and labeling percent can be calculated by the disappearance of the OmpG
refolded or denatured band.
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1.3.4 Single channel recording of OmpG proteins
Single channel recording of OmpG was similar to the previous study.50 Briefly,
experiments were performed in an apparatus containing two chambers separated by a
25 µm thick Teflon film. An aperture of approximately 100 µm diameter had been made
near the center of the film with an electric spark. The aperture was pretreated with a
hexadecane/pentane (10% v/v) solution before each chamber was filled with buffers as
indicated specifically. An Ag/AgCl electrode was immersed in each chamber with the cis
chamber grounded. 1,2-Diphytanoyl-sn-glycerol-3-phosphocholine (Avanti Polar Lipids,
USA) dissolved in pentane (10mg/ml) was deposited on the surface of the buffer in both
chambers and monolayers formed after the pentane evaporated. The lipid bilayer was
formed by raising the liquid level up and down across the aperture. OmpG proteins (~1
nM, final concentration) were added to the cis chamber and +200mV was applied to
facilitate OmpG insertion. After a single OmpG pore inserted, the applied voltage was
lowered to 50 mV for recording. OmpG proteins inserted in the planar lipid bilayer bidirectionally with its extracellular loops located at either cis or trans side. After 10 min
recording, the orientation of the OmpG pore in the lipid bilayer was determined by
analyzing the asymmetrical gating pattern at positive and negative potentials.
Streptavidin or antibodies were added to the cis or trans chamber depending on the pore
orientation and the solution was stirred for 10 s. We define a positive potential as the
potential of the chamber where the extracellular loops were exposed to is positive.
Current was amplified with an Axopatch 200B integrating patch clamp amplifier (Axon
Instruments, Foster City, CA). Signals were filtered with a Bessel filter at 2 kHz (unless
otherwise stated) and then acquired by a computer (sampling at 50 µs) after digitization
with a Digidata 1320A/D board (Axon Instruments).
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1.3.5 Single-channel current analysis
For power spectra analysis, data were recorded with a Bessel filter at 50 kHz and
acquired at 250 kHz. Power spectra were calculated from a 20 s recording trace in
Clampfit using segment lengths of 32768 samples (spectra resolution 7.62 Hz) by
applying Hamming window. Data shown were derived from averaged spectra segments
with 50% window overlap. To analyze the mAb and polyclonal antibody binding, power
spectra of multiple binding events from a total of 20 s recording time were calculated and
averaged. The power spectra densities for all traces were plotted in OriginPro 9.1.

1.4 Results
1.4.1 Detection of Streptavidin by OmpG-PEG11-biotin pore
To detect proteins, we designed an OmpG nanopore with a ligand tethered to
loop 6 to “fish” for target proteins. We hypothesized that target binding would alter the
flexibility of loop 6 and therefore alter the gating pattern as a recognizable signal to
indicate detection. To validate the concept of the OmpG sensor, we first chose biotin
and streptavidin as the model ligand and target protein because of its very low
dissociation constant of ~10-15 M.57 The OmpG D224C was expressed in E. coli as
inclusion bodies and purified by ion-exchange chromatography. Purified OmpG D224C
proteins were labeled with maleimide-(PEG)11-biotin and the resulting OmpG-PEG11biotin construct was refolded to its native structure (Figure 1.1).

A single cysteine

mutation was introduced to the D224 residue of OmpG by site-directed mutagenesis
(Figure 1.2).
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Figure 1.2. Structures of OmpG and its gating activity. (a) The top view (left) and side view
(right) of the structural alignment of the open and closed states. Loop 6 is highlighted in blue
in the open state and red in the closed state. The D224C mutation is shown in ball and stick
model. (b) Single channel recording trace of a wild type OmpG pore. The data was obtained
in buffer 10 mM Tris·HCl, pH 8.0, 150 mM KCl at +50 mV.

Single-channel recording of OmpG-D224C and OmpG-PEG11-biotin pores
revealed that neither the mutation nor the tethered biotin group induced a measurable
change in the unitary conductance or the gating pattern of OmpG when compared to
wild type (Figures 1.3a-1.3c). The maleimide-PEG11-biotin ligand could fully extend from
loop 6 by approximately 60Å to facilitate the capture of the analyte proteins (Figure
1.4a). Within minutes, the addition of 3 nM streptavidin to the chamber containing loop 6
of the labeled OmpG-PEG11-biotin pore could induce an irreversible change in its gating
pattern. A marked increase in gating frequency from 111±30 s-1 to 199 ±27 s-1 (n=3)
was observed when streptavidin was bound to OmpG-PEG11-biotin labeled pores at pH
5.7 (Figures 1.4b, 1.4c). We plotted all the gating events according to their amplitude
(pA) and duration (ms) in a two-dimensional (2D) distribution plot (Figure 1.4d). From
the 2D plot analysis, we observes two populations of events. Population 1 only partially
blocks the pore with amplitudes between 0 to 7.5 pA and dwell times between 0-0.4 ms
(Figure 1.5); population 2 almost fully blocks the pore with amplitudes larger than 10 pA
(10-20pA) and dwell times longer than 1ms i.e. 1-50 ms (Figure 1.5).
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Figure 1.3. Point mutation or biotinylation of OmpG does not affect its inherent gating
behavior. Single channel recording traces of (a) OmpG wt, (b) OmpG D224C (unlabeled), (c)
OmpG-Peg11-biotin and (d) OmpG-Peg2-biotin. Buffer used was 10 mM sodium phosphate
buffer, pH 6.0, 300 mM KCl and the applied potential was +50 mV.

Figure 1.4. Detection of streptavidin by OmpG-PEG11-biotin. (a) Schematic model showing
the OmpG-PEG11-biotin. The proteins were generated using PDB files of OmpG (2IWV) and
streptavidin (3RY1). The streptavidin was placed approximately 60Å away from the OmpG
pore in the model of the bound state. (b) Representative traces of the OmpG pore before and
after the addition of the streptavidin (3 nM). The measurements were performed in buffer 10
mM sodium phosphate, pH5.7, 150 mM KCl at +50 mV. (c) All current histogram of the
corresponding traces in b. (d) Two dimensional histogram of the gating events. Gating events
collected from a 15s recording trace were distributed based on their intensity versus duration.
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Figure 1.5. Characteristic of the two gating event populations of streptavidin binding.
Histograms of amplitude and dwell time of gating events before (a) and after streptavidin
binding (b).

From previous studies and known structures of OmpG,47, 50 we expect that loop 6
cannot fully block the pore on its own as it cannot occupy sufficient space within the
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lumen. For complete blockage, we expect that as much as one third of strand 12 must
also unfold so that loop 6 is long enough to completely occlude the opening. We give
the term “flickering” and “bending” to describe partial vs complete blockages,
respectively. This distinction is important when considering the behavior observed in the
2D plots. For example, flickering events (population 1) seem relatively constant in the
presence or absence of target, while the bending events (population 2) shorten
considerably when the target binds (Figure 1.5d). By contrast, the average dwell time of
the bending events decreased from 5.1±0.14 ms to 3.8±0.15 ms (n=3) (Figure 1.6) when
streptavidin was bound. In particular, those bending events of especially long duration
(>10 ms), indicated with red asterisks, were eliminated during the streptavidin-bound
state (Figures 1.4b, 1.4d).

Figure 1.6. Effect of streptavidin binding on the bending events. Histogram of the
duration time (τoff) of the gating events before and after streptavidin binding to OmpG-Peg11biotin. Data were fitted with single exponential function yielding an average τoff of 5.0 ms
before and 3.9 ms after streptavidin binding.

We hypothesize that the bending events are shortened by bound streptavidin by
destabilizing the closed state. However, due to the increased gating frequency, the open
probability of the OmpG pore actually reduced slightly from 0.58±0.09 to 0.51±0.10 (n=
3) upon streptavidin binding as revealed by the decrease of the open state peak (Figure
1.4c). As controls, streptavidin has also been added to the unmodified OmpG-D224C
pores (15 pores tested), we have not observed any change in the gating pattern (Figure
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1.7). Thus, specific binding of streptavidin to the tethered biotin induces a clear but
slight change in the gating properties of OmpG-PEG11-biotin pore.

Figure 1.7. Gating behavior due to streptavidin binding is specific. The addition of
streptavidin to OmpG D224C does not change the behavior of the pore at either (a) 10 mM
sodium phosphate buffer, pH 5.7, 150 mM KCl or (b) 10 mM sodium phosphate buffer, pH 6.0,
300 mM KCl.

1.4.2 Shortening the ligand linker to strengthen signal
Since the binding between the OmpG-PEG11-biotin and streptavidin produced a
relatively small effect on the gating, we hypothesized that the polyethylene linker was too
long to effectively restrict the dynamic movement of loop 6. Therefore, we shortened the
length of the PEG linker to just two units, creating the OmpG-PEG2-biotin construct
where the biotin could extend ~30 Å into solution (Figure 1.8a). The shortened linker did
not affect the gating pattern when compared to OmpG D224C or OmpGwt (Figure 1.3).
By shortening the linker, the effect of streptavidin binding was much more pronounced,
permanently reducing the frequency and amplitude of gating events (Figures 1.8b,1.8c).
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Figure 1.8. Detection of streptavidin by OmpG-PEG2-biotin pore. (a) Schematic model
showing the OmpG nanopore chemically modified with a maleimide-PEG2-biotin. The
streptavidin is placed around 30Å away from the OmpG pore in the model of the bound state.
(b) Representative single channel recording traces of the OmpG pores before and after the
addition of the streptavidin (3 nM). The measurements were performed in buffer 10 mM sodium
phosphate, pH 5.7, 150 mM KCl at +50 mV. (c) All current histogram of the corresponding
traces in (b). (d) Two dimensional histogram of the gating events. Total number of 4000 gating
events collected from ~220 s and ~40s recording traces of OmpG pore with and without
streptavidin bound were distributed based on their intensity versus duration. The color scale
indicates the number of the events.

Quantitative analysis of three OmpG-PEG2-biotin pores showed that the gating
event frequency was reduced by more than 6 fold from 104 ± 6 s-1 to 16 ± 2 s-1 (n=3).
Comparison of the two-dimensional plots of all events reveals that the occurrence of
bending events with long duration time (>0.1ms) and high intensity (>10 pA) were mostly
eliminated due to streptavidin binding (Figure 1.8d). Gating events of transient duration
time (<0.1 µs) and low intensity (<10 pA) still persist albeit with greatly reduced
frequency. The data indicate that streptavidin bound to the PEG2 linker can strongly
restrict bending but not the flickering of loop 6. As a control, streptavidin was added to
OmpG D224C pores and no change was observed (10 pores tested).

Adding excess

BSA (1µM) to the OmpG-PEG2-biotin pore also did not show any effect (Figure 1.9).
These observations confirmed that the alteration of the gating pattern is caused by the
specific interaction between the streptavidin and the tethered biotin ligand. In summary,
binding of streptavidin to the OmpG-PEG2-biotin nanopore can be detected via reduction
in gating behavior.
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Figure 1.9. BSA does not elicit change in OmpG behavior. The addition of BSA to
OmpG-Peg2-biotin does not change its gating pattern. This condition was performed in 10
mM sodium phosphate buffer, pH 6.0, 300 mM KCl.

1.4.3 Detection of reversible antibody binding
The biotin-streptavidin interaction is effectively irreversible, thus only one binding
event can be detected with the nanopore sensor during a 4 hr recording and
unfortunately we cannot extract kinetic information from the streptavidin analyte. Here,
we introduced proteins with weaker dissociation constants to take a closer look at
reversible interactions. Mouse monoclonal anti-biotin antibodies (mAb) were added to a
recording chamber with a single OmpG-PEG2-biotin (Figure 1.10a). The electrical trace
showed that the presence of the anti-biotin antibody induced a dose-dependent gating
pattern that was distinct from the unbound state and surprisingly also distinct from the
streptavidin bound state (Figure 1.10b). During antibody binding, the pore shifted to
more closed conformation as revealed by the larger closed state peak in the all-current
histograms (Figures 1.10b, 1.10c). Indeed the calculated open probability was reduced
from 0.73±0.04 at the no binding or unbound state to 0.52±0.04 at the bound state (n=6).
In addition, although the current fluctuates between open and closed states during both
the antibody-free and antibody-bound states, the current of the pore in the fully open
conformation was slightly reduced by 3.5±0.86 pA or 13.6±3.8% (n=6) during the
antibody bound state compared to the unbound state (Figure 1.10c). This dampening
effect on the open conductance was not observed during the experiments using
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streptavidin and might suggest that the antibody is in closer proximity to the pore
opening when bound and therefore occluding ion flow through the OmpG-PEG2-biotin
nanopore.

As a control, addition of mAb to OmpGwt and unmodified OmpG D224C

pores did not induce any detectable binding signal (Figure 1.11a). Neither were mouse
anti-histag

nor

anti-Glyceraldehyde

3-phosphate

dehydrogenase

(anti-GAPDH)

monoclonal antibodies (20 nM) detected by current recording with OmpG-PEG2-biotin
pores (Figure 1.11b). Thus, these gating events resulted from the specific mAb binding
to the tethered biotin.

Figure 1.10. Detection of monoclonal anti-biotin antibody by OmpG-PEG2-biotin pore.
(a) Schematic model showing the reversible binding of monoclonal anti-biotin antibody to
OmpG-PEG2-Biotin pore. The model is generated in Pymol using pdb files of OmpG (2IWV)
and a mouse monoclonal anti-phenobarbital antibody (1IGY). The antibody was placed
approximately 30Å away from the OmpG pore in the captured model. (b) Representative
single channel recording traces at various mAb concentrations. The mAb binding regions in
the recording traces are highlighted in red. Increase of the mAb binding frequency was
observed with increasing concentration of mAb. The measurements were performed in buffer
10 mM sodium phosphate, pH 6.0, 300 M KCl at +50 mV. (c) All current histogram of the
corresponding traces in (b). The green and red dashed lines emphasize the shift of the fully
open states in current at unoccupied and mAb bound states respectively. (d) (e)
Concentration dependence of the 1/τoff and 1/τon. Error bars represent the standard deviations
from the measurements of at least three independent pores.
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Figure 1.11. Monoclonal anti-biotin antibody (mAb) binding is specific.
(a)
Representative trace of OmpG D224C pore in the absence and presence of mAb. (b)
Representative trace of OmpG-Peg2-biotin in the absence and presence of control antibodies
anti-GAPDH and anti-His6. 10 mM sodium phosphate buffer, pH 6.0, 300 mM KCl was used
in both experiments. The applied potential was +50 mV. Neither the addition of mAb to (a)
OmpG D224C nor the addition of anti-His, anti-GAPDH mouse mAb to (b) OmpG-Peg2-biotin

Next, the dwell time (τoff) and inter-event intervals (τon) of mAb binding was
calculated (Figure 1.12). The average dissociation rate constant (koff=1/τoff) of the mAb
binding events was 0.25±0.04 s-1 (n=4) which was independent of the antibody
concentration (Figure 1.10d). The observed association constant (kon’=1/τon) increased
linearly with the increasing concentration of antibody (Figure 1.10e). The association
rate constant kon of antibody binding was 2.30±0.43×107M-1·s-1 (n=4). The equilibrium
dissociation constant (Kd) of the mouse monoclonal antibody to biotin was 1.12±0.28
×10-8M-1 (n=4). At the lowest mAb concentration tested (1 nM), the mean inter-event
interval was 74.5 ± 31 s meaning the OmpG-PEG2-biotin sensor can detect 1nM antibiotin mAb within tens of min.
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Figure 1.12. Analysis of kinetic parameters of mAb binding to OmpG-PEG2-biotin.
Histograms of the dwell time and the inter-event duration of these events were fitted with
single exponential decay function to derive the average time constants.
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1.4.4 Influence of voltage on the mAb binding
OmpG exhibits asymmetrical gating pattern at positive and negative voltages,
where at one voltage it generates a “quiet” gating pattern while at the opposite voltage it
generates a “noisy” pattern.50 Therefore, we were interested to see if the polarity of the
voltage could similarly affect the dynamic motion of loop 6 during the mAb bound state.
Figure 1.13a shows that mAb binds to OmpG-PEG2-biotin at both +50 mV and -50 mV.
The open probability of the mAb bound state at +50 mV and -50 mV is 0.52±0.04 (n=6)
and 0.40±0.09 (n=6) respectively, in comparison to 0.73±0.04 (n=6) and 0.71±0.01 (n=3)
of the non-binding or unbound state. Thus in the mAb bound state, the pore switched to
a more closed state at both negative and positive potentials (Figure 1.13). In addition,
the decrease in OmpG open probability was more significant in the mAb bound state
when a negative voltage was applied i.e. a 30% open probability decrease at negative
voltage vs a 20% decrease in open probability at positive voltage.
The OmpG-PEG2-biotin pore also showed a decreased current (amplitude) by
1.2±0.4 pA (n=3) at its fully open state at -50 mV. This decrease is ~5.4% of the initial
current of a non binding state in comparison to the 13.6% decrease in current at the
positive potential in the bound state. Moreover it had a partial closure state with 6 pA of
residual current as indicated by the red arrow in the recording trace and all current
histograms (Figure 1.13b). This result shows that the loop gating during the mAb bound
state is still significantly influenced by the polarity of the applied potential. This is a useful
feature that can be used for sensing because the asymmetric response of OmpG to
target protein binding adds one more parameter for specific analyte protein recognition.
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Figure 1.13. Effect of voltage on the mAb binding. (a) Representative single channel
recording trace of OmpG-PEG2-biotin showing reversible binding of mAb at both +50 mV and
-50 mV. We define the positive potential as the potential of the chamber where the loops are
located is positive. The measurement was performed in buffer, 10 mM sodium phosphate,
pH 6.0, 300 mM KCl in the presence of 10 nM mAb. (b) Representative single channel
recording traces of OmpG-PEG2-biotin at the unoccupied or mAb bound states at +50 mV
and -50 mV. All current histogram of the corresponding current recording traces are also
shown. The green and red dashed lines emphasize the shift of the fully open states in current
at unoccupied and mAb bound states respectively. The positive potential caused a larger shift
of the open state current than the negative potential. (c) (d) Voltage independence of 1/τon
and 1/τoff. The measurements were performed in buffers 10 mM sodium phosphate buffer, pH
6.0, 300 mM KCl in the presence of 10 nM mAb at various applied voltages ranging from -50
mV to +50 mV.

Previous studies on nanopore detection have shown that voltage could alter
analyte binding kinetics.28,43,58 Therefore, single channel recording was performed at
applied voltages ranging from -50 mV to +50 mV in the presence of mouse mAbs. The
voltage-dependent gating of OmpG prevented us from testing higher potentials as
OmpG tends to close completely at ±75 mV.46 Neither τon nor τoff exhibited a strong
dependence on voltages (Figures 1.13c, 1.13d, 1.14). Thus, we concluded that the mAb
binding to biotin is not affected at applied potentials ranging from -50mV to +50 mV. The
independence of binding from voltage at this range is advantageous since proteins can
be analyzed regardless of the applied potential.
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Figure 1.14. Analysis of kinetic parameters of mAb binding to OmpG-Peg2-biotin at
various applied voltages. Histograms of the inter-event duration (τon) and dwell time (τoff) of
mAb binding events were fitted with single exponential decay function to derive the average
time constants.
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1.4.5 Simultaneous detection of mouse mAb and goat polyclonal anti-biotin
antibodies
Although the antibody and streptavidin both bound the biotinylated OmpG, they
produced remarkably unique gating patterns. We wondered how sensitive the OmpG
sensor would be to various factors such as a protein’s size, shape, surface charge or
rigidity. In an attempt to distinguish between these, we analyzed the binding of a
polyclonal anti-biotin antibody derived from goat. The polyclonal antibody alone did not
induce a change in ionic current of the unmodified OmpG D224C pore (Figure 1.15),
also no change in gating patterns were seen when antibodies and streptavidin were
added sequentially to unmodified OmpG D224C (Figure 1.16).

Figure 1.15. Representative traces of single channel recording of OmpG D224C in the
presence of polyclonal anti-biotin antibody (pAb). OmpG D224C pores were recorded for
2 hours after the addition of 200 nM pAb at +50 and -50 mV. Buffer 10 mM sodium phosphate
buffer, pH 6.0, 300 mM KCl was used. No detectable change in the gating pattern of the pore
was observed.
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Figure 1.16. A complex mixture of biotin binding proteins elicits no effect on the gating
of OmpGwt. The gating behavior of OmpGwt was recorded after each biotin binding protein
was subsequently added to the chamber in which loop 6 was located. As shown in the figure,
the gating behavior of OmpGwt never changes even after adding several biotin binding
proteins into the same chamber. The behavior was recorded for 1 hour. 10 mM sodium
phosphate buffer, pH 6.0, 300 mM KCl was used.

However to our surprise, the polyclonal antibody produced gating patterns
distinct from the structurally very similar mAb tested earlier (Figures 1.17a, 1.17b).
Furthermore, the polyclonal sample showed clear evidence that at least two readily
distinguished populations of antibody were present (Figures 1.17b, 1.17c).

We

categorized their gating activities into two classes, called type I and type II. During type I
binding (pAb.1) the current decreased by 50% and contained few gating events. During
type II (pAb.2) binding events, the open state conductance was unchanged but the
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gating frequency was slightly reduced (Figures 1.17c, 1.17d). Mouse mAb was then
added to the chamber already containing pAb and the binding was observed (Figure
1.17b). All types of antibodies bound with their respective characteristics regardless of
the presence of the other antibodies. This is the first example of a nanopore than can
distinguish between three antibodies with virtually identical shape in a complex mixture.

Figure 1.17. Detection of mouse mAb and polyclonal Ab binding by OmpG-PEG2-biotin
pore. (a) Schematic model of simultaneous detection of multiple target proteins by OmpG
nanopore. (b) Representative current trace of a single OmpG-biotin. The measurement was
performed in the presence of mouse mAb (1 nM) and goat pAb (72 nM) in 10 mM sodium
phosphate, pH 6.0, 300 mM KCl at applied potential of +50 mV. The mAb and polyAb binding
events were highlighted in colors, i.e. mAb in red, pAb. 1 in green and pAb.2 in blue. (c)
Representative current recording trace of OmpG-PEG2-biotin pore at the unoccupied and mAb
and polyAb bound states. (d) All current histogram of the corresponding current recording
traces.

1.4.6 Power spectrum analysis and fingerprint of analyte protein binding signal
Nanopore sensing often relies on blockade amplitude and/or the mean duration
time of binding to discriminating target molecules. For the OmpG nanopore, the binding
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of analyte not necessarily induced a current blockage. Instead, alteration of the
gating/noise of OmpG was indicative of the interaction. To compare the streptavidin
binding with other biotin-binding proteins under the same condition, streptavidin
experiments were re-performed in 10 mM sodium phosphate, pH 6.0, 300 mM KCl
(Figure 1.18). Electrical traces under this condition were used to derive the power
spectra and the fingerprint characteristics.

Figure 1.18. Detection of streptavidin by OmpG-PEG2-biotin pore. (a) Schematic model
showing the OmpG-PEG2-biotin. (b) Representative single channel recording traces of the
OmpG pores before and after the addition of the streptavidin (3 nM). The measurements
were performed in buffer 10 mM sodium phosphate buffer, pH 6.0, 300 mM KCl at +50 mV.
(c) All current histogram of the corresponding traces in (b). (d) 2D histogram of the gating
events of the bound and unbound state.

Noise spectral density analysis of all OmpG constructs alone were obtained and
showed very small changes in noise (Figure 1.19a). Noise spectral density analysis of
each biotin-binding protein in the bound state revealed that mAb showed a higher noise
than the unbound state. pAb.1 exhibited the lowest noise while the level of streptavidin
and pAb.2 was between that of pAb.1 and the unbound state (Figure 1.19b).
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Figure 1.19. Comparison of the gating patterns of OmpG-PEG2-biotin at analyte binding
states. (a) Power spectra of the OmpG constructs. (b) Power spectra of protein-binding
states for four biotin-binding proteins with OmpG-PEG2-biotin. Electrical recording traces were
obtained in 10 mM sodium phosphate buffer, pH 6.0, 300 mM KCl at +50 mV.

Figure 1.20. Gating events fingerprint analysis. The current recording traces were analyzed
by Clampfit 10.3 using single channel search to identify gating events which were defined as
current blockages larger than 2pA (4% of fully open pore current). The open probability was
calculated as the time the pore stays in the open state divided by the recording time. The
gating frequency was calculated as the number gating events divided by the recording time.
The average inter-event duration (τon) and event duration (τoff) were obtained by fitting the
histogram of these duration values with single exponential function the same as in Figure 1.6
and 1.12. The open pore current is indicated with a blue dashed line.
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However, spectral noise analysis alone is insufficient for analyte identification.

For

example, the mAb-bound state was similar to the unbound state and the open pore
current cannot be seen by noise analysis. To thoroughly analyze the characteristics of
the traces at the analyte binding state, we analyze five parameters: (i) open probability,
(ii) gating events frequency, (iii) inter gating event duration, (iv) duration of gating events
and (v) the open state conductance to identify the protein by a specific fingerprint
characteristic (Figure 1.20). We quantified the gating characteristics for each biotinbinding protein and summarized the results into Table 1. We then generated a fingerprint
graph for each analyte based on the results in Table 1 (Figure 1.21) and found that the
OmpG-biotin sensor can unambiguously detect and discriminate between the four biotinbinding proteins that we tested, including three antibody species (two pAb and one mAb)
that share highly homologous structures.

Table 1.1. Fingerprint of each type of gating events using the OmpG-PEG2-biotin pore

Open
probability

Event

Inter-event

Gating

frequency

duration

duration

(s-1)

(ms)

(ms)

Relative
conductance
of open state
(%)

No binding

0.73±0.04*

97±3.6

8.68±2.14

2.93±0.52

100

Streptavidin

0.95±0.08

45±7

22.75±3.2

0.62±0.19

100±4.2

mAb

0.52±0.04

201±103

3.67±1.57

4.20±1.90

86.4±1.3

pAb.1

0.99±0.01

7±1

n/a

n/a

52.3±4.7

pAb.2

0.94±0.02

57.5±2

12.2±1.3

1.09±0.21

106.5±6.5

*Values were calculated from at least three independent experiments. The errors
indicate the standard deviation.
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Figure 1.21. Fingerprints of the four biotin binding proteins. The gating events of different
analyte protein binding states were characterized by five parameters, i.e. open probability,
gating frequency, inter-event duration, event duration and the conductance of the open pore
state. Changes of these parameters relative to the no binding state generate the fingerprint
unique for each protein.

1.5 Discussion
Since proteins of the same size and shape produce unique signals, we
hypothesize that the OmpG sensor recognizes unique targets based on other factors
such as charge, hydrophobicity or perhaps post-translational modification of the surface.
The structure of OmpG, along with the data presented here, sheds some light on the
possible mechanism of protein detection via the nanopore strategy. Although the four
biotin-binding proteins trigger a characteristic gating pattern upon binding to the OmpG
nanopore, they can be categorized into two groups. In pAb.2 and streptavidin cause a
decreased gating frequency, which suggests binding to the PEG2 tethered biotin
hindered the dynamics of the loop 6. According to the crystal structure, the D224 residue
traverses approximately 7.5 Å between the open and closed states.47 However, a recent
NMR study of OmpG shows this residue may migrate as far as 30 Å between the fully
open and closed conformers.49,59 Our results suggest that such a large conformational
change is strongly hindered by streptavidin binding and moderately by pAb.2 binding.
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The results also suggest minimal interaction between the streptavidin and pAb.2 with the
loops at the opening of OmpG.

In another category, mAb and pAb.1 both caused a

decrease of current in the fully open state. This observation suggests that the two
antibodies obstruct the current flow at the entrance, presumably by partially docking to
the extracellular loops of OmpG. Because all seven loops at OmpG’s entrance are net
negatively charged, the two antibodies are likely positively charged or have a positively
charged patch near the biotin-binding site that mediate this interaction. This speculation
is supported by the observation of mAb’s asymmetrical behavior under an applied
potential. Namely, a positive potential might push the mAb closer towards the OmpG
pore to cause 13.6% partial block of the current (Figure 1.13). In contrast, at negative
potential, the electric field would repel mAb away from the pore entrance. Indeed, we
observed that the open pore conductance was less affected, only ~5.4% blockage seen.
These results suggest that not only the ligand-tethered loop, but all the loops on the
extracellular entrance may be involved in sampling the target proteins, which explains its
ability to discriminate between highly structurally homologous proteins.

Our data

suggests a novel mechanism underlying OmpG nanopore sensing that contains two
steps (Figure 1.22). First, OmpG captures the target protein via its tethered high-affinity
ligand. Consequently, the bound protein interferes with the movement of loop 6
generating its characteristic gating pattern. Second, the extracellular loops of OmpG
may sample the target protein via unspecific interactions which further alters the ionic
current providing additional readout. While further study is required to delve deeper into
the precise mechanism of protein detection, our sensor’s ability to discriminate between
structurally homologous antibodies within a multi-component mixture represents a
powerful advance over previous approaches.
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Figure 1.22. Schematic model illustrating the interactions between OmpG nanopore and
analyte protein. The proposed principle of OmpG nanopore sampling and detection of a
protein analyte via interactions with the OmpG loops.

Previously,

the

detection

of

streptavidin

and

anti-biotin

antibody

was

demonstrated using αHL that contained a PEG biotin group tethered to its vestibule.30 In
the absence of the target, the PEG polymer traversed through the constriction site from
the cis and trans chamber and back through the pore. This movement was manifest as
rapid gating. Analyte protein binding of the biotin group eliminated the gating and
provided the readout signal for protein sensing. In contrast to our OmpG nanopore, αHLbiotin sensor did not differentiate binding events derived from streptavidin and mAb
which differ greatly in size, shape and surface properties. Two features of OmpG may
contribute to its higher resolution compared to αHL (Figure 1.23). The first is the location
of the constriction site which is the narrowest part of the pore that determines the
conductance. The constriction site of OmpG-PEG2-biotin is located at the entrance to the
pore next to the ligand interaction site while the location of the constriction site of αHL is
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in the middle making it inaccessible for large folded analyte protein. Because of this,
analyte protein binding at the pore entrance directly affected the conductance of OmpG
but not αHL.

Secondly OmpG has flexible loops at the binding site which allows

conformational changes to occur in response to analyte protein binding. Instead, αHL
possesses a rather stable and rigid structure at the two ends.60 Although the biotinbinding proteins might also interact with the two entrances of αHL nanopore, the rigidity
of the αHL structure does not allow large conformational changes to occur, so the
interaction of different target proteins with the entrance did not induce noticeable
changes in the current flow that passed through the constriction site.

Figure 1.23. Structures of αHL and OmpG. The side view shows a cross-section of both
proteins to reveal the constriction site. For αHL, the constriction site is located in the middle of
the pore. In contrast, the narrowest site of the pore is located at the top entrance of OmpG. The
top view structures show that αHL has β-strands packing into a highly ordered structure at its
entrance while OmpG contains seven flexible loops.

Our study points out an alternative design in the architecture of nanopore
sensors. By creating a nanopore with a dynamic structure that changes upon analyte
binding, new regions of data may be interpreted that give a greater sensitivity and
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selectivity for detecting protein analytes. We have shown that even protein isoforms in a
mixture can be clearly distinguished using this new sensing scheme. These features are
not available in other nanopore sensing strategies, making the OmpG sensor particularly
useful. Further, monomeric proteins such as OmpG are ready to use after refolding and
require no further assembly and purification steps compared to other oligomeric
nanopores.

1.6 Conclusion
We have shown that binding of target protein to an OmpG-biotin nanopore can
be deduced from changes in the gating activity of OmpG. The principle of the OmpG
nanopore relies on detecting the modulation of loop dynamics upon target protein
binding rather than the occupation in the pore lumen. More importantly, the OmpG
nanopore exhibited the ability to resolve protein homologues that share the same highaffinity ligand, making this sensing approach well suitable for screening for homologous
disease markers in complex mixtures. In the future, this principle may be extended to a
broader spectrum of analytes, such as proteins, viruses, or bacteria without the need to
use a far larger nanopore.
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CHAPTER 2
ELECTROSTATIC INTERACTIONS BETWEEN OMPG NANOPORE AND
ANALYTE PROTEIN SURFACE CAN DISTINGUISH BETWEEN
GLYCOSYLATED ISOFORMS
Reprinted (adapted) with permission from M. A. Fahie and M. Chen, “Electrostatic
Interactions between OmpG Nanopore and Analyte Protein Surface Can Distinguish
between Glycosylated Isoforms,” J. Phys. Chem. B, vol. 119, no. 32, pp. 10198–10206,
2015. Copyright 2015 American Chemical Society.
2.1 Summary
The flexible loops decorating the extracellular entrance of the OmpG nanopore
especially the longest loop, L6, move dynamically and rapidly during ionic current
recording. The current fluctuations or gating caused by these flexible loops are usually
altered when a specific target protein is bound. We previously attached a ligand onto L6
and observe changes in OmpG gating when target proteins are bound. The gating is
characterized by parameters including frequency, duration and open-pore current and
these features combine to reveal the identity of a specific analyte protein. Each analyte
protein generates a specific gating fingerprint. Here, we show that OmpG nanopore
equipped with a biotin ligand can distinguish glycosylated and deglycosylated isoforms
of avidin by their differences in surface charge. Our studies demonstrate that the direct
interaction between the nanopore and analyte surface, induced by the electrostatic
attraction between the two molecules, are essential for protein isoform detection. Our
technique is remarkably sensitive to the analyte surface, which may provide a useful tool
for glycoprotein profiling.
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2.2 Introduction
Conventional nanopore sensing is based on the modulation of ionic current
flowing through a nano-scale pore as an analyte translocates through the opening.1,2
Nanopores come in two main flavors: biological and synthetic. Protein nanopores, which
make up the largest class of biological nanopores, are usually derived from pore-forming
proteins with well-defined structures at atomic precision. Solid-state nanopores that are
fabricated from synthetic material, have the advantage of being robust and easily
integrated into microelectronics. Although the technique has been extensively explored
for the detection of nucleic acids and single-molecule DNA sequencing,3–5 nanopores
are also particularly useful for detecting protein molecules.6,7 Nanopore-based detection
of protein analytes has used various strategies, including: i) translocation of native
analytes through unmodified8 and modified pores;9,10 ii) binding of native proteins to
nanopores either directly or via tethered high-affinity binding sites such as aptamers,11–13
ligands14,15 and peptide binding sequences16 and iii) binding of proteins to an auxiliary
polymer in solution which alters the translocation of polymers through nanopore.17–19 As
a single molecule analytical tool, nanopores have been used to investigate the
biochemical and biophysical properties of proteins, e.g. folding20 and unfolding,21–23
protein aggregation,24 ubiquitin linkage type,25 and enzymatic activity.17,26 Recently, the
unfolding and threading of a protein through a nanopore by an unfoldase demonstrated
the unidirectional and processive translocation of a linearized peptide strand which
opens the possibility for nanopore-based protein sequencing.27,28 Another study used a
nanopore to identify phosphorylation sites by threading.29
Despite these advances, it remains a challenge to detect a single protein in a
complex analyte mixture. Bell et al. have recently addressed this problem by introducing
DNA carriers containing precisely positioned protein binding sites along a double
stranded DNA.18 Binding of target proteins to the DNA carrier altered the current
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signature when it translocated through a glass solid-state nanopore. Using this
approach, they demonstrated that a single protein species can be identified in a protein
mixture. Recently, we have explored an alternate nanopore sensing scheme based on
outer membrane protein G (OmpG).30 OmpG from Escherichia coli (E. coli) is a β-barrel
protein with 14 strands connected by seven short turns on the periplasmic side and
seven long loops on the extracellular side (Figure 2.1a).31–33 Loop 6 moves dynamically,
switching the protein between open and closed conformations resulting in gating signal
in the current recording (Figure 2.1b).34–36 Previously we showed that the flexible
architecture of the OmpG nanopore can be used to resolve between structurally
homologous protein analytes in mixtures.30 Specifically, upon binding to a biotin group
tethered to loop 6, a mixture of anti-biotin antibodies raised from different host species
was clearly distinguished. Each antibody species was identified by its unique gating
fingerprint and no interference from the other antibodies was observed. So far, no other
nanopore has shown the ability to differentiate among a mixture of proteins that bind to
the same high affinity ligand and share similar structural organization. The principle
behind such high selectivity in OmpG is intriguing. It was previously speculated that the
antibodies not only bind the biotin ligand but also non-specifically interact with the OmpG
loops.30 The latter plays an essential role in distinguishing among similar analytes.
Here, we probe the nature of non-specific interactions between OmpG and target
proteins. To do so, we interrogate the interaction between the loops of OmpG and three
homologous biotin binding proteins, streptavidin, avidin and extravidin. Our results reveal
that electrostatic forces may be the dominating inter-molecular interaction between the
OmpG nanopore and the target protein. Such interactions between the positively
charged target protein surface and the negatively charged loops of the OmpG sensor
are essential for decimating among protein homologous and isoforms.

58

2.3 Materials and Methods
Reagents were purchased from Fisher Scientific and Boston Bioproducts unless
otherwise stated. The biotin-peg-maleimide reagent, EZ-Link Maleimide-PEG2-Biotin
(Cat# 21902BID), was purchased from Piercenet (Thermo Scientific). Streptavidin (Cat#
Z7041) was purchased from Promega.
E2511) were purchased from Sigma.

Avidin (Cat# A9275) and extravidin (Cat#

Diphytanoylphosphatidylcholine (DPhPC, Cat#

850356P) were from Avanti polar lipids. Octyl-glucoside (OG, Cat# O-110-5) and tris(2carboxyethyl)phosphine

(TCEP,

Cat#

TCEP5)

were

purchased

from

GoldBio

Technology. Disposable capillary cells (DTS1070) for zeta potential measurement were
purchased from Malvern Instruments. Anion exchange columns Hi-Trap QFF (Cat#175156-01) and desalting columns (Cat#17-1408-01) were purchased from GE Healthcare.
Protein ladder (P7702S) was purchased from New England Biolabs (NEB).

2.3.1 Zeta potential Measurement
Proteins (previously dissolved in deionized water at at least 1 mg/ml) were
diluted to a final concentration of 0.1 mg/ml in 5 mM buffered solution. Sodium acetate,
sodium phosphate and N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffers were
used to obtain the zeta potential values of the proteins at pH 4, 6 and 10 respectively.
Protein solutions were passed through a 0.22 µm filter to remove any insoluble
precipitates prior to analysis with Zetasizer Nano instrument (Malvern Instruments).
Three replicates were measured and then averaged. The error values show the standard
deviation of the three measurements.

2.3.2 Purification of OmpGD224C
OmpGD224C was constructed as previously described.30 OmpGD224C plasmid
was expressed in BL21 (pLys) E. coli chemically competent cells and allowed to grow to
an optical density (OD600) of 0.5-0.6 at 37°C in LB-ampicillin media. The culture was
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then induced with 0.5 mM IPTG for 3 hrs at 37°C. After induction, the culture was
harvested. The harvested pellet was lysed in buffer containing 50 mM Tris-HCl pH 8.0,
1 mM EDTA, 2 mM TCEP, 200 µg/ml lysozyme at ~23°C for 15 mins and then sonicated
on ice for 8 mins. The lysate was centrifuged 15 mins at 13,000 rpm, 4°C and the
supernatant was discarded. The inclusion body pellet was resuspended in wash buffer
containing 1.5 M Urea, 50 mM Tris-HCl pH 8.0, 2 mM TCEP for 10 mins at ~23°C.
Thereafter the pellet was obtained after centrifugation at 13,000 rpm for 15 mins. The
inclusion body was then solubilized in binding buffer (8.0 M Urea, 50 mM Tris-HCl pH
8.0, 2 mM TCEP) with constant stirring for 15 mins at ~23°C. This solubilized inclusion
body was then centrifuged for 15 mins at 13,000 rpm. The supernatant was passed
through a 0.45 µm filter before FPLC purification.

OmpG was purified using anion

exchange with binding and elution buffer (8.0 M Urea, 50 mM Tris-HCl pH 8.0, 2 mM
TCEP, 500 mM NaCl).

2.3.3 Labeling and refolding of OmpG-biotin proteins
OmpG proteins were desalted in buffer 50 mM HEPES pH 7.0, 200 mM NaCl,
8.0 M Urea to remove the TCEP and Tris-HCl buffer. The protein concentration of
OmpG D224C was estimated by Bradford assay and then incubated with maleimidePEG2-biotin in a molar ratio 1:10 (protein to biotin) at room temperature (~23°C) for 1.5-2
hours with constant shaking. The reaction mixture was passed through the desalting
column once again to remove the unconjugated biotin. The biotin labeled OmpG was
then diluted with refolding buffer 50 mM Tris-HCl, pH 9.0, 3.25% OG in 2:3 volume ratio
(OmpG to refolding buffer). Samples were then incubated at 37°C for 3 days. The
biotinylation and refolding efficiency was determined by gel shift assay with and without
streptavidin and visualized by SDS-PAGE.
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2.4 Results

2.4.1 Discrimination among Avidin Homologues
The OmpG-PEG2-biotin nanopore was constructed as previously described
(Figure 2.1).30 First, we investigated the ability of OmpG nanopore to detect the three
biotin-binding protein homologues. Streptavidin from Streptomyces avidinii and avidin
from egg white share ~45% sequence similarity. They have very similar structures,
molecular weights and both exhibit high affinity (dissociation constant ~ 10-15 M) for the
biotin ligand.37 Avidin has a basic isoelectric point (pI~10.5) due to its N-linked glycan
composed largely of mannose and N-acetylglucosamine.38 Streptavidin is a nonglycosylated protein with a pI of ~6.3. Extravidin is a commercially available
deglycosylated form of avidin with a pI ~6.4, similar to that of streptavidin.

Figure 2.1. Schematic diagram of the OmpG nanopore sensor. (a) OmpG-PEG2-biotin
pore. A biotin was tethered to a cysteine residue located on loop 6 (highlighted in blue) via a
polyethylene glycol linker that could extend the biotin away from the nanopore by 30 Å. (b) A
representative current trace of OmpG-PEG2-biotin nanopore. Buffer used was 10 mM sodium
phosphate, pH 6.0, 300 mM KCl.

As a negative control and specificity test, all three biotin binding avidin proteins
(unless otherwise stated) were added to unlabeled OmpGwt. Neither of the proteins
produced any noticeable change in the wild type OmpG gating behavior indicating that
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any change in gating signal seen when the OmpG-biotin sensor is used is specific
binding of the analyte proteins used (Figure 2.2).

Figure 2.2. Single channel current traces of OmpGwt in the presence of streptavidin
homologues at various buffer conditions. OmpGwt in the absence (a) and presence (b) of
streptavidin homologues in 10mM sodium phosphate, pH 6.0, 300mM KCl buffer. Streptavidin
homologues do not affect OmpGwt gating behavior in 10 mM sodium acetate pH 4.0 1.0 M
KCl buffer (c, d) 10 mM CAPS pH 10.0, 300 mM KCl (e, f) nor 10 mM CAPS pH 10.0, 4.0 M
KCl (g, h) buffers.

As observed previously,23 streptavidin binding to OmpG-PEG2-biotin resulted in
an irreversible decrease in OmpG’s gating frequency (Figure 2.3a). By contrast, when
avidin was bound to OmpG-PEG2-biotin the gating frequency increased from 160±24 s-1
to 227±26 s-1 (Table 2.1). More importantly, avidin binding resulted in a permanent
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decrease in the open pore current from 25.8±2.7 pA to 13.8±1.1 pA (n=3) (Figure 2.3b).
When extravidin was tested its addition resulted in three different effects in OmpG
gating. These three populations were categorized by their effect on OmpG open pore
current specifically. The majority (10 of 19 trials) of extravidin binding events caused a
gating behavior that was similar to that of streptavidin (Figure 2.3a, 2.3c): the gating
frequency decreased from 160±24 s-1 to 30±9 s-1 and unlike avidin, the open-pore current
was not affected. We refer to this population of extravidin as E1.

Figure 2.3. Detection of biotin binding protein homologues by OmpG-PEG2-biotin
nanopore. (a, b, c) Typical current recording traces of streptavidin (a), avidin (b) and extravidin
(c) bound to OmpG-PEG2-biotin at +50 mV in 10 mM sodium phosphate, pH 6.0, 300mM KCl
buffer. Red and green dashed line indicates the open pore current before and after analyte
protein binding. The relative open pore current of analyte bound state to unbound state is
indicated above the dashed line.

Two minor populations, termed extravidin 2 – E2 (6 of 19 trials) and extravidin 3
– E3 (3 of 19 trials), caused a differential decrease in the open pore current with E3
showing an effect similar to that of avidin while E2 showed an effect intermediate
between E1 and E3 (Figure 2.4). The E2 population induced a slightly decreased open
pore current but reduced OmpG gating in a fashion similar to that of streptavidin (Figure
2.4a). We surmise that the extravidin gating population data may reflect sub-populations
in the protein sample that have different levels of deglycosylation. The E3 population for
example seems similar to fully intact, fully glycosylated avidin (Figure 2.3b, 2.4b). E1
was most similar to streptavidin and could therefore be fully deglycosylated while E2
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may represent several partially deglycosylated forms. Because of the variability of
extravidin’s gating patterns, we focused mainly on data that represent the E1
characteristics for the following experiments.

Figure 2.4. Detection of extravidin subpopulations by OmpG nanopore. (a) OmpGPEG2-biotin in the absence and presence of extravidin 2 (E2) analyte, where the open pore
current reduces to 85%. (b) OmpG-PEG2-biotin bound to extravidin 3 (E3) variant, where the
open pore current reduces to 66%. All pores were recorded in buffer containing 10mM
sodium phosphate pH 6.0, 300mM KCl at +50mV.

Noise spectral density analyses showed that streptavidin (red) and extravidin E1
(orange) had similar spectra which was lower in noise than the unbound pore (black),
while avidin binding (blue) induced an even lower noise amplitude which was most likely
due to its significantly reduced open pore current compared to the unbound pore (Figure
2.5a).
We then generated a fingerprint profile for each analyte using five parameters of
OmpG gating. The relative change of these parameters after analyte binding compared
to the unbound state determined the fingerprint of the protein. Clearly, avidin showed a
distinct fingerprint in comparison to streptavidin and extravidin E1 (Figure 2.5b). The five
parameters of OmpG gating included: open probability, gating frequency, inter-event
duration, event duration and open pore current (Figure 2.5c, Table 2.1).23

To our

knowledge, this is the first report that demonstrates the discrimination of glycosylated
protein isoforms using protein nanopores.
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Figure 2.5. Spectral and fingerprint analysis of OmpG nanopore bound to the
streptavidin homologues. (a) Power spectra and (b) fingerprint analysis of before and after
target bound to OmpG-PEG2-biotin. (c) Single channel recording of a representative trace of
the gating behavior of OmpG-PEG2-biotin in buffer 10mM sodium phosphate pH 6.0, 300mM
KCl. Three parameters of OmpG gating behavior are highlighted: event duration (red), interevent duration (green) and open pore conductance. The gating event frequency is defined as
the number of events per second. The open probability is the duration of the pore in the open
state over unit time. The fingerprints obtained for OmpG in the unbound and bound states (5b)
are derived from these five parameters.

Table 2.1. Gating characteristics for streptavidin, avidin and extravidin.

No binding

0.83±0.08

Gating
frequency
(s-1)
106±24

Streptavidin

0.95±0.03

56±6

27.6±7.8

0.32±0.01

23.6±3.5

Avidin

0.89±0.08

227±26

7.5±2.1

0.46±0.09

14.6±1.7

Extravidin

0.95±0.03

30±9

29.1±0.4

0.29±0.06

21.7±5.7

Open
probability

Inter-event
duration
(ms)
8.5±2.1

Event
duration
(ms)
0.83±0.18

Open pore
conductance
(pA)
24.8±4.4

Values were calculated from at least three independent experiments that were carried out in
buffer 10mM sodium phosphate pH 6.0, 300 mM KCl at +50 mV. The errors indicate the standard
deviation.
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Because avidin has an identical amino acid sequence to extravidin and is
homologous to streptavidin with a 41% sequence similarity, their key difference lies in
the glycosylated vs non-glycosylated states which directly affects their unique surface
charges.

At pH 6.0, the zeta potential of avidin is 7.8±0.9 mV making it positively

charged while streptavidin and extravidin are negatively charged with a zeta potential
value of -7.0±0.5 mV and -8.0±1.9 mV respectively (Table 2.2).

Table 2.2. Zeta potential measurements of analyte proteins under various pH conditions
pH
4.0
6.0
10.0

Zeta potential value (mV)
Streptavidin
Avidin
Extravidin
2.5±0.8
7.8±1.5
1.0±0.5
-7.0±0.5
7.8±0.9
-8.0±1.9
-18.3±5.0
-0.2±0.4
-13.3±3.0

Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.

Our experiments suggest that a positive charge on the avidin surface may be the
key factor that caused the open-pore current to significantly reduce by ~40% when
avidin was bound to OmpG. The seven extracellular loops on OmpG consist of many
charged residues including 17 aspartic acid residues (ASP), 8 glutamic residues (GLU)
and 5 arginines (ARG) and 4 lysines (LYS). This concentration of charged amino acid
residues in an approximate 0.8 nm region of the pore creates a surface rich in negative
charge (Figure 2.6). We hypothesize that the negative charges on OmpG pull strongly
on a positively charged region of avidin after specific binding to the biotin ligand tethered
to loop 6. Thus, the avidin might closely interact with the surface of the pore through
electrostatic attractions, partially occluding ionic flow and therefore causing a reduction
in open pore current.

In addition, the close proximity of avidin might confine the

oscillations of loop 6 to a smaller space. This restricted movement might explain why
avidin binding causes an increase in gating frequency of the OmpG nanopore.
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Figure 2.6. Electrostatic potential map of the extracellular loops (L1-L7) of OmpG. (a)
Top view and (b) side view of the loop environment. PDB file 2IWW was used.

2.4.2 Influence of Ionic Strength on Binding
If the reduction of open pore current is dependent on electrostatic interactions of
the bound avidin with OmpG, then we expect this dependence to be reduced under
charge screening conditions.

Therefore, we investigated avidin binding at various

concentrations of salt KCl ranging from 0.3 M to 4.0 M. We also tested 0.15 M KCl,
however we could only detect changes in the open pore current before and after avidin
bound to the OmpG nanopore (Tables 3.3 & 3.4). After avidin bound to OmpG in 0.15 M
KCl solution, the current was too small ~8 pA to accurately assign events and interevents.
Evidently, with higher salt concentration, the open pore current of the unbound
OmpG pore also increased proportionally, however, we found that the gating pattern of
OmpG-PEG2-biotin after avidin binding was indeed influenced by the concentration of
salt. Specifically, as the salt concentration increased, avidin binding induced a less
significant reduction in the open pore current (Figure 2.7).

The relative open pore

current (of the avidin bound state) increased from 0.6±0.07 to 0.98±0.18 with increasing
salt concentration (Figure 2.7a-e). Thus at high salt concentrations i.e. > 1.0 M KCl the
open pore current after avidin binding was similar to that of the unbound state. At 4.0 M
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KCl, there was no difference in the open pore current between the avidin bound and
unbound states (Figure 2.7e, 2.7f).

Thus, our data suggests that electrostatic

interactions between avidin and OmpG govern the bound-state open pore conductance
because these interactions can be screened with excess salt.

Figure 2.7. Effect of ionic strength on the gating characteristic of OmpG nanopore
induced by avidin binding. (a-e) Typical current recording traces of OmpG-PEG2-biotin
before and after avidin binding in buffers containing various KCl concentrations. Relative
change in open pore current of OmpG at avidin bound state (green line) to unbound state (red
line) is indicated in the histogram. Experiments were performed at +50 mV in 10 mM sodium
phosphate at pH 6.0 containing KCl, the concentration of which is indicated in figures. (f)
Fingerprint of avidin binding at various KCl concentration.

Clearly, other gating characteriscs of OmpG were also influenced by the salt
concentration, for example the open probability generally increased with increased salt
except at 4.0 M KCl where it decreased, while the gating frequency decreased from 0.15
M to 0.6 M and then plateaued (Figure 2.8, Tables 2.3 & 2.4). However, as opposed to
the open pore current, the relative changes in these parameters after avidin binding did
not show a strong correlation with increasing ionic strength (Figure 2.8, Tables 2.3 &
2.4).

68

Figure 2.8. The effect of avidin binding on the five gating characteristics of OmpGPEG2-biotin in various salt concentrations. The effect of salt concentration on OmpG
gating characteristics in the unbound (grey) and avidin bound (blue) states (a, c, e, g, i). The
relative change in open probability (b), gating frequency (d), inter-event duration (f), event
duration (h) and pore conductance (j) in the avidin bound state over several KCl
concentrations. Values were calculated from at least three independent experiments. The
errors indicate the standard deviation.
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Table 2.3. Gating characteristics of avidin at various salt concentrations at pH 6.0, +50
mV
Salt
Gating
Inter-event Event
Open
Open
concentration
frequency
duration
duration
conductance
probability
(M)
(s-1)
(ms)
(ms)
(pA)
No bind 0.84±0.06
125±11
5.2±1.5
0.52±0.08
16.3±1.0
0.15
Avidin
N/D
N/D
N/D
N/D
8.0±1.0
No bind 0.83±0.08
106±24
8.5±2.1
0.83±0.18
24.8±4.4
0.30
Avidin
0.89±0.08
227±26
7.5±2.1
0.46±0.09
14.6±1.7
No bind 0.90±0.07
51±6
14.0±4.9
0.48±0.02
44.6±1.6
0.60
Avidin
0.95±0.02
68±3
9.9±0.5
0.29±0.003 34.8±1.0
No bind 0.93±0.01
58±14
15.1±2.4
0.61±0.01
68.2±1.4
1.00
Avidin
0.92±0.03
95±26
8.3±1.8
0.36±0.05
59.8±1.3
No bind 0.92±0.05
51±7
11.7±3.1
1.52±0.18
111.8±2.4
2.00
Avidin
0.91±0.03
89±2
10.7±2.1
0.50±0.10
104.7±3.2
No bind 0.71±0.12
51±11
10.1±3.0
4.40±1.30
174.2±23.3
4.00
Avidin
0.74±0.11
68±13
10.5±2.9
1.40±0.40
171.3±20.8
Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.

Table 2.4. Fingerprint characteristics of avidin at various salt concentrations at pH 6.0,
+50 mV
Salt
Relative
Relative
Relative
Relative
Relative open
concentration
open
gating
inter-event event
conductance
(M)
probability
frequency
duration
duration
No bind N/D
N/D
N/D
N/D
1.00±0.06
0.15
Avidin
N/D
N/D
N/D
N/D
0.49±0.14
No bind 1.00±0.09
1.00±0.23
1.00±0.25
1.00±0.22 1.00±0.18
0.30
Avidin
1.07±0.11
2.14±0.13
0.88±0.22
0.54±0.03 0.60±0.07
No bind 1.00±0.07
1.00±0.11
1.00±0.35
1.00±0.05 1.00±0.04
0.60
Avidin
1.05±0.10
1.33±0.20
0.71±0.22
0.60±0.15 0.78±0.05
No bind 1.00±0.01
1.00±0.24
1.00±0.16
1.00±0.01 1.00±0.02
1.00
Avidin
0.99±0.02
1.64±0.26
0.55±0.16
0.59±0.07 0.88±0.03
No bind 1.00±0.05
1.00±0.14
1.00±0.26
1.00±0.12 1.00±0.02
2.00
Avidin
0.99±0.03
1.74±0.14
0.91±0.16
0.33±0.09 0.94±0.04
No bind 1.00±0.17
1.00±0.22
1.00±0.30
1.00±0.30 1.00±0.13
4.00
Avidin
1.04±0.10
1.33±0.29
1.04±0.24
0.32±0.01 0.98±0.18
Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.

2.4.3 Effect of pH on Binding
To further support the idea that electrostatic interactions influence the binding of
the avidin homologues, we investigated the effect of pH on the gating signal after the
analytes bound. Specifically, by protonating or deprotonating the loop residues at the
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pore-protein interface, we expect the loop dynamics to change in response to the gain or
loss of charges. First, the binding effect of the three analytes to OmpG nanopore was
recorded at pH 4.0. For these experiments, we used 1.0 M KCl because the open pore
current of OmpG in buffer pH 4.0, 300 mM KCl was on average 8 pA or less which was
too small to allow for precise analysis of the gating parameters (Figure 2.9).

Figure 2.9. OmpG generates small, closed pores in low salt, low pH buffer.
Representative trace of an OmpG-D224C pore in 10mM sodium acetate pH 4.0, 300 mM KCl
and recorded at +50 mV.

Indeed the gating characteristic of the OmpG nanopore was significantly altered
at low pH (Figure 2.10) compared to its gating behavior at pH 6. The open probability
significantly reduced from 0.93±0.01 at 1.0 M pH 6 to 0.34±0.07 at 1.0 M pH 4. Thus,
protonation of the OmpG negatively charged residues on the OmpG loops shifted the
gating equilibria from a mainly open pore to a mainly closed pore. However, we were
able to detect binding of the three avidin homologues.
At pH 4.0, avidin is strongly positively charged while streptaviin and extravidin
have a slight net positive charge on their surfaces as indicated by zeta-potential
measurements (Table 2.2). When bound to OmpG all proteins shared similar gating
features (Figure 2.10a-c): (i) a decreased open-pore current albeit to a different level and
(ii) a significantly reduced open probability due to elongated closure events (Figure
2.10e, Tables 2.5 & 2.6).
As a control, we verified that none of the protein analytes bind to the wild type
nanopore under any pH condition (Figure 2.2). At low pH, streptavidin and extravidin
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acquire positive charge and, like avidin at pH 6.0, are able to reduce the open pore
current when bound (Figure 2.10). As a result, the fingerprints of these three proteins
are almost the same, suggesting that the OmpG nanopore is not able to distinguish
among these protein analytes under acidic conditions (Figure 2.10d, 2.10e).

Figure 2.10. Effect of acidic pH on the gating signal of analyte proteins. (a, b, c) Typical
current recording traces and corresponding histograms of OmpG-PEG2-biotin nanopore before
and after binding of streptavidin (a) avidin (b) and extravidin (c). Relative open pore current of
OmpG at avidin bound state (green line) to unbound state (red line) is indicated in the
histogram. Experiments were performed in 10mM sodium acetate pH 4.0, 1.0 M KCl at +50
mV. (d) Power spectra and fingerprint analysis (e) of before and after target bound to OmpGPEG2-biotin.

Table 2.5. Effect of pH 4 on gating characteristics for streptavidin, avidin and extravidin
at 1.0 M KCl pH 4.0, +50mV
Gating
Event
Open
Inter-event
Open
frequency
duration
conductance
duration (ms)
probability
(s-1)
(ms)
(pA)
No binding

0.34±0.07

189±28

1.44±0.39

3.1±0.8

47.0±1.3

Streptavidin

0.21±0.05

206±39

0.98±0.19

4.5±0.2

37.5±1.0

Avidin

0.25±0.07

211±56

0.64±0.05

3.8±0.8

39.3±1.8

Extravidin

0.25±0.08

209±52

0.69±0.09

3.5±0.5

35.8±1.8

Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.
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Table 2.6. Effect of pH 4 on fingerprint characteristics for streptavidin, avidin and
extravidin at 1.0 M KCl pH 4.0, +50 mV
Relative
Relative
Relative
Relative
Relative
open
gating
inter-event
event
open pore
probability
frequency
duration
duration
conductance
No binding

1.00±0.21

1.00±0.15

1.00±0.27

1.00±0.27

1.00±0.03

Streptavidin

0.62±0.14

1.1±0.25

0.68±0.23

1.45±0.36

0.80±0.03

Avidin

0.67±0.18

1.12±0.23

0.47±0.13

1.23±0.04

0.84±0.05

Extravidin

0.67±0.01

1.11±0.14

0.48±0.08

1.13±0.29

0.77±0.07

Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.

After observing that all three avidin homologues could not be distinguished by
OmpG at acidic conditions, we then tested OmpG’s discrimination ability under basic
conditions. The OmpG nanopore is mainly in an open state at pH conditions above 5.0
and so we used the original lower salt concentration of 0.3 M KCl. At pH 10.0, OmpGPEG2-biotin pore fluctuates between a fully open (31.5±3.4 pA, O1), a partially open
(23.8 pA±3.6, O2) state and gating (closed) states (Figure 2.11a-c). We define the open
probability as the probability of the pore staying at either fully open or partially open
state.
Power spectral analysis of OmpG-PEG2-biotin pore does not show a significant
change in the noise of the unbound and analyte bound states (Figure 2.11d) at pH 10.
However, streptavidin and extravidin binding slightly increased the open probability due
to a 50% reduction in gating frequency and event duration (Figure 2.11e, Tables 3.7 &
3.8). The fingerprint pattern of streptavidin and extravidin binding are similar at pH 6.0
and pH 10.0. This is not surprising as the two proteins are negatively charged at both
pH conditions.

In contrast, when avidin is bound to OmpG-PEG2-biotin the gating

frequency increased by three fold and the open probability decreased slightly. The open
pore current was reduced from 31.5±3.4 pA to 16.4±4.1 pA at +50mV.
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Figure 2.11. Binding of analyte proteins at pH 10. (a-c) Typical current recording traces and
corresponding histograms of OmpG-PEG2-biotin nanopore before and after binding of
streptavidin (a) avidin (b) and extravidin (c). Relative open pore current of OmpG at avidin
bound state (green line) to unbound state (red line) is indicated in the histogram. Experiments
were performed in buffer 10mM CAPS pH 10.0, 300mM KCl at +50 mV. (d) Power spectrum
and (e) Fingerprint analysis of the three biotin binding proteins on OmpG-PEG2-biotin
behavior. (f-h) Binding of analyte proteins at high salt concentration. Typical current recording
traces of OmpG-PEG2-biotin nanopore and corresponding histograms before and after binding
of streptavidin (f) avidin (g) and extravidin (h). Experiments were performed in buffer 10mM
CAPS pH 10.0, 4.0 M KCl at +50 mV.

Table 2.7. Effect of pH 10 on gating characteristics for streptavidin, avidin and extravidin
at 0.3 M KCl pH 10.0, +50 mV
Gating
Inter-event
Event
Open
Open
frequency duration
duration
conductance
probability
-1
(s )
(ms)
(ms)
(pA)
No binding

0.94±0.05

23.4±6.6

35.4±9.8

1.35±0.30

31.5±3.4

Streptavidin

0.95±0.03

10.2±4.2

56.5±13.1

0.63±0.09

28.5±5.9

Avidin

0.93±0.06

68.2±18.3

25.8±8.6

1.16±0.20

16.4±4.1

Extravidin

0.98±0.02

11.2±2.5

51.8±12.7

0.72±0.07

31.4±1.3

Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.
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Table 2.8. Effect of pH 10 on fingerprint characteristics for streptavidin, avidin and
extravidin at 0.3 M KCl pH 10.0, +50 mV
Relative
open
probability

Relative
gating
frequency

Relative
inter-event
duration

Relative
event
duration

Relative
open
conductance

No binding

1.00±0.05

1.00±0.28

1.00±0.28

1.00±0.22

1.00±0.11

Streptavidin

1.01±0.03

0.44±0.11

1.6±0.6

0.47±0.07

0.97±0.04

Avidin

0.99±0.09

2.90±0.27

0.73±0.16

0.86±0.40

0.53±0.09

Extravidin

1.04±0.01

0.82±0.16

1.46±0.05

0.53±0.07

0.99±0.08

Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.

The zeta-potential measurement at pH 10 shows that the charge on the avidin
surface approaches zero (Table 2.2). Since the avidin still induced a strong reduction in
open pore current at pH 10.0, we suspect that an electrostatic attraction, albeit to a
lesser strength than at lower pH conditions, is still present between OmpG and avidin.
One possibility to explain why electrostatic attractions between OmpG and avidin
may still exist at pH 10 is that some of the positively charged residues on the OmpG
loops may become deprotonated at pH 10.0. For example, there are a total of 2 lysine
and 3 arginine residues found in loops L2, L3, L5 and L6 of OmpG and if all are
deprotonated, the net result would be a more negatively charged surface. Thus, the loss
of positive charge on avidin at high pH may be compensated by a gain of negative
charge on OmpG’s surface.
Alternatively, the local charge on avidin might still be positive near the biotin
binding site even though the total charge on avidin approaches zero.

Indeed the

glycosylation site of avidin is found on residue Asn-17 (blue), adjacent to residue Ser-16
(gold) which comprises part of the biotin binding pocket32 (Figure 2.12) and could
potentially interact directly with the loops of the OmpG.
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Finally, when all proteins were tested at pH 10.0 in the presence of charge
screening conditions (4.0 M KCl), the gating pattern of bound avidin was
indistinguishable from streptavidin or extravidin (Figure 2.11f-h). The open probability of
the OmpG-PEG2-biotin increased slightly from 0.87 ±0.05 to around 0.97 ± 0.02 when
bound to any of the three protein analytes (Table 2.9). In summary, pH, ionic strength or
both can be used to modulate the molecular interactions and hence the gating behavior
between the loops of OmpG and bound target proteins. These findings clearly illustrate
the role that electrostatic interactions play in OmpG’s ability to differentiate between very
similar protein analytes.

Figure 2.12. Proximity of the glycosylation site Asn-17 to the biotin binding pocket of
the avidin monomer. Top view (a) and side view (b) of the biotin binding residues in gold
with the Asn-17 residue highlighted in blue. PDB code 1VYO was used to generate the
images.

Table 2.9. Fingerprint values for bind 1 and bind 2 of streptavidin, avidin and extravidin
at 4.0 M KCl pH 10.0, +50 mV
Gating
Inter-event
Event
Relative
Open
frequency
duration
duration
open
probability
(s-1)
(ms)
(ms)
conductance
No binding

0.87±0.05

31.5±7.7

39.9±9.6

3.74±1.08

1.00±0.04

All 3

0.97±0.02

9.5±2.3

92±27

0.45±0.1

0.98±0.02

Values were calculated from at least three independent experiments for each analyte protein. The
errors indicate the standard deviation.
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2.4.4 Influence of Applied Voltage on Bound-State Gating Behavior
Next, we investigated how the applied potential affects the gating characteristic
of the OmpG nanopore during the analyte bound state by varying the applied potential
from -75 mV to +75 mV. Here, we define the polarity of the potential relative to the
orientation of OmpG’s loops. A negative potential is when OmpG’s loops are on the
negative side of the membrane relative to the positive side (Figure 2.13a). A positive
voltage is the opposite scenario (Figure 2.13b).

The most significant effect was

observed using the open pore current of the avidin bound state which decreased linearly
with increasing voltage (Figure 2.13d, 2.13g, Figure 2.14, Tables 2.10 & 2.11).

In

addition, the gating frequency was higher at positive voltages than at negative voltages
(Figure 2.14c, 2.14d). Other avidin-induced changes in the gating characteristics, e.g.
open probability, inter-event duration and event duration, appeared to be less dependent
on applied voltage. In contrast to avidin, there was no direct correlation between the
gating behavior of OmpG in the streptavidin and extravidin bound states at different
applied voltages (Figure 2.13c, 2.13e, 2.13f, 2.13h, Figure 2.14, Tables 2.10 & 2.11).
We expect that the following phenomena could explain the dependence of the
avidin bound state on the applied potential: electroosmosis, electrophoresis and
electrostatics. Molecular dynamics simulation studies indicate that the electric field is
strongest in the center of the nanopore and becomes weaker at the entrance and
essentially negligible outside of the pore.39,40 When the avidin molecule is captured by
the biotin ligand it may be up to 30 Å away from the pore entrance, thus the
electrophoretic effect may likely be negligible compared with the electroosmotic effect at
this point. Thus, an electroosmotic flow moving from the loop side to the periplasmic
side might be generated at a positive potential which drives the avidin towards the
nanopore. At or near the pore entrance, the electrophoretic effect would bring the avidin
analyte closer to the OmpG loops, thus promoting the electrostatic interaction between
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the two molecules. These three effects combine to force OmpG and avidin together and
further decrease the open pore current. On the other hand, a negative potential has an
opposite effect where the avidin is pushed away from the loops.

In this case the

electroosmotic and electrophoretic effects counteract the electrostatics between avidin
and OmpG. As a consequence, avidin blocks the open pore current of OmpG to a
lesser degree under an applied negative potential.

Figure 2.13. Effect of voltage on the gating characteristics of OmpG at analyte bound
state. (a, b) Schematic illustration of analyte binding at negative (a) and positive potential (b).
(c, d, e) Single channel recording traces of OmpG-PEG2-biontin nanopore at the unbound
(grey traces) and analyte bound state (black traces). Data were acquired in buffer 10 mM
sodium phosphate, pH 6.0, 300 mM KCl at various applied potentials. (f, g, h) Voltage
dependence of the open pore current in the streptavidin, avidin and extravidin bound states
respectively.
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Figure 2.14. Effect of voltages on the gating characteristics of OmpG-PEG2-biotin after
analyte binding. Absolute values of gating characteristics before and after analyte binding
(a,c,e,g,i). Relative change in gating characteristics after analyte binding (b,d,f,h,j). Values
were calculated from at least three independent experiments. The errors indicate the standard
deviation.
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Table 2.10. Voltage effect on gating characteristics for streptavidin, avidin and extravidin
binding at various voltages in 300 mM KCl pH 6.0 buffer
InterEvent
Open
Gating
Voltage
event
Open
duration
conductance
frequency
(mV)
duration
probability
(ms)
(pA)
(s-1)
(ms)
No
0.83±0.06
54±11
17.2±3.9
2.43±0.52
-46.4±4.6
bind
Strep
0.96±0.04
8±3
46.5±9.7
0.58±0.003
-49.8±6.0
-75
Avidin
0.89±0.01
77±8
14.7±0.1
0.85±0.06
-37.3±1.5
Extrav
0.98±0.01
12±3
44.8±4.0
0.25±0.05
-46.5±5.4
No
0.77±0.08
69±14
12.9±3.3
2.46±0.55
-27.2±5.2
bind
Strep
0.94±0.03
17±3
56.9±13.7
0.89±0.18
-26.7±3.3
-50
Avidin
0.84±0.13
89±17
13.2±1.1
1.25±0.35
-22.0±2.5
Extrav
0.96±0.04
16±5
51.7±18.5
1.30±0.40
-24.5±7.1
No
0.78±0.07
74±13
11.7±2.5
2.44±0.49
-14.0±2.6
bind
Strep
0.97±0.02
12±3
28.6±0.3
0.45±0.07
-13.9±1.4
-25
Avidin
0.85±0.05
104±42
9.8±3.1
1.10±0.20
-11.0±0.8
Extrav
0.98±0.01
15±1
31.4±4.8
0.18±0.06
-14.3±2.8
No
0.83±0.05
97±17
9.0±2.2
1.30±0.25
12.9±2.8
bind
Strep
0.98±0.02
31±4
48.9±5.4
0.33±0.02
12.5±2.9
+25
Avidin
N/D*
N/D
N/D
N/D
7.8±0.8
Extrav
0.98±0.01
31±4
45.9±2.2
0.32±0.09
12.6±1.5
No
0.83±0.08
106±24
8.5±2.1
0.83±0.18
24.8±4.4
bind
Strep
0.95±0.03
56±6
27.6±7.8
0.32±0.01
23.6±3.5
+50
Avidin
0.89±0.08
227±26
7.5±2.1
0.46±0.09
14.6±1.7
Extrav
0.95±0.03
30±9
29.1±0.4
0.29±0.06
21.7±5.7
No
0.87±0.05
103±21
8.5±1.8
0.67±0.13
38.2±7.1
bind
Strep
0.98±0.02
27±2
26.9±0.9
0.30±0.05
35.9±4.8
+75
Avidin
0.79±0.11
261±31
2.6±0.4
0.53±0.06
20.1±3.2
Extrav
0.96±0.01
23±5
18.6±0.2
0.24±0.06
37.8±4.6
*Avidin characteristics at +25 mV were not determined because after avidin binding, the
conductance was too small to accurately calculate the gating characteristics other than pore
conductance.
Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.
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Table 2.11. Voltage effect on fingerprint characteristics for streptavidin, avidin and
extravidin binding in 300 mM KCl pH 6 buffer
Relative
Relative
Relative
Relative
Voltage
interRelative open
event
open
gating
(mV)
event
conductance
duration
probability
frequency
duration
No bind
1.00±0.07
1.00±0.19
1.00±0.23 1.00±0.21
1.00±0.10
Strep
1.16±0.08
0.16±0.05
2.72±0.59 0.24±0.05
1.07±0.10
-75
Avidin
1.07±0.16
1.42±0.25
0.85±0.07 0.35±0.11
0.86±0.05
Extrav
1.18±0.09
0.22±0.01
2.60±0.55 0.10±0.03
1.0±0.03
No bind
1.00±0.10
1.00±0.20
1.00±0.26 1.00±0.22
1.00±0.19
Strep
1.22±0.15
0.25±0.07
4.41±0.49 0.36±0.04
0.98±0.03
-50
Avidin
1.09±0.19
1.29±0.24
1.02±0.17 0.51±0.21
0.82±0.04
Extrav
1.25±0.09
0.24±0.04
4.01±0.71 0.53±0.21
0.92±0.05
No bind
1.00±0.09
1.00±0.18
1.00±0.22 1.00±0.20
1.00±0.19
Strep
1.24±0.04
0.17±0.04
2.44±0.41 0.18±0.02
0.99±0.04
-25
Avidin
1.09±0.19
1.41±0.54
0.84±0.29 0.45±0.13
0.78±0.05
Extrav
1.26±0.10
0.21±0.03
2.68±0.50 0.07±0.02
1.02±0.01
No bind
1.00±0.06
1.00±0.17
1.00±0.25 1.00±0.19
1.00±0.21
Strep
1.18±0.03
0.32±0.05
5.44±0.35 0.25±0.10
0.97±0.04
+25
Avidin
N/D
N/D
N/D
N/D
0.64±0.07
Extrav
1.18±0.03
0.32±0.01
3.42±0.67 0.25±0.04
0.98±0.09
No bind
1.00±0.09
1.00±0.23
1.00±0.25 1.00±0.22
1.00±0.18
Strep
1.14±0.20
0.53±0.10
3.25±0.29 0.39±0.06
0.95±0.06
+50
Avidin
1.07±0.11
2.14±0.13
0.88±0.23 0.55±0.03
0.60±0.07
Extrav
1.14±0.04
0.28±0.07
3.42±0.67 0.35±0.10
0.90±0.08
No bind
1.00±0.05
1.00±0.21
1.00±0.22 1.00±0.20
1.00±0.19
Strep
1.13±0.09
0.26±0.06
3.16±0.62 0.45±0.06
0.94±0.07
+75
Avidin
0.91±0.10
2.53±0.44
0.31±0.04 0.79±0.03
0.55±0.1
Extrav
1.10±0.01
0.22±0.06
2.19±0.73 0.36±0.12
0.99±0.04
Values were calculated from at least three independent experiments. The errors indicate the
standard deviation.

While the gating behavior of the nanopore with bound avidin was relatively
straightforward to understand in terms of electrostatic interactions, our voltage
dependent studies using extravidin revealed more subtle information. When we
examined the E1 form of extravidin, the gating behavior was not affected by the voltage
polarity (Figure 2.13e, 2.13h). However, the E2 and E3 forms of extravidin showed open
pore currents that did respond to voltage. Namely, the open pore current of OmpGPEG2-biotin, upon binding to E2 or E3, decreased linearly with increasing voltage from 81

75 mV to 75 mV (Figure 2.15). This observation suggests that E2 and E3 population
bear net positive charges due to an incomplete removal of glycan from the surface.
Notably, the voltage induced a current reduction to similar levels in E3 and avidin while
to a lesser extent in E2. This result supports our speculation that E3 was intact avidin
and E2 was the intermediate product of the deglycosylation reaction. Taken together, the
voltage can influence the binding signal of a charged analyte by either strengthening or
weakening the interaction between the OmpG nanopore and the analyte protein.

Figure 2.15. The relative open pore conductance of OmpG-PEG2-biotin when bound to
the avidin homologues. Binding of the homologues to OmpG-PEG2-biotin affects the open
pore current over several voltages. All trials were recorded in buffer containing 10mM sodium
phosphate pH 6.0, 300 mM KCl. Values were calculated from at least three independent
experiments. The errors indicate the standard deviation.

2.5 Discussion
We have demonstrated that analyte proteins with positively charged surfaces are
attracted to the negatively charged loops of OmpG. The interaction leads to a reduction
of the open-pore current through the nanopore. In control experiments, we showed that
our proteins did not induce any significant current change when using wild type OmpG,
indicating the interaction of the avidin species only occurs after they bind to the biotin
ligand. Therefore, these results strongly support a two-step mechanism for OmpG
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nanopore sensing (Figure 2.16). The first step is the capture where the protein binds the
ligand on OmpG. The capture of an analyte protein brings it in close proximity to the
nanopore opening which then facilitates electrostatic attraction between the two
surfaces. In the second step, the analyte interacts directly with the loops of OmpG to
obstruct ionic flow through the pore and alter the dynamic movement of the loops. In
essence, the flexible loops of OmpG sense and communicate information about the
surface of the analyte protein. This process is termed “sampling”.

Figure 2.16. Schematic representation of the sampling mechanism for OmpG nanopore.
The OmpG loops and protein analyte are attracted electrostatically.

Though all three avidin species were clearly captured by the biotin ligand, some
did not undergo the sampling step. For example, streptavidin and extravidin at pH 6.0 do
not induce a change in the open pore current which indicates that the loops and target
surface are repelled by their like charges. At high salt concentrations (4.0 M KCl),
charges were screened and avidin also did not cause a change in open pore current. In
scenarios where sampling did not occur, the OmpG nanopore could not distinguish
between biotin-binding species. Therefore, system conditions that favor sampling are
essential for sensitive analyte discrimination.
Importantly, protein analytes that are sampled by the OmpG loops could induce
distinct gating signal. For example, at pH 6.0 in low salt (0.3 M KCl), avidin-OmpG loop
interactions increased the gating frequency, indicating that loop 6 oscillates between the
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closed and open state more rapidly. However, it caused a reduction in the gating event
duration by 30%. The effect of bound avidin on the loops was remarkably different from
the effect of a mouse monoclonal anti-biotin antibody (mAb) used in a previous study.30
Under identical conditions, mAb binding increased both the gating frequency and event
duration, which led to a decrease in open probability. Furthermore, one polyclonal antibiotin antibody eliminated all gating events and resulted in a constantly open pore.30 The
differences in loop interactions between the monoclonal and polyclonal antibodies and
the avidin clearly demonstrate that the gating induced by OmpG’s loops depends on the
unique interaction with the analyte interface. In nature, protein-protein interactions are
typically mediated by weak intermolecular forces such as hydrophobic, hydrogenbonding and electrostatic forces. The OmpG nanopore so far seems predominantly
sensitive to attractive electrostatic interactions. Indeed, we note that conditions that
leave an avidin species nearly neutral or negatively charged (i.e., conditions that prevent
sampling) abolish OmpG’s discrimination abilities. The current version of the OmpG
nanopore sensor is nearly identical to the wild type save the addition of the biotin ligand.
We speculate that further modifications to the loops might allow the use of hydrophobic
or hydrogen bond interactions for enhanced sampling of neutral and negative analytes.
We also show that experimental conditions, such as pH, salt concentration and
voltage can be tuned to facilitate detection. Sampling process is the key to OmpG’s
discrimination ability, so parameters that modulate sampling may also be used to
enhance sensitivity. This can be accomplished by two general strategies. First, the
electrostatic interaction between the analyte and nanopore can be tuned by altering the
surface charge of both analyte protein and nanopore. Second, we also showed that
voltage could either enhance or weaken the interaction by electrophoretic forces that
move the protein closer to or away from the pore entrance. Thus, by optimizing the
conditions, we can maximize the relative difference in the fingerprint analysis to generate
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unambiguous detection patterns. These strategies may also be particularly useful to
ameliorate the effect of interference from other species in complex samples.
Post-translational modifications (PTMs) have an important impact on the physical
properties and biological functions of proteins. Altered or missing modifications have
profound effects on cellular function and are often associated with human diseases,41,42
such as neurodegenerative disease,43 cancer44 and inflammatory diseases.45 Mass
spectrometry, as the key technology for identifying PMTs, has contributed tremendously
our understanding of PTMs in cell.46–48 However, analysis of PTMs by mass
spectrometry can be challenging due to the instability of the modifications during the MS
analysis or the effect of the modification of the peptide’s ionization efficiency. Singlemolecule strategies using nanopore for detecting modifications are especially appealing
because it can identify modifications and variants within an intact protein. Along these
lines, Rosen et al. recently demonstrated the use of αHL in detecting changes in the
phosphorylation of thioredoxin.22 Here we showed OmpG nanopores can recognize
changes in glycosylation patterns of proteins through their differences in surface charge.
This is especially important, as many forms of glycosylation e.g. sialylation and
acetylglucosaminylation add negative or positive charge, respectively. Current
glycoprotein profiling methods using mass spectrometry often run in tandem with a
separation technique, such as liquid chromatography or gel electrophoresis. Equipped
with a specific ligand for the protein of interest, OmpG nanopore could be used for
differential profiling of cellular glycoproteins in native states without prior separation
procedure or liberation of glycan.
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2.6 Conclusion
We demonstrated that an engineered OmpG nanopore can distinguish between
protein homologues and post-translationally modified isoforms through their differences
in surface charge. This is achieved by the electrostatic interaction between the nanopore
loops and analyte proteins and yields a gating fingerprint readout for the analyte.
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CHAPTER 3
SELECTIVE DETECTION OF PROTEIN HOMOLOGUES IN SERUM USING AN
OMPG NANOPORE

Reprinted (adapted) with permission from M. A. Fahie, B. Yang, M. Mullis, M. A. Holden,
and M. Chen, “Selective detection of protein homologues in serum using an OmpG nanopore,” Anal. Chem., vol. 87, no. 21, pp. 11143–11149, 2015. Copyright 2015 American Chemical Society.
3.1 Summary
Outer membrane protein G is a monomeric β-barrel porin that has seven flexible
loops on its extracellular side. Conformational changes of these labile loops induce gating spikes in current recordings that we exploited as the prime sensing element for protein detection. The gating characteristics - open probability, frequency and current decrease – provide rich information for analyte identification. Here, we show that two antibiotin antibodies each induced a distinct gating pattern, which allowed them to be readily
detected and simultaneously discriminated by a single OmpG nanopore in the presence
of fetal bovine serum. Our results demonstrate the feasibility of directly profiling proteins
in real-world samples with minimal or no sample pretreatment.

3.2 Introduction
Nanopore sensing is a single molecule technique that measures the ionic current
flowing through a nanoscopic pore in a membrane.1–3 Analytes are detected when they
cause transient current blockades as they bind or translocate through the pore. The intensity and duration of the blockades provide information about the structure, size and
dynamic properties of analytes while the frequency of the blocking events indicates the
concentration. Nanopores have been used to detect a large variety of analytes,4 ranging
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from small molecules, e.g. metal ions,5 organic chemicals6,7 and large biological macromolecules, including nucleic acids8–11 and proteins.12 For protein sensing, nanopores are
usually coupled with a binding site for target proteins to ensure specific detection. The
high affinity binding sites used so far have been derived from ligands,13,14 inhibitors,15
peptide sequences,16,17 antibodies18 and aptamers.19–21 These binding sites are either
introduced inside of the nanopore,18,21 located at the entrance,17,19,20 or conjugated with
an auxiliary polymer in the solution.13,22–24 In the latter case, detection is achieved when
an analyte binds to a ligand at a polymer and alters the characteristic ionic current signatures derived from the polymer translocation through the nanopore.22,23
Outer membrane protein G (OmpG) is a 14 stranded β-barrel protein derived
from Escherichia coli (E. coli).25–27 Compared to other well studied protein nanopores,
e.g. αHL28 and MspA9,29 that are rigid, oligomeric membrane protein channels, OmpG is
a monomeric protein with seven long flexible loops decorated at the extracellular entrance (Figure 3.1).30 Loop 6 is the most flexible loop, causing the OmpG protein pore to
oscillate between the open and closed states.25,31–33 As a result, OmpG exhibits frequent
gating in current recordings (Figure 3.1). Although pores exhibiting continuous nongating
conductance have been considered a necessity for nanopore sensing, the gating
noise/pattern of OmpG has been exploited as a sensing element for protein
detection.34,35 In OmpG sensing, analyte binding induces not only a current decrease by
obstructing the pore entrance, but also a significant change in gating patterns by altering
the dynamic movement of loop 6.34 The gating pattern is sensitive to the interface formed
between OmpG and analyte proteins.35 Characteristics of gating, such as open probability, gating frequency, event duration and inter-event duration of the gating events provide
multiple parameters for analyte identification. Using this strategy, multiple analytes were
identified and simultaneously discriminated using a single OmpG nanopore in buffered
solutions.34
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One of the main challenges of protein sensing using nanopores is to identify target proteins in a complex mixture.36 Most experiments have been performed under ideal
conditions using only pure analytes in buffers. To apply this technique as a diagnostic
tool for medical use, it is necessary to test the applicability of nanopores for detecting
target analytes in clinically relevant samples, e.g. serum, urine or saliva. In this work, we
show that two antibiotin antibodies can be readily detected and simultaneously discriminated by a single OmpG nanopore in the presence of 10-fold diluted serum. Our results
demonstrate the feasibility of directly profiling proteins in real-world samples with minimal or no sample pre-treatments.

3.3 Materials and Methods
All chemicals were obtained from Fisher Scientific or Boston Bioproducts unless
otherwise stated. Chemicals were used without further purification. SB58C mouse monoclonal antibody was obtained from Southern Biotech (Cat# 6406-01) and BTN.4 mouse
monoclonal antibody was obtained from Thermo Scientific (Cat# MS-1048-P1). Diphytanoylphosphatidylcholine (DPhPC) lipids were obtained from Avanti Polar Lipids. Teflon
film was obtained from Goodfellow. The maleimide-PEG2-biotin linker was obtained from
Thermo Scientific. Octylglucoside (OG) was obtained from Gold Biotechnology. Hexadecane and pentane were obtained from Sigma Aldrich.

3.3.1 OmpG biosensor preparation
OmpG D224C was purified and labeled with maleimide-PEG2-biotin as previously
described.34, 35 Briefly, OmpG D224C was expressed in BL21 (DE3) E. coli as inclusion
bodies. The inclusion body pellet was solubilized in 8.0 M Urea, 50 mM Tris·HCl pH 8.0,
2 mM DTT for an hour prior to loading onto a HiTrap Q FF (GE Healthcare Life Sciences). OmpG D224C was then eluted with a gradient of 0-500 mM NaCl, 50 mM Tris-HCl,
pH 8.0, 8 M urea and 2 mM DTT over 60 minutes. Purity of OmpG D224C was verified
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by SDS-PAGE. Prior to labeling, OmpG D224C was desalted in 50 mM HEPES buffer,
pH 7.0 and 8 M Urea to remove DTT and adjust the pH. OmpG D224C was then labeled
with maleimide-PEG2-biotin by mixing OmpG and ligand in a 1:10 molar ratio for 2 hours
with constant shaking at room temperature. OmpG was desalted once more in 50 mM
Tris-HCl buffer, pH 8.0 in 8 M Urea to remove excess chemicals. OmpG was then diluted
1.5 times in refolding buffer 20 mM Tris-HCl, pH 9.0 with 3.25% octylglucoside and incubated for three days at 37 ºC. Refolding and labeling efficiency was tested via a gel-shift
assay as previously described (Figure 3.1).34 OmpG-biotin was stored at -80 ºC in 20%
glycerol until further use.

Figure 3.1. SDS-PAGE analysis of refolding and labeling efficiency of OmpG-biotin.
After three days refolding at 37°C, samples of the OmpG-biotin protein was heated to 95°C
for 15 minutes in Laemelli buffer or loaded without boiling to the 15% gel. To determine the
labeling efficiency, the sample was mixed with streptavidin in a 1:1 molar ratio for 1 minute
and then mixed with Laemelli buffer without boiling. Labeled OmpG forms a SDS-resistant
complex with streptavidin which migrate slower in the gel. The intensity of the protein bands
were analyzed by gel imager to calculate the labeling efficiency which was about 85%.

3.3.2 Single Channel Recording
Single channel recording was done as previously described.34 Briefly, a 100 µm
diameter aperture on a 25 µm thick Teflon film separating two chambers was painted
with 10% hexadecane in pentane. The pentane was allowed to evaporate prior to filling
the two chambers with buffer (10 mM sodium phosphate pH 6, 300 mM KCl). The bilayer
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was formed by adding 15 µL 10 mg/mL DPhPC lipids in pentane on the aqueous surface
of each chamber. Once the pentane evaporated, the buffer was pipetted up and down to
coat the aperture with lipids. An Ag/AgCl electrode, with the cis electrode connected to
ground, was immersed in each chamber. OmpG was pipetted into the cis chamber and
200 mV was applied to promote pore insertion into the bilayer. Once a pore was inserted, the voltage was decreased to 50 mV. Since OmpG inserts into the bilayer bidirectionally, the pore gating behavior was observed at both positive and negative 50 mV for
five minutes to determine pore orientation.37 All analyte proteins were introduced to the
chamber where the OmpG loops are located. Unlabeled OmpG D224C was tested with
SB analyte and did not generate a change in gating behavior (Figure 3.2). The positive
potential is defined as the chamber where the loops are facing is positive. All data was
acquired at ±50 mV unless otherwise stated. The Axopatch 200B integrating patch
clamp amplifier (Axon Instruments) was used to amplify the current and a 2 kHz Bessel
filter was applied. Data was digitized with a Digidata 1320A/D board (Axon Instruments)
and acquired at a sampling rate of 100 µs.

Figure 3.2. Single channel current trace of OmpG D224C. SB58C (2 nM) was added to
unlabeled OmpG D224C and the ionic current monitored. There was no change in OmpG
ionic current behavior. Buffer used was 10 mM sodium phosphate pH 6, 300 mM KCl and the
ionic current recorded at both -50 and +50 mV. OmpG was recorded with a 2 kHz Bessel
filter at a sampling rate of 100 µs.
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3.3.3 Single Channel analysis
OmpG gating was analyzed in Clampfit 10.3 software using the single channel
search tool from at least 5 s of gating from several independent pores. The extracted
dwell times of the open (inter-event) and closed state (event) were used to calculate the
open probability, the inter-event duration, event duration, as well as the gating frequency. To determine the open probability, the sum of the open dwell times (τon) were divided
by the total time analyzed, which includes both open and closed states of the OmpG
pores. To determine the inter-event duration, the open dwell times (τon) were plotted in a
histogram and fit with a single exponential function. The event duration was similarly calculated, but the closed dwell times (τoff) were fit instead. For gating frequency, the trace
was first filtered with a low pass Gaussian filter with a 1 kHz -3dB cut off. The total count
of gating events was divided by the total time. To determine the open pore conductance,
an all-events histogram of the trace was fit with a Gaussian function.

3.3.4 Analysis of gating characteristics
Gating characteristics used for generating the fingerprints of the two antibodies
namely – open probability, gating frequency, event duration, inter-event duration and
open conductance – are defined as shown in Figure 3.3. To calculate the gating characteristics of SB and BT binding at least 10 binding events with dwell times of at least 1 s
from three independent traces or more were analyzed using the single channel search
function in Clampfit 10.3. For SB analysis, its gating characteristics were further divided
into three different gating types: A, B and C. These three gating types were analyzed
independently from one another. Errors represent the standard deviation from the three
independent pores (at least 30 events in total).
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Figure 3.3. Gating characteristics of the OmpG ionic current. Three of the five gating parameters are defined in the trace. Open probability is the ratio of the open and closed state
while gating frequency is the number of events per second. This trace is the SB binding states
in the absence of serum at +50 mV. Buffer used was 10 mM sodium phosphate pH 6, 300
mM KCl. SB binding was recorded with a 2 kHz Bessel filter at a sampling rate of 100 µs.

3.4 Results
Our OmpG nanopore (OmpG-PEG2-biotin) contains a tethered biotin ligand that
can potentially extend into the solution up to 30 Å away from the OmpG loop 6 (in red) to
which it is attached via a covalent linkage between mutated loop residue C224 and a
maleimide moiety on the biotin ligand (Figure 3.4). We previously used this OmpG nanopore to detect and discriminate several biotin-binding proteins namely streptavidin,
three anti-biotin antibodies: one mouse monoclonal (BTN.4) and two polyclonal antibodies raised in sheep34 as well as two streptavidin homologues avidin and extravidin.35
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Here, we first examined whether the OmpG-PEG2-biotin nanopore could also detect an
alternative anti-biotin mouse monoclone, SB58C (SB).

Figure 3.4. The open (2IWV) and closed (2IWW) structures of OmpG. The loop 6 is highlighted in red and is covalently attached to the biotin ligand. The ionic current trace was obtained in 10mM sodium phosphate pH 6, 300mM KCl buffer.

Addition of 1 nM SB to the loop-facing chamber induced a significant change in
current traces (Table 3.1, Figure 3.5). At -50 mV, OmpG-biotin nanopore in the SB bound
state exhibited the following characteristics: i) the current of the fully open state decreases slightly by 2 pA as shown in the histogram (Figure 3.5a-3.5c); ii) the current
traces displayed gating patterns markedly different from that of the unbound states (Figure 3.5a, 3.5b). Interestingly, the gating pattern of the SB bound state is heterogeneous,
i.e. a single SB binding event induced three different current fluctuation patterns which
we named types A, B and C (Figure 3.5d). We categorize the three types of gating pat-
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terns by their open-pore current, open probability and gating frequency (Table 3.1). Type
A gating shows that the current was almost constant at -18.3 ± 0.8 pA which is 62 % of
the fully open state current. Due to the lack of full gating events, the open probability is 1
and the gating frequency is 0 (Figure 3.5c, 3.5d).

Type B binding shows that OmpG

stays mostly closed where the open probability reduces from 0.76 ± 0.03 to 0.13 ± 0.04
with a residual current of 2.1 ± 0.5 pA and a lowered gating frequency of 32 ± 4 s-1 (Figure 3.5d). Type C gating shows that the current fluctuates rapidly with a gating frequency
of 77 ± 3 s-1, a 13% increase over that of the unbound state (68 ± 5 s-1) and has an open
probability of 0.60 ± 0.06. Each single SB binding event contains multiple combinations
of these three types of gating (Figure 3.5a). This result is interesting as none of the previous biotin-binding protein analytes, including three streptavidin homologues and three
biotin antibodies showed such a phenomenon.34,35

Table 3.1. The relative change in open probability, gating frequency and open current of
OmpG-biotin during type A, B and C binding of SB58C
Loop Voltage
(mV)

SB58C binding
state

Relative Open
Probability

Relative Gating
Frequency

Relative Open
pore current

No bind

1.00 ± 0.04

1.00 ± 0.22

1.00 ± 0.05

Type A

1.31 ± 0.06

N.D.

0.62 ± 0.02

Type B

0.16 ± 0.05

0.46 ± 0.06

0.07 ± 0.02

Type C

0.79 ± 0.07

1.1 ± 0.04

0.94 ± 0.04

No bind

1.00 ± 0.02

1.00 ± 0.09

1.00 ± 0.03

Type A

1.22 ± 0.03

N.D.

0.54 ± 0.03

Type B

0.19 ± 0.05

0.55 ± 0.10

0.04 ± 0.01

Type C

0.83 ± 0.06

1.38 ± 0.08

0.92 ± 0.05

-50

+50

*The errors indicate standard deviations from at least three independent pores.
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Figure 3.5. Detection of SB58C by OmpG-biotin nanopore. (a,b) The electrophysiology
traces and all events histograms of unbound (UB) and SB-bound states of OmpG-biotin at -50
mV and +50 mV. (c) Zoomed-in electrophysiology traces and all-events histograms of the unbound state and (d) the three independent SB-binding states types A, B and C. Buffer used
was 10 mM sodium phosphate pH 6, 300 mM KCl. 1nM SB antibody was added to the recording chamber. SB binding was recorded with a 2 kHz Bessel filter at a sampling rate of 100 µs.

Because the gating pattern of the analyte bound state is dictated by the interaction between analyte and OmpG surface, this result indicates when SB bound to the
tethered ligand, it often altered the way in which it interacted with the OmpG surface.
Our previous study demonstrated that electrostatic attractions are the dominant force
that triggers the interaction between analyte and the OmpG loops.35 Consistent with our
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previous finding, increasing the salt concentration to 1.0 M KCl in the recording buffer
almost abolished the type B and A binding while the type C binding became similar to the
unbound state (Figure 3.6).
Here, we speculate that the SB antibody might contain multiple positively
charged regions separately located in areas close to the biotin-binding site. Each positive region can form a unique binding interface with the negatively charged OmpG loops
which triggers a gating pattern different from each other. The ability to trigger multiple
gating signatures within one binding event is a great advantage for analyte identification
and reveals the sensitivity of our OmpG sensor to subtle changes in the analyte surface.
At +50 mV, we also observed that a single SB induced the three types of gating
patterns albeit with slight variations from those at -50 mV. For example, in Type A binding, the open current changes more than at -50 mV, to 54% of the fully open state current (Table 3.1). Type B has essentially no residual current and a gating frequency of 59
± 10 s-1. Finally, type C gating frequency is 149.5 ± 8.2 s-1 (a 38% increase to that of the
unbound state) and an open probability of 0.68 ± 0.05 (17% reduction from the unbound
state). This observation is consistent with previous finding that the polarity of voltage
has a strong influence on the gating characteristics of the analyte bound state. This is
due to two factors: i) the polarity of voltage has a strong influence on the gating of OmpG
which exhibits asymmetric current gating at positive and negative potential

34

and ii) the

voltage could alter the strength of OmpG and analyte interaction through electroosmotic
and/or electrophoretic effects. The binding of SB to OmpG-biotin nanopore was specific
as no change in behavior occurred with un-biotinylated OmpG D224C (Figure 3.2). The
SB antibody appeared to have a high affinity for the biotin ligand as the binding events
usually lasted for at least 2 min, 30 times longer than that of a monoclonal antibody
BTN.4 that was previously tested, which had a dissociation constant of 1.12 ± 0.28 x 108
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M-1.34 SB bound for so long that we were not able to calculate the binding kinetics, mainly because the bilayer does not last long to allow to collect enough (~1000) events for
accurate data analysis. The lowest concentration of SB we detected was 15 pM within
60 min indicating the high sensitivity of our approach and sensor.

Figure 3.6. Detection of SB58C by OmpG-biotin nanopore in high salt. At both -50 and
+50 mV, binding state C was the predominant state. Binding state B was completely abolished, while binding state A was periodically seen at +50 mV. Buffer used was 10 mM Tris-HCl
pH 8, 1.0 M KCl. Traces were recorded with a 2 kHz Bessel filter at a sampling rate of 100 µs.
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Previously, we have demonstrated that the OmpG-biotin nanopore could discriminate among three anti-biotin antibodies in an antibody protein mixture.34 To use OmpG
nanopore in clinical applications, OmpG would need to detect analyte and possibly discriminate among homologous proteins in a biological sample such as blood serum.
Therefore, we investigated how the presence of serum affected the gating of the OmpGbiotin nanopore.
In the presence of 25% (v/v) fetal bovine serum the bilayer was unstable at ±50
mV thus we lowered the concentration to 10% (v/v). We initially added the serum to
both chambers, however, under these conditions OmpG could not remain in an open
state at any applied potential for long periods of time (Figure 3.7).

Figure 3.7. The effect of 10% serum added to both chambers on the gating behavior of
OmpG-biotin. 100 µl of FBS was added to both chambers to a final concentration of 10%
(v/v). The buffer was 10 mM sodium phosphate pH 6.0, 300 mM KCl. OmpG was recorded
with a 2 kHz Bessel filter at a sampling rate of 100 µs. Arrows indicate a switch in voltage polarity.

Thus we decided to add 10% (v/v) serum to only the chamber where the loops
were located. This induced a noisier gating signal in the OmpG nanopore at both volt-
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ages (Figure 3.8). The gating frequency almost doubled at -50 mV (Table 3.2). Also, the
inter-event duration was significantly reduced from 6.37 ± 1.88 ms to 0.96 ± 0.31 ms i.e.
a 6.6-fold reduction. The open probability and event duration were also affected, undergoing a 5% and 61% reduction, respectively (Table 3.2).
At +50 mV, in addition to an increase in gating behavior, frequent full blockage
events were observed (similar to when serum was added to both chambers). These
blockage events could last from seconds to minutes if the voltage was left unperturbed.
Unblocking the pore could be achieved by switching the voltage polarity from +50 to -50
mV. The increased gating frequency and the long closures were likely due to the interaction of serum constituents. These possibly included small molecules and proteins that
may have been driven by diffusion, electro-osmosis and electrophoresis near the OmpG
loops and into the lumen. Importantly, despite the high protein content in serum, we did
not observe any gating pattern changes that were similar to the analyte protein binding,
thereby demonstrating the high specificity of OmpG nanopore detection.

Figure 3.8. The effect of serum added to one chamber only on the gating behavior of
OmpG-biotin. 100 µl of FBS was added to the loop-containing chamber to a final concentration of 10% (v/v). The buffer was 10 mM sodium phosphate pH 6.0, 300 mM KCl. OmpG was
recorded with a 2 kHz Bessel filter at a sampling rate of 100 µs.
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Table 3.2. The gating characteristics of the unbound state, the BT and SB bound states
in the absence and presence of 10% (v/v) serum.
Open
probability

Gating
Frequency
(s-1)

Inter-event
duration
(ms)

No bind - FBS

0.78 ± 0.03

68 ± 15

6.37 ± 1.88

No bind + FBS

0.73 ± 0.06

121 ± 13

0.96 ± 0.31

BTN.4 - FBS

0.52 ± 0.08

113 ± 4

0.97 ± 0.21

BTN.4 + FBS

0.48 ± 0.16

146 ± 24

0.56 ± 0.19

Event
duration
(ms)
2.23 ±
0.50
1.35 ±
0.32
1.76 ±
0.34
1.46 ±
0.34

SB58C Type A
1.00 ± 0.00
0±0
N.D.
N.D.
- FBS
SB58C Type A
1.00 ± 0.00
0±0
N.D.
N.D.
+ FBS
SB58C Type B
3.92 ±
0.13 ± 0.04
32 ± 4
0.70 ± 0.04
- FBS
0.23
SB58C Type B
2.16 ±
0.12 ± 0.04
20 ± 5
0.44 ± 0.03
+ FBS
0.08
SB58C Type C
0.60 ± 0.06
77 ± 3
1.41 ± 0.07
0.86 ± 0.3
- FBS
SB58C Type C
0.74 ±
0.60 ± 0.11
121 ± 13
0.39 ± 0.10
+ FBS
0.21
*The error bars indicate standard deviations from at least three independent pores.

Open pore
conductance
(pA)
-29.3 ± 1.4
-30.1 ± 2.3
-27.7 ± 1.3
-28.7 ± 2.1
-18 ± 0.6
-20.2 ± 1.0
-2.1 ± 0.5
-3.8 ± 0.9
-27.5 ± 1.0
-29.9 ± 1.2

Because the serum-induced blockages at +50 mV reduced the fraction of time
that the OmpG nanopore was able to receive an analyte protein, we focused on testing
the discriminatory ability of OmpG-biotin at -50 mV. As shown in Figure 3.9a, the addition of two monoclonal antibodies – clones SB58C (SB) and BTN.4 (BT) – to the recording chamber containing only buffer triggered binding signals with distinct characteristics
that can be recognized qualitatively and quantitatively.
Both proteins induced a slight decrease ~ 6% in open pore current (Table 3.2,
Figure 3.9b). The SB-type binding exhibited its typical heterogeneous gating signal
while the BT-binding triggered a gating pattern containing a partially closed state with a
residual current of 6 pA, which is consistent with previous finding when BT was added to
the OmpG-biotin alone.34 Thus, in the absence of FBS, OmpG could discriminate SB
from BT by their respective binding signatures (Figure 3.9a-c).
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Figure 3.9. Discrimination of two antibodies in the presence of serum. (a) Binding of SB
(blue) and BT (red) to OmpG-biotin in the absence of serum. (b) Electrophysiology traces and
(c) histograms of the unbound state in comparison with the BT and SB bound states. Buffer
used was 10 mM sodium phosphate pH 6.0, 300 mM KCl and recorded at -50 mV. SB (1 nM)
and BT (5 nM) were added to the recording chamber. (d) BT and SB binding in the presence
of serum. (e) Electrophysiology traces and (f) histograms of BT and SB binding in the presence of serum. In addition to SB and BT, serum (10% v/v) was added to the loop-containing
chamber. SB and BT binding were recorded with a 2 kHz Bessel filter at a sampling rate of 100
µs.

105

In the presence of 10% (v/v) serum, the current traces of SB and BT bound
states were noisier than those without serum (Figure 3.9a-f). Nevertheless, individual
binding signatures of SB and BT were well-preserved; both analytes still induced a decrease in the open pore current. The heterogenous gating pattern induced by SB was
readily visible. Clearly, the different gating patterns between SB and BT allowed us to
resolve between two homologues in serum (Figure 3.9).

Figure 3.10. Simultaneous detection of two antibodies in serum. A continuous trace (170
s) of SB (1 nM, blue) and BT (5 nM, red) binding to OmpG-biotin in the absence of 10% (v/v)
serum. Buffer used was 10 mM sodium phosphate pH 6, 300 mM KCl and the ionic current
recorded at -50 mV. SB and BT were recorded with a 2 kHz Bessel filter at a sampling rate of
100 µs.

Although a previous study has also shown a protein A coated solid-state nanopore can discriminate IgG species, the detection relied on their difference in dwell
times, which differ by an order of magnitude.18 Although BT and SB possessed markedly different dwell times (Figure 3.10), differentiation among the two analytes by OmpG
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was achieved through their characteristic binding signals.

Therefore, this detection

mechanism would allow the differentiation of different analytes that have similar dwell
times, an advantage that is beginning to be seen with other engineered nanopores.20,38
To quantitatively study how serum affected the gating of the analyte-bound state,
we calculated five parameters: open probability, gating frequency, event duration, interevent duration and open pore current in the presence and absence of serum. When BT
bound to OmpG-biotin in the presence of serum, the open probability, event duration and
open pore current were not significantly different from those in the absence of serum
(Figure 3.11, Table 3.2).

Figure 3.11. The effect of serum on the fingerprint pattern of BT and SB. The gating
events of different analyte protein binding states were characterized by five parameters, i.e.
open probability, gating frequency, inter-event duration, event duration and the conductance
of the open pore state. Changes of these parameters relative to the no binding state generate
the fingerprint unique for each antibody. For SB, the three types of gating pattern were analyzed separately. The error bars indicate standard deviations from at least three independent
pores.

The inter-event duration was decreased by ~1.5 times and the gating frequency
increased by 1.3 times. Similar to BT, moderate changes were also observed for SB type
C binding characteristic in the presence of FBS. FBS showed little effect on the type A
and type B signals probably due to the lack of gating in these two types of signals. In
previous studies, we used the relative values of bound and unbound states to create a
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fingerprint for analyte identification.34,35 The gating fingerprint of BT in the presence of
serum compared to the absence of serum was different. This altered fingerprint in the
presence in serum was due mainly to the non-specific effects of serum molecules on
OmpG gating, rather than a direct effect on the antibody-OmpG interaction. Despite the
effect of serum, the fingerprints of the two analytes are clearly distinguishable.

Figure 3.12. Effect of FBS on the kinetics of antibody binding. Histograms of the interevent duration (τon) and dwell time (τoff) of mAb binding events were fitted with single exponential decay function to derive the average time constants. Tau-on values for BT were calculated from 10 nM. Buffer used was 10 mM sodium phosphate pH 6, 300 mM KCl and the
ionic current was recorded at both -50 mV. Averages and standard deviations were taken
from three independent pores.
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Next we analyzed the effect of serum on the kinetics of analyte binding. The association rate constant kon and dissociation rate constant koff of BT were calculated from
the τon and τoff, respectively, in the absence and presence of FBS (Figure 3.12). The koff
value slightly increased in serum from 0.24 ± 0.05 s-1 to 0.30 ± 0.09 s-1 (n=3). However,
the kon value decreased from 2.27 ± 0.52 x107 M-1s-1 to 0.83 ± 0.18 x107 M-1s-1 by ~3-fold
in FBS. The slower kon of BT in the presence of serum could be due to molecular crowding effects in the high concentration of serum proteins that interact non-specifically with
BT (and OmpG) and slow down its diffusion to the pore.39 This result indicates the serum
slightly impedes the sensitivity of OmpG, since detection of the same number of binding
events in serum-free buffer would require longer operating and recording time in the
presence of serum.
Recently several reports have focused on the issue of sensing specific analytes
in protein mixtures.16,22 Specifically, an engineered phi29 nanopore containing an engineered peptide sequence was shown to detect a target antibody in 1% (v/v) serum.16 In
this study, current blockage histograms of antibody binding in the presence of serum exhibited two slightly overlapping peaks corresponding to the target protein and serum protein, respectively. Because a small portion of serum protein binding events induced current blockades similar to target antibody, detection could be achieved only when the
concentration of target protein is significantly above the interfering impurities. Our work
shows that the target binding signals are readily distinguishable from that of serum constituents, allowing unambiguous recognition of each target binding events. Moreover, the
fact that OmpG could distinguish two homologous analytes in the presence of serum
represents an exciting step forward in nanopore sensing. To date, our OmpG-biotin sensor has been able to discriminate among eight analytes: two monoclonal antibodies, two
polyclonal antibodies34 and four avidin glyco-isoforms.35 To our knowledge, no other nanopore thus far has shown such selectivity towards as many analytes. The flexible struc-
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ture of OmpG may adopt distinct conformations for each analyte, which serves as the
foundation for generating many unique current gating signals. The high selectivity of the
OmpG nanopore can be exploited for profiling of protein homologues or posttranslationally modified isoforms. The ability to identify cell-specific isoforms could aid in
the discovery of potential therapeutic targets and disease diagnostics.40,41 Thus, as a
complementary approach to mass spectrometry and protein micro-arrays for proteomic
study, our OmpG nanopore sensor provides a powerful detection platform that could deliver rapid readouts with little to no sample preparation.

3.6 Conclusions
In this study, we have shown that the OmpG nanopore is able to simultaneously
detect multiple homologous antibody analytes in serum with high specificity and selectivity. Our study demonstrates the feasibility of protein isoform profiling in a real-world
setting.
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CHAPTER 4
TUNING THE SELECTIVITY AND SENSITIVITY OF AN OMPG NANOPORE SENSOR
BY ADJUSTING LIGAND TETHER LENGTH
Reprinted (adapted) with permission from M. A. Fahie, B. Yang, B. Pham, and M. Chen,
“Tuning the Selectivity and Sensitivity of an OmpG Nanopore Sensor by Adjusting
Ligand Tether Length,” ACS Sensors, vol. 1, no. 5, pp. 614–622, 2016. Copyright 2016
American Chemical Society.
4.1 Summary
We have previously shown that a biotin ligand tethered to the rim of an OmpG
nanopore can be used to detect biotin-binding proteins. Here, we investigate the effect
of the length of the polyethylene glycol tether on the nanopore’s sensitivity and
selectivity.

When the tether length was increased from 2 to 45 ethylene repeats,

sensitivity decreased substantially for a neutral protein streptavidin and slightly for a
positively charged protein (avidin). In addition, we found that two distinct avidin binding
conformations were possible when using a long tether.

These conformations were

sensitive to the salt concentration and applied voltage. Finally, a longer tether resulted
in reduced sensitivity due to slower association for a monoclonal anti-biotin antibody.
Our results highlight the importance of electrostatic, electroosmotic and electrophoretic
forces on nanopore binding kinetics and sensor readout.

4.2 Introduction
Nanopores sensing is a single molecule approach by which analytes are sensed
when they interfere with ionic current flowing through the pore during an applied
potential.1–5 Nanopores are broadly grouped into two classes: solid state nanopores and
protein nanopores.1,4 Solid-state nanopores are fabricated from silicon nitride, glass or
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polymer substrates.6–8 Solid-state nanopores possess several advantages including the
physical and chemical robustness, tunable pore size and shape. On the other hand
protein nanopores always have the same, atomically precise structure.

Generally,

nanopores detect proteins by one of two mechanisms: translocation-dependent or
translocation-independent. For translocation-dependent sensing, the analyte is drawn
into the pore by electrophoresis, which partially blocks the flow of ionic current. Both
solid-state and protein nanopores applied this strategy to detect targets including BSA,9–
11

streptavidin/avidin,12,13 antibodies,12,14 and polyarginine peptides.15 Alternatively, some

proteins may be sensed via binding to an auxiliary polymer that threads through the
nanopore.16–18

Because ionic current is sensitive to the size, shape, and surface

properties of the analyte protein, as well as analyte-lumen interactions, nanopores are
able to distinguish complex protein isoforms,19–22 e.g. ubiquitin dimeric isoforms20 and
two configurations of aptamer-thrombin complex.22

In addition, the amino acid

composition of a protein may be revealed as an unfolded polypeptide is threaded
through a nanopore.23–27 Nanopores were also used as a single molecule analytical
approach to investigate the protein folding,28,29 unfolding,23,30 aggregation12,31 and
enzymatic activity.32,33
Despite the utility of these methods, the translocation-dependent approach is
generally not suited for directly analyzing proteins that are too large to fit into the pore.
While it is relatively straightforward to control the size of solid-state nanopores during
fabrication, adjusting the size of protein nanopores is challenging due to our limited
understanding of the connection between amino acid sequence and protein structure,
(i.e. the folding riddle). To overcome this limitation, large proteins have been detected
by protein nanopores via a translocation-independent mechanism. Typically, an analyte
binds to a high affinity site located on the exterior of the nanopore. The binding site can
be (i) a peptide sequence introduced into a region of the protein nanopore,34–37 or (ii) a
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covalently attached ligand in the lumen38 or on the rim of the nanopore.7,39,40 Using this
approach, a single nanopore can detect proteins of any size, eliminating the need to
search for pores or fabricate pores of suitable dimensions. Recently, we have used
outer membrane protein G (OmpG) from Escherichia coli (E. coli) to detect large
proteins. For example, we distinguished several structural homologues and isoforms of
biotin-binding proteins in complex mixture.40–42 OmpG contains seven flexible loops on
the extracellular side.43–45 Dynamic loop movement induces current fluctuations (called
gating) in ionic current measurements. Our engineered sensor had a biotin covalently
attached to the long loop 6 of OmpG.46,47 Proteins were detected via changes in the
gating pattern when they bound to biotin. Eight biotin-binding proteins, including four
streptavidin homologues and four anti-biotin antibodies were differentiated by their
characteristic current gating signals.40-42

Compared to other multimeric protein

nanopores,21,36,38,48 such as αHL,49 MspA,50 ClyA51 and phi29 motor,52 OmpG is a
monomeric protein nanopore with flexible loops at the entrance. OmpG sensing relies
on the interaction of its flexible loops with the analyte protein which generates distinct
characteristic signal for each analyte. The high selectivity of the OmpG nanopore was
attributed to the ability of its loops to undergo distinct conformational changes when
interacting with each analyte. Such a high selectivity is rarely observed among other
nanopores because their rigid structures are unable to undergo large conformational
changes when bound by an analyte.
Electrostatic attractions between the nanopore loops and the analyte played an
important role in OmpG selectivity.41 Such interactions only occurred when the analyte
proteins were bound to the tethered ligand and confined in close proximity to the OmpG
nanopore. Here, we investigated how the proximity between the ligand and nanopore
might affect the sensitivity and selectivity of our detection system. We increased the
length of the polyethylene glycol (PEG) biotin linker and measured changes in gating
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signals as well as binding kinetics. While a longer linker allowed a greater range of
motion and therefore new gating states induced by biotin-bound proteins, this also
adversely impacted the kinetics and impaired sensitivity. This work shows that the linker
length of a tethered ligand influences the selectivity and sensitivity of the OmpG sensor
and is important in the design of future sensors.

4.3 Materials and Methods
All reagents and materials were purchased from Fisher Sci. or Boston
Bioproducts unless otherwise noted.

Mouse anti-biotin monoclonal antibody BTN.4

clone (MS-1048-P1) was purchased from Thermo Scientific.
purchased from Sigma.

Avidin (A9275) was

Streptavidin (Z7041) was purchased from Promega.

Maleimide-PEG45-biotin molecule was purchased from Creative PEG works (BiotinPEG-MAL, MW 2k (PJK-1930)). Maleimide-PEG2-biotin and maleimide-PEG11-biotin
were purchased from (ThermoFisher Scientific).

Diphytanoylphosphatidylcholine

(DPhPC) were from Avanti polar lipids. Tris(2-carboxyethyl)phosphine (TCEP) and octylglucoside (OG) and were purchased from GoldBio Technology.

4.3.1 Cell culture and protein purification
OmpG mutant D224C was created and expressed in E. coli cells as previously
described.42 OmpG was purified from an inclusion body under denaturing conditions in
50 mM Tris-HCl pH 8, 5 mM TCEP, 8 M urea using anion exchange chromatography.
Prior to labeling with the MAL-PEGn-biotin ligands, OmpG-containing fractions were
desalted on a HiTrap column into an 8 M urea, 50 mM HEPES pH 7 buffer to remove the
reducing agent TCEP and the amine containing buffer Tris-HCl and to lower the pH for
an optimal maleimide-thiol reaction. After desalting, OmpGD224C and MAL-PEGn-biotin
were immediately mixed in 1:10 (protein to ligand) molar ratio and incubated for 2 hrs at
room temperature (~23°C) with constant, gentle shaking. The mixture was desalted a
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second time using a HiTrap 5 ml desalting column (GE Healthcare) to remove
unconjugated MAL-PEGn-biotin. The labeled OmpG was then diluted in refolding buffer
(110 mM octyl glucoside, 20 mM Tris-HCl, pH 9) in a 2:3 v/v (OmpG to refolding buffer)
ratio and incubated at 37°C for 3 days (no agitation needed). The labeling and refolding
efficiency of the OmpG proteins were analyzed by gel-shift assay.

Labeling and

refolding percentages were both determined to be more than 70% for all constructs
(Figure 4.1). Proteins were aliquoted and stored at -80°C in 20% glycerol.

Freshly

thawed aliquots were used for the experiments.

Figure 4.1. The refolding and labeling efficiency of OmpG-PEGn-biotins. Denatured
OmpG-PEGn-biotin migrates slower than refolded protein as shown on the 15% SDS PAGE
gel. Labeled OmpG-PEGn-biotin shifts to an SDS-resistant high molecular weight complex in
the presence of excess streptavidin. OmpG-PEG45-biotin, OmpG-PEG11-biotin and OmpGPEG2-biotin each have a labeling efficiency of 75%, 83% and 87% respectively.

4.3.2 Single Channel recording
Single channel recording experiments were performed as previously described.42
For recording OmpG-PEGn-biotin behavior in planar lipid membranes, signals were
filtered with a 2 kHz Bessel filter (unless otherwise stated) and acquired at a sampling
rate of 100 μs after digitization with a Digidata 1320A/D board (Axon Instruments). The
current was amplified with an Axopatch 200B integrating patch clamp amplifier
(Molecular Devices). To create the bilayer, 2 µl of a 10% v/v hexadecane in pentane mix
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was applied to both sides of a 25 µm Teflon film with a 100 µm aperture separating two
chambers. Buffer (900 µL) was added to each chamber and approximately 15 µL of 10
mg/ml

1,2-Diphytanoyl-sn-glycerol-3-phosphocholine

pentane was dropped onto the surface of the buffer.

(DPhPC)

lipids

dissolved

in

The pentane was allowed to

evaporate for 2 min after the addition of hexadecane and the DPhPC lipids to the chip.
One Ag/AgCl electrode was inserted into each chamber, where one electrode
was in the grounded cis chamber and the other connected to the trans chamber. The
liquid level was pipetted slowly in one chamber at a time to form the lipid bilayer in the
aperture. Once a stable bilayer formed that could withstand 200-300 mV for at least 5
mins, about 1 nM (final concentration) OmpG proteins were added to the cis chamber. A
positive voltage of 200-250 mV was applied to induce pore insertion. The voltage was
lowered to 50 mV immediately after a single pore was inserted in order to hinder the
insertion of multiple pores into the bilayer. The orientation of nanopore was determined
based on its asymmetric gating behavior at positive and negative potentials.53 OmpG
behavior was recorded in the absence and presence of analyte proteins that were added
to the chamber facing the loop side.

4.3.3 Single channel data analysis
To determine the open probability of OmpG pores, traces were analyzed in
Clampfit 10.3 using the single channel search. The open probability was calculated as
the sum of the dwell time of open states divided by the total time analyzed.

To

determine the kinetics of the mouse monoclonal antibody bound and unbound states,
the dwell times of 300-500 bound events and 300-500 unbound events were extracted
manually and fit with a single standard exponential to derive the averaged inter-event
time (τon from the unbound events) and event duration (τoff from the bound events). To
identify when the antibody was binding to the OmpG nanopore, the decrease of the open
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pore conductance and the increase in gating frequency were used as clear identifiers to
guide accurate data extraction. The dwell times of the binding sub-states of avidin B1
and B2 (when the OmpG-PEG45-biotin sensor was used) were also extracted manually
and similarly analyzed as the anti-biotin mAb in order to extract the binding kinetics.
4.4 Results
4.4.1 Effect of PEG linker length on analyte recognition
A single cysteine mutant, OmpG (D224C) was purified under denaturing and
reducing conditions then labeled with one of the following: maleimide-PEGn-biotin, where
n is 2, 11 or 45, respectively.

The resulting constructs -OmpG-PEG2-biotin, OmpG-

PEG11-biotin and OmpG-PEG45-biotin - contained biotin moieties that could fully extend
approximately up to 30, 60 and 170 Å from the cysteine, C224, on loop 6 as estimated
by chemical linkage (Figure 4.2). However, in reality, the biotin ligand was most likely
closer to the OmpG pore entrance, as PEG molecules are not often in a stretched state.

Figure 4.2. The design of the OmpG-PEGn-biotin constructs. The biotin ligand attached to
residue D224C of the OmpG nanopore via PEG2, PEG11 and PEG45 linkers could extend up
to 30, 60 and 170 Å away from loop 6 respectively.
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The dynamic movement of the loop 6, which moves in and out of the OmpG
entrance, contributes to more than 95% of the intrinsic gating signal.46,47

Chemical

modification of the OmpG proteins with biotin reagents had minimal effect on the gating
behavior of OmpG (Figures 4.3, 4.4).

Figure 4.3. Effect of the tethered ligand on OmpG gating. The tethered Maleimide-PEGnbiotin ligands do not significantly affect the gating behavior of OmpG.
(a) Typical
electrophysiology traces of OmpGwt, OmpG-PEG2-biotin, OmpG-PEG11-biotin and OmpGPEG45-biotin in 10 mM sodium phosphate pH 6, 300 mM KCl buffer at +50 mV. (b) Power
spectra analysis of OmpGwt, OmpG-PEG2-biotin, OmpG-PEG11-biotin and OmpG-PEG45biotin. (c) Analysis of the open probability of OmpG pores in 10 mM sodium phosphate pH 6,
300 mM KCl buffer at +50 mV. Averages were calculated from at least three independent
pores. Error bars indicate the standard deviation. A p value > 0.05 indicates that the open
probabilities of the four proteins are not significantly different from one another. Signals in (a)
were filtered with a 2 kHz Bessel filter and acquired at a sampling of 100 μs. For power spectra
analysis pores were filtered with a 100 kHz Bessel filter and acquired at a sampling of 4 μs.
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Figure 4.4 Extended electrophysiology traces of OmpGwt and OmpG-PEGn-biotin
constructs. The tethered Maleimide-PEGn-biotin ligands do not affect the gating behavior of
OmpG. Single channel current traces of OmpGwt, OmpG-PEG2-biotin, OmpG-PEG11-biotin
and OmpG-PEG45-biotin were recorded in 10 mM sodium phosphate pH 6, 150 mM KCl
buffer at ±50 mV applied in the trans chamber. Signals were filtered with a 2 kHz Bessel filter
and acquired at a sampling rate of 100 μs.
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Before we tested the biotin binding proteins with the OmpG-PEGn-biotin
constructs we tested these proteins with unlabeled OmpG pores (OmpG-D224C).
These negative control experiments showed that none of the biotin-binding protein
analytes could trigger a signal change in the gating behavior of the OmpG-D224C
nanopore indicating that non-specific binding of streptavidin, avidin (and the mouse
monoclonal anti-biotin antibody) to unlabeled OmpG was negligible (Figure 4.5).

Figure 4.5. Electrophysiology traces showing the effect of biotin binding proteins on
OmpG-D224C gating activity. The gating behavior of OmpG-D224C is not significantly
altered in the presence of a mixture of streptavidin, avidin and anti-biotin mAb. This pore is a
representative of four independent pores. 10 mM sodium phosphate pH 6, 300 mM KCl buffer
was used at +50 mV. Signals were filtered with a 2 kHz Bessel filter and acquired at a
sampling rate of 100 μs.

We then examined how the different OmpG-PEGn-biotin nanopore constructs
responded to the two biotin-binding homologous proteins – streptavidin and avidin. We
observed that streptavidin binding resulted in a permanent increase in open probability
(n = 10, p = 0.05) for OmpG-PEG2-biotin (Figure 4.6, Figures 4.7a, 4.7d) as we had
previously seen.40,41 The open probability of the streptavidin bound state increased due
to the fact that the gating frequency of the OmpG-PEG2-biotin pore significantly
decreased when streptavidin was bound. The duration of the closed events shortened
while the duration of the open state increased (Figure 4.6). Furthermore, we did not
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observe any dissociation of the bound streptavidin molecule from the OmpG-PEG2biotin pore during our recordings.
However, the addition of streptavidin to the loop facing chamber of OmpGPEG11-biotin as well as that of OmpG-PEG45-biotin unfortunately did not induce any
quantifiable change in the gating activity of more than 15 OmpG-PEG11-biotin
nanopores and 13 OmpG-PEG45-biotin pores (Figure 4.7b-4.7d).40,41

Figure 4.6. The effect of streptavidin binding to the OmpG-PEG2-biotin pore. The open
probability of the OmpG-PEG2-biotin construct increases. The trace shown is a representative
of over 15 pores. The pore was recorded in 10 mM sodium phosphate pH 6, 300 mM KCl
buffer at +50 mV. Streptavidin was added to the loop chamber at a final concentration of 5 nM.
Signals were filtered with a 2 kHz Bessel filter and acquired at a sampling of 100 μs.
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Figure 4.7. Streptavidin binding to OmpG-PEGn-biotin constructs. Current recordings of
(a) OmpG-PEG2-biotin (b) OmpG-PEG11-biotin and (c) OmpG-PEG45-biotin before and after
streptavidin binding at +50 mV. Buffer used was 300mM KCl, 10mM sodium phosphate pH 6.
(d) Comparison of open probability of OmpG nanopores before and after streptavidin binding.
Error bars represent standard errors from at least 5 pores. Statistical analysis was performed
with an unpaired two sample t-test (n>5, p = 0.05).

In contrast, significant changes in current traces of all three constructs were
observed using avidin (Figures 4.8-4.10). Avidin binding caused a ~45% decrease of
the OmpG-PEG2-biotin and OmpG-PGE11-biotin open pore current (Figure 4.8a, 4.b).
The open current decreased from 24.8 ± 4.4 pA to 14.6 ± 1.7 pA (n = 6) for OmpGPEG2-biotin while for OmpG-PEG11-biotin it decreased from 27.4 ± 0.9 pA to 14.4 ± 3.4
pA (n = 4). Interestingly, when avidin bound to OmpG-PEG45-biotin, it induced two
distinct current patterns during the bound state (Figure 4.8c).

In the predominant

pattern, termed B1, the open pore current decreased from 23.6 ± 1.0 pA to 21.1 ± 1.3 pA
(n = 6), an 11% decrease in the open state. The minor pattern B2, had an open pore
current of 14.9 ± 2.5 pA (n = 6) which was 37% decrease of the unbound state (UB)
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(Figure 4.8c). Notably there were no significant changes to the open probability of either
the three OmpG-PEGn-biotin pores after avidin was bound (Figure 4.8d), unlike the
significant change in open current (Figure 4.8e).

Figure 4.8. Avidin binding to OmpG-PEGn-biotin constructs. Current recordings and the
corresponding histograms of (a) OmpG-PEG2-biotin (b) OmpG-PEG11-biotin and (c) OmpGPEG45-biotin before and after avidin binding at +50 mV. Buffer used was 300mM KCl, 10mM
sodium phosphate pH 6. The relative open pore current of the avidin bound states (blue and
red dash lines) to the unbound state (UB, green dash line) are indicated on the top of the
histograms. (d-e) Comparison of open probability (d) and open pore current (e) of OmpG
nanopores before and after avidin binding. Error bars represent standard errors from at least 4
pores. Statistical analysis were performed with an unpaired two sample t-test (n > 4, p = 0.05).
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Figure 4.9. Single channel current traces of OmpG-PEGn-biotin. Representative traces of
(a) OmpG-PEG2-biotin (b) OmpG-PEG11-biotin and (c) OmpG-PEG45-biotin before and after
avidin binding. B1 and B2 states of OmpG-PEG45-biotin are highlighted in black and blue,
respectively in (c). Pores were recorded in 10 mM sodium phosphate buffer pH 6, 300 mM
KCl at +50 mV. Avidin was added at a final concentration of 5 or 10 nM.
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Figure 4.10. Power spectra analysis of noise in the absence and presence of avidin. (a)
Spectra noise at 5 s of OmpG-PEG45-biotin, OmpG-PEG11-biotin and OmpG-PEG2-biotin
after avidin binding. (b) Power spectra analysis of OmpG-PEG45-biotin before and after avidin
binds during a 200 ms time scale. 10 mM sodium phosphate pH 6, 300 mM KCl buffer was
used and trace recorded at +50 mV. For power spectra analysis recordings were filtered with
a 2 kHz Bessel filter and acquired at a sampling of 100 μs.

Previous studies using OmpG-PEG2-biotin revealed that analyte proteins could
be classified into two categories based on their current signatures. Specifically, some
analytes interact with the OmpG pore surface while others do not. We found that noninteracting proteins were either neutral or negatively charged molecules under the
experimental conditions used.41 Typically, a decrease of the gating activity was observed
for these proteins which may hinder the dynamic movement of loop 6 through drag or
friction forces. One example was streptavidin. The fact that streptavidin binding inhibited
gating in OmpG-PEG2-biotin but not OmpG-PEG11-biotin or OmpG-PEG45-biotin
suggest that a linker with 11 or more PEG units is flexible enough to allow loop 6 to
freely move even with a ~60 kDa protein attached.
On the other hand, proteins that interacted with OmpG’s loops usually induced a
reduction in the open pore current by occluding ionic flow.41 Such protein-protein
interactions were dominated by electrostatic attraction between the negatively charged
OmpG loops and the positively charged analyte protein surface, such as avidin.41 Avidin
binding to OmpG-PEG11-biotin triggered an almost identical effect to that of the OmpG128

PEG2-biotin, suggesting that the avidin bound states of these two constructs were
similar (Figures 4.8e, 4.9-4.10).

The avidin bound state of OmpG-PEG45-biotin

exhibited two distinct gating signatures with relative open pore current of 87% and 60%.
We presume this shows that avidin interacted with OmpG-PEG45-biotin in two different
configurations (Figures 4.8e, 4.9-4.10).
Our results show that OmpG lost its ability to detect neutral or negatively charged
molecules with an elongated linker but was able to recognize the positively charged
protein analytes.

This study also suggests that we could adjust the PEG linker to

optimize the selectivity of OmpG toward one specific analyte such as a glycosylated
protein, like avidin, while removing any interfering signals from related non-glycosylated
homologues, like streptavidin.

4.4.2 Effect of voltage on OmpG-PEG-biotin - avidin interaction
The OmpG-PEG45-biotin is the first variant to show multiple unique bound
states, specifically with avidin. Since we suspect that electrostatic forces govern the
interactions between the loops and analyte, we tested the effect of applied voltage on
the bound states to see if they responded to electric fields. Here, positive potential was
defined as the potential of the chamber in which the OmpG loops were facing was
positive relative to the other chamber (Figure 4.11). The relative open current of OmpGPEG2-biotin and that of OmpG-PEG11-biotin showed a significant voltage dependence
(Figure 4.11a, 4.11b, 4.11d). The relative open pore current of the B1 state to the
unbound state showed a weak voltage dependence (Figures 4.11c, 4.11d). Increasing
the potential from -75 mV to 75 mV caused the open pore current to decrease slightly.
On the other hand, the relative open current of the B2 state showed a strong
dependence.
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Figure 4.11. Voltage effect on avidin binding to OmpG-PEGn-biotin. Current recordings of
(a) OmpG-PEG2-biotin (b) OmpG-PEG11-biotin and (c) OmpG-PEG45-biotin before and after
avidin binding at various voltages. (d) Effect of voltage on the relative open pore current of the
avidin bound states of all three OmpG-PEG-biotins. (e) Effect of voltage on the dwell time of
B1 and B2 states of OmpG-PEG45-biotin. The B1 and B2 avidin binding states are indicated
by the red and blue bars respectively. Buffer used was 300mM KCl, 10mM sodium phosphate
pH 6.

Because the open pore current and voltage dependence of the B2 state were
similar to the avidin bound states of OmpG-PEG2-biotin and OmpG-PEG11-biotin
(Figures 4.11d, 4.12), we speculated that avidin interacted with OmpG surface in a
similar manner in each scenario. The avidin B1 and B2 data suggests that a long PEG
linker such as PEG45 (<170 Å) or longer could allow the analyte (which should have
strong electrostatic interaction with the OmpG loops) to sample or interact with more
than one binding area of the OmpG loop surface or event a binding distance once it is
bound to the tethered ligand. The voltage dependent open pore current of the avidin
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bound B1 and B2 states of OmpG-PEG45-biotin was likely due to the proximity of the
bound avidin molecule to the entrance of OmpG under an applied potential.

Figure 4.12. Comparison of open pore current of the OmpG-PEGn-biotin constructs
before and after avidin binding at various voltages. Both OmpG-PEG2-biotin and OmpGPEG11-biotin exhibit a significant change in open pore current from -75mV to +75mV once
avidin is bound. The B2 signal of the avidin-bound OmpG-PEG45-biotin is significant at -75mV
to +75mV whereas the B1 signal is only significant at positive voltages. At negative voltages,
the B1 avidin-bound state is not different from that of the –avidin gating. Asterisks (*) represent
data that have p values < 0.05 compared to the -avidin condition (white bars). Data that have
p values > 0.05 are indicated by n.s. signifying that there is no significant difference in the
current after avidin is bound. Error bars indicate the standard deviation. More than 15 bound
and 15 unbound events from at least three independent pores were analyzed. The pores were
recorded in 10 mM sodium phosphate pH 6, 300 mM KCl buffer at +50 mV with a 2 kHz Bessel
filter and an acquisition sampling rate of 100 μs. Avidin was added at a final concentration of 5
or 10 nM.

We then measured the dwell times of both the B1 and B2 avidin bound states of
OmpG-PEG45-biotin at voltages ranging from -75 mV to +100 mV. First, we observed
that the B1 dwell time in the 300 mM KCl buffer condition was not voltage dependent
where the dwell times fluctuated rather randomly as the voltage varied. On the other
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hand, the B2 dwell time initially did not significantly change at negative potential but
slowly and exponentially increased after an increasing positive potential was applied
(Figures 4.11e, 4.13, 4.14). This result suggests that the avidin and OmpG-PEG45biotin electrostatic interaction could be strengthened (increase in B2 dwell time) or
weakened (decrease in B2 dwell time) by manipulating the applied potential across the
bilayer.

Figure 4.13. Electrophysiology traces showing the dwell times of the avidin B2 state of
OmpG-PEG45-biotin at various loop voltages. The B2 state dwell time (blue line) increases
as the loop potential increases. The pores were recorded in 10 mM sodium phosphate pH 6,
300 mM KCl buffer at the indicated loop voltages. Signals were filtered with a 2 kHz Bessel
filter and acquired at a sampling of 100 μs.
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Figure 4.14. First order exponential fitting analysis of B1 and B2 dwell times at
various voltages. B1 and B2 of OmpG-PEG45-biotin was analyzed from -75 to +100 mV.
The histograms are from a single representative pore but the calculated dwell time is the
average from at least three independent pores and the error is the standard deviation. 10
mM sodium phosphate pH 6, 300 mM KCl buffer was used.
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Because avidin, which bears a positive charge and OmpG’s loop surface carries
a net negative charge, we expect a strong electrostatic attraction between them and
previously confirmed this phenomena.41 In addition, electrophoretic (EP) and
electroosmotic (EO) forces act on the bound avidin in a voltage dependent manner.41
The OmpG lumen is decorated with 14 positively (12R and 2K) and 16 negatively (13E
and 3D) charged residues. At pH 6.0, the lumen had a -2 net negative charge. Thus, at
positive potential, EP and EO align to push avidin into the loop surface of the OmpG
nanopore.

At negative potential, the two forces push in the opposite direction,

weakening the electrostatic attraction between the OmpG nanopore and the bound
avidin molecule.
In protein nanopores such as αHL and solid-state nanopores such as glass,
simulations have shown that the strength of EO and EP fields peak at the constriction
site of the nanopore and diminish rapidly between the nanopore and bulk solution.54,55
Because the B2 state is voltage dependent, we surmise that during this state, the bound
avidin must be close enough to the pore to be influenced by EO and EP forces. On the
other hand, avidin in the B1 state might be further away from the pore entrance as it is
not affected by voltage. Here, we have shown that the characteristic gating pattern used
to identify analytes and homologues can be tuned and possibly optimized to trap desired
states by manipulating the voltage.

4.4.3 Effect of salt concentration on the interaction between OmpG-PEG45-biotin
and avidin
The electrostatic interactions between OmpG-biotin and avidin, EP and EO are
sensitive to salt concentration.41 Thus we observed whether the avidin-bound complex to
OmpG-PEG45-biotin responded to changes in salt concentration at +100 mV (Figure
4.15).
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Figure 4.15. The effect of KCl concentration on the avidin binding states B1 and B2 of
the OmpG-PEG45-biotin pore. Pores were recorded in 10 mM sodium phosphate pH 6 buffer
at +100 mV in the indicated KCl concentrations. Asterisks (*) indicate data that have p values
< 0.05 which are statistically significant from the -avidin condition. Data that has p value >
0.05 is indicated by n.s. signifying that there is no significant difference in the open current
after avidin is bound. Error bars indicate the standard deviation. More than ten B1 and ten B2
events were collected from at least three independent pores to determine the average current
reduction.

At 150 mM KCl, only the B2 state was observed (Figure 4.15, 4.16a). At higher
salt concentrations, the bound avidin switched between B1 and B2 states (Figures
4.16b-4.16e). The dwell time of the B2 state decreased rapidly with increasing salt
concentration with a corresponding increase in B1 dwell time (Figures 4.16f, 4.17).

In

addition, the relative open current of the avidin B1 and B2 states increased with
increasing salt concentration. At 750 mM KCl, the B2 state was still recognizable, while
the open current of the B1 state was indistinguishable from that of the unbound state
(Figure 4.5d, 4.5e). This suggested that the avidin molecule occluded the ionic flow
through OmpG-PEG45-biotin to a lesser degree at higher salt concentration. At 1.0 M
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KCl, we did not observe any significant change in gating after the addition of avidin,
indicating that avidin no longer interacted electrostatically with the nanopore surface.

Figure 4.16. Salt effect on OmpG-PEG45-avidin binding states. Typical current recording
of a single OmpG-PEG45-biotin pore at unbound and traces of avidin bound states (B1 and
B2). Single channel recording were carried out in 10mM sodium phosphate buffer pH 6
containing KCl ranging from (a) 150mM (b) 300mM (c) 450mM and (d) 750mM KCl. (e) The
effect of salt concentration on the relative open pore current and (f) the dwell time duration of
avidin B1 and B2 states.

Because salt screens the surface charge of the bound avidin and the OmpG,
increasing salt concentration could essentially weaken all three forces that act on avidin.
This explains why at low salt concentration (150 mM KCl), avidin stayed tightly bound
(B2) while the loosely-bound state (B1) became dominant when salt concentration
increased. Thus, the salt concentration of the recording buffer is an important factor to
modulate the detection of the binding signature of the chosen target.
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Figure 4.17. First order exponential fitting analysis of B1 and B2 dwell times in various
salt conditions. B1 and B2 of OmpG-PEG45-biotin in 300 to 750 mM KCl (10 mM sodium
phosphate pH 6) buffers was measured at +100 mV. The histograms were generated from at
least 300 events from a single representative pore. The average dwell times were calculated
from the extracted dwell times of at least three independent pores and the error is the standard
deviation.

4.4.4 Effect of linker length on the binding kinetics
To assess the effect of PEG linker length on binding kinetics, a reversible-binding
mouse monoclonal anti-biotin antibody (mAb) was used in place of streptavidin and
avidin. The recording buffer salt was lowered to 150 mM because the gating activity of
OmpG-PEG45-biotin pores did not change in the presence of mAb in 300 mM KCl buffer
(n = 10). The mAb bound all three nanopore constructs and generated gating signatures
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differing in open pore current and gating frequency which lowers the open probability
compared to the unbound state (Figure 4.18, 4.19). Although mAb increased the gating
frequency for all OmpG-PEGn-biotin constructs (Figure 4.20a), the relative open current
was 71± 15% (n = 15), 77 ± 10% (n = 15) and 94 ± 7% (n = 15) as the length of PEG
increased from 2 units to 45 units (Figure 4.20b). Additionally, the three constructs
varied in the mAb association (k’on) as the longer PEG linker resulted in a slower kon
(Table 4.1, Figures 4.20c, 4.21).

The linker length showed less effect on dissociation

(koff) rates as the differences among the three constructs were insignificant (Table 4.1,
Figures 4.20d, 4.21). As a consequence, the observed dissociation equilibrium constant
Kd for OmpG-PEG45-biotin was five times weaker than the OmpG-PEG2-biotin. This
result shows the apparent binding affinity of mAb to OmpG-PEGn-biotin constructs
decreased with the increasing length of the linker (Tables 4.1, 4.2).

Figure 4.18. Detection of an anti-biotin mouse monoclonal antibody (mAb) by the three
OmpG-PEGn-biotins. Current recordings and all events histograms of anti-biotin mAb binding
to (a) OmpG-PEG2-biotin (b) OmpG-PEG11-biotin (c) OmpG-PEG45-biotin. Green dashed
lines indicate the open current of the pores in the unbound state and red dashed lines indicate
the open current in the avidin bound state. Buffer used is 150mM KCl, 10mM sodium
phosphate pH 6. The applied voltages were +50 mV.
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Figure 4.19. The binding signal and the defined ton and toff events of anti-biotin mAb to
OmpG-PEGn-biotin. When the mAb binds to the OmpG pore (shown in red) the result is a
reduction in the open probability of the pore as well as a reduction in the open current. The
pores were recorded in 10 mM sodium phosphate pH 6, 150 mM KCl buffer at +50 mV.
Signals were filtered with a 2 kHz Bessel filter and acquired at a sampling of 100 μs.
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Figure 4.20. Statistic analysis to compare the binding of mAb to the OmpG-PEGn-biotin
constructs. The change in (a) open probability (b) open current (c) on-rate (ton) and (d) and
off-rate toff when mAb binds to OmpG-PEG2-biotin, OmpG-PEG11-biotin and OmpG-PEG45biotin are shown. The pores were recorded in 10 mM sodium phosphate pH 6, 150 mM KCl
buffer at +50 mV. The average open probabilities were calculated using at least 5000 open
and closed events from each pore. At least three independent pores were analyzed. The
average open current was determined from at least four independent pores. More than 30
mAb bound and 30 unbound events were extracted from each pore. To determine the ton and
toff, approximately 1000 events were extracted from each pore. At least three independent
pores were analyzed for binding kinetics. P values > 0.05 (highlighted in black) reveal data
that has no significant difference (n.s.) while p values < 0.5 (highlighted in red) reveal data
that are statistically different.

In nanopore sensing, the electroosmotic flow, electrophoretic force and
electrostatic forces strongly influence the molecule’s motion within the nanopore and
near the entrance.56,57 Steep potential gradients and strong flow velocity that occur at
the constriction site of a nanopore can create an absorbing force to facilitate the capture
of the analyte by the nanopore.58,59 All three forces, when acting on the analyte in the
same direction, can potentially promote stronger binding with OmpG-PEGn-biotin by
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enhancing the mAb association and inhibiting dissociation. Since these forces were
strongest in the pore entrance and decrease rapidly with increasing distance, increasing
the PEG linker length reduced the binding affinity. Thus, although a longer linker may
potentially improve the selective detection, it would compromise the detection sensitivity.

Figure 4.21. First order exponential fitting analysis of ton and toff dwell times of antibiotin
mAb. mAb binding to OmpG-PEG45-biotin, OmpG-PEG11-biotin, OmpG-PEG2-biotin was
performed in 10 mM sodium phosphate pH 6, 150 mM KCl buffer and measured at +50 mV.
Dwell times are measured in seconds. The histograms were plotted from the dwell times
extracted from a single representative pore. The dwell times are the averages from three
independent pores and the error is the standard deviation.
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Table 4.1. Linker effect on the binding kinetics of an anti-biotin
mouse monoclonal antibody.
Biotin
construct
OmpG-PEG2

k’on
(x106 M-1s-1)
20.3 ± 6.7

koff
(s-1)
0.30 ± 0.08

K’D
(x10-8 M)
1.5 ± 0.6

OmpG-PEG11

16.6 ± 5.0

0.48 ± 0.06

2.9 ± 0.6

OmpG-PEG45

7.5 ± 1.2

0.47 ± 0.07

6.3 ± 1.2

Table 4.2. Summary of the binding effects of streptavidin, avidin and anti-biotin mAb to
OmpG-PEGn-biotin constructs.
OmpGVoltage
Binding
Target
Buffer
Binding Signal
biotin
(mV)
Characteristic
300
• Open probability
mM
+50
PEG2
increases by
pH 6
17%
300
• No change in
mM
+50
Streptavidin PEG11
gating activity
pH 6
PEG45

Avidin

PEG2

300
mM
pH 6

+50

• No change in
gating activity

300
mM
pH 6

-75

• Current
decreases by
13.8%

300
mM
pH 6

-50

• Current
decreases by
17.0%

300
mM
pH 6

-25

• Current
decreases by
22.4%

300
mM
pH 6

+25

• Current
decreases by
35.7%

300
mM
pH 6

+50

• Current
decreases by
39.6%
• No change in
open probability

300
mM
pH 6

+75

• Current
decreases by
44.8%
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PEG11

Avidin

PEG11

Avidin

300
mM
pH 6

-75

• Current
decreases by
10.5%

300
mM
pH 6

-50

• Current
decreases by
15.1%

300
mM
pH 6

-25

• Current
decreases by
16.0%

300
mM
pH 6

+25

300
mM
pH 6

+50

300
mM
pH 6

+75

300
mM
pH 6

-75

300
mM
pH 6

-50

300
mM
pH 6

-25

300
mM
pH 6

+25

• Current
decreases by
39.0%
• Current
decreases by
42.8%
• No change in
open probability
• Current
decreases by
47.3%
• B1 current
indistinguishable
from -avidin
• B2 current
decreases by
16.7%
• B1 current
indistinguishable
from -avidin
• B2 current
decreases by
18.9%
• B1 current
indistinguishable
from -avidin
• B2 current
decreases by
28.5%
• B1 current
decreases by
9.4%
• B2 current
decreases by
29.5%

PEG45
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Avidin

PEG45

300
mM
pH 6

+50

300
mM
pH 6

+75

300
mM
pH 6

+100

150
mM
pH 6

+100

450
mM
pH 6

+100

750
mM
pH 6

+100

PEG2

150
mM
pH 6

+50

PEG11

150
mM
pH 6

+50

• B1 current
decreases by
10.8%
• B2 current
decreases by
36.8%
• No change in
open probability
• B1 current
decreases by
17.3%
• B2 current
decreases by
47.7%
• B1 current
decreases by
20.2%
• B2 current
decreases by
37.8%
• Current
decreases by
62%
• B1 current
decreases by
12.7%
• B2 current
decreases by
29.7%
• B1 current
indistinguishable
from -avidin
• B2 current
decreases by
25.4%
• Current
decreases by
28.6%
• Open probability
decreases by
27.6%
• Kd = 14.6 ± 5.77
nM
• Current
decreases by
22.5%
• Open probability
decreases by
17.4%

Anti-biotin
mAb
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PEG45

150
mM
pH 6

• Kd = 29.2 ± 6.3
nM
• Current
decreases by
6.0%
• Open probability
decreases by
9.9%
• Kd = 62.6 ± 11.6
nM

+50

4.5 Conclusion
By varying the length of the tether connecting biotin to OmpG, we showed how
distance influenced OmpG’s detection selectivity and sensitivity. Our data demonstrated
that electrostatic interactions, electroosmotic and electrophoretic forces not only strongly
modulate the signal characteristics of the bound state but also affect their binding
kinetics. Increasing the linker length weakened these forces resulted in the decrease in
sensitivity. On the contrary, a longer linker allowed a bound analyte to sample multiple
interactions at the interface with the nanopore, which may enhance analyte identification
and differentiation.
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CHAPTER 5
A NON-CLASSICAL ASSEMBLY PATHWAY OF ESCHERICHIA COLI PORE
FORMING TOXIN CYTOLYSIN A
Reprinted (adapted) with permission from M. Fahie, F. Romano, C. Chisholm, A. P.
Heuck, M. Zbinden, and M. Chen, “A non-classical assembly pathway of Escherichia coli
pore forming toxin cytolysin A.,” J. Biol. Chem., vol. 288, no. 43, pp. 31042–31051, Sep.
2013. Copyright 2013 Journal of Biological Chemistry.

5.1 Summary
Cytolysin A (ClyA) is an alpha-helical pore forming toxin (α-PFT) from pathogenic
Escherichia coli (E. coli,) Shigella and Salmonella enteric strains. PFTs are virulent factors secreted as monomers by bacteria but can assemble to oligomeric pores when they
encounter their target cell membrane. Here, we report that E. coli ClyA can assemble
into an oligomeric structure in solution at physiological temperature in the absence of
either bilayer membranes or detergents. These soluble ClyA oligomers can rearrange to
create transmembrane pores when in contact with detergents or biological membranes.
Intrinsic fluorescence measurements revealed that the oligomers adopted an intermediate state found during the transition between monomer and transmembrane pore.
These results suggest that the water-soluble oligomers represent a prepore intermediate
state. Furthermore, our data suggests that ClyA does not form transmembrane pores on
reconstituted E. coli lipid membranes. Since ClyA can be delivered to the target host cell
in an oligomeric conformation within outer membrane vesicles (OMVs), our findings support a model that suggests that ClyA forms a prepore oligomeric structure independently
of the lipid membrane within the OMV. This proposed model for ClyA represents a nonclassical PFT assembly pathway to attack eukaryotic host cells.
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5.2 Introduction

Pore-forming toxins (PFTs) represent the largest family of bacterial protein toxins
and constitute important bacterial virulence factors.1,2 Their cytolytic function operates
by introducing a large, water-filled pore into target cell membranes. These pores either
deliver toxic effector proteins to the target cell or lead to cell lysis through leakage.3
Most bacterial PFTs are secreted into the extracellular environment in a water-soluble
form, where they subsequently diffuse and assemble on host cell membranes. Poreforming toxins are classified as α-PFTs or β-PFTs depending on the predominant secondary structure of the transmembrane pore, i.e. α-PFTs contain α-helical transmembrane domains and β-PFTs form a β-barrel.1,2
Cytolysin A (ClyA), also known as silent hemolysin A (SheA) or hemolysin E
(HlyE), is a cytolytic α-PFT that causes the hemolytic phenotype of several Escherichia
coli (E. coli) strains.4–9 Its homologues are also found in other pathogenic organisms,
including Salmonella typhi and Shigella flexneri.10,11 The E. coli ClyA monomer is a 34kDa soluble protein that has a rod shape formed by a core bundle of four long α-helices
(~90 Å long).10 At the end of the bundle that contains the N-terminal region, an additional shorter (~30 Å long) helix from the C-terminal region packs against the core bundle,
forming a five-helix bundle for about one-third the length of the molecule. The structure
of the transmembrane pore shows a hollow funnel consisting of 12 subunits (protomers).12,13 Each protomer contributes one amphipathic α-helix that packs in an iris-like
structure to form the transmembrane barrel. The narrowest opening of the channel at
the transmembrane site has a diameter of 35 Å while the top or widest part of the funnel
is 70 Å.12
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The general model for multimeric PFT attack action involves three steps1: (i)
docking of the soluble monomer to the target cell membrane; (ii) assembly of the monomer into a ring-like prepore structure that lacks the transmembrane domain structure at
the membrane surface; (iii) penetration of the transmembrane domain across the target
cell membrane. In the first step, cholesterol, carbohydrates or membrane proteins on
the host’s cell surface may serve as receptors for the association of the toxins with the
membrane.14–18 ClyA toxin is also believed to follow a similar strategy when attacking
host cells.1 However, unlike the well-studied β-toxins α-hemolysin and protective antigen from anthrax toxin (PA), which are secreted by gram-positive bacteria into the extracellular environment as a soluble monomer,19,20 ClyA is secreted from E. coli via a vesicle-mediated pathway.21–23 Similar to the budding of yeast cells, the outer membrane of
E. coli bubbles out and pinches off to form the outer membrane vesicles (OMVs).24 During the formation of the OMV, many outer membrane proteins as well as periplasmic
proteins (of which ClyA is a member) are incorporated into the OMV. The vesiclemediated pathway has been found to deliver several toxins, including heat-labile enterotoxin and Shiga toxin.25–27 So far, it remains unclear how these toxins are released from
the OMVs to carry out their cytolytic function.25
Of note, Wai et al. discovered that ClyA in the OMV adopted a ring-like oligomeric structure when viewed under an electron-microscope.21 This observation contradicts
the typical PFT strategy of assembling pores from water-soluble monomers at the surface of the target cell. These ClyA oligomers were speculated to represent transmembrane pores, thus raising a question about how transmembrane pores already embedded in E. coli lipid membranes could then transfer to the host cellular membrane. Nevertheless, its secretion pathway is distinct from the well-studied β-toxins, which suggests
that ClyA may have an unexpected mechanism to carry out its cytolytic function.
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In this study, we report that ClyA assembles into soluble hemolytically active oligomers in the absence of lipid bilayers or detergents. The water-soluble oligomer may
represent a prepore intermediate undergoing the transition from the monomer to the
transmembrane pore. This data could provide important evidence to elucidate the structural organization of the oligomeric ClyA proteins in the OMV, which is a step further towards understanding the attack mechanism for the ClyA toxin.

5.3 Materials and Methods
All the chemicals were purchased from Fisher Scientific unless otherwise specified. Luria Broth (LB) Miller version medium was purchased from Boston BioProducts.

5.3.1 Cloning and mutagenesis of ClyA
The E. coli ClyA gene was amplified from the E. coli K-12 genome (ATCC) and
cloned into a pT7 vector with a C-terminal hexa-histidine tag XhoI and HindIII restriction
cut sites to insert the gene into the multiple cloning site. The cysteine-less ClyA (C87S,
C285S) was obtained by the overlap PCR method using the plasmid containing the Cterminal hex-histidine tagged ClyAwt gene (pT7-ClyAwt) as a template. The PCR was
performed using Phusion polymerase reaction (New England Biolabs). The primers for
C87S

were

5’-

ATGAATGGTCTGGTGTTGCGACGCAATTG

(forward)

and

5’-

CGTCGCAACACCAGACCATTCATACACTG (reverse). These two primers were used
in a pair with the primers SC47: 5’-CAGAAGTGGTCCTGCAACTTTATC (reverse) and
SC46: 5’-ATAAAGTTGCAGGACCACTTCTG (forward) which annealed to the middle of
the plasmid in the Ampicillin resistance cassette. The two PCR products were then
mixed in an approximate 1:1 molar ratio and subjected to DpnI digestion for three hours
at 37°C to degrade the parental plasmid. Competent E. coli DH5α cells were then cotransformed with the PCR mixture and colonies containing the desired mutant construct
pT7-ClyA C87S were identified by DNA sequencing. The same procedure was repeated
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to generate pT7-ClyA ΔCys (C87S C285S) construct using the pT7-ClyA C87S as template. The two primers used for introducing the C285S mutation into the C87S mutant
plasmid

were

5’-AACACCTCTAATGAGTATCAGAAAAGAC

ACTCATTAGAGGTGTTAATCATTTTTTTGG (reverse).

(forward)

and

5’-

The single cysteine mutant

pT7-ClyA C304 was constructed in the same way by using pT7-ClyA ΔCys as a template
for PCR. Primers were 5’-CTGAAGTCTGCCACCATCACCATCACC (forward) and 5’TGGTGGCAGACTTCAGGTACCTCAAAG (reverse).

All primers were obtained from

Fisher Scientific.

5.3.2 Expression and purification of ClyA
The resulted plasmids were transformed into E. coli BL21. Cells were grown in
LB medium at 37°C to OD600 0.5. Isopropyl β-D-1-thiogalactopyranoside (0.5 mM) was
then added to the cell culture to induce protein expression. Cells were grown for 3 hours
and then harvested by centrifugation. To purify the ClyA protein, cell pellets (1.0 L culture) were resuspended in 50 ml 50 mM Tris•HCl, pH 8.0, 200 µg/ml lysozyme and 1
mM EDTA, 0.1 mM phenylmethanesulfonylfluoride (Sigma). The cell lysate was incubated on ice for 30 minutes. To reduce the viscosity, 50 kU DNase I and 3 mM MgCl2
were added to the mixture and incubated for 30 minutes at room temperature. The lysate was centrifuged at 20,000 g for 30 min. After passing through a 0.45 µm filter, the
supernatant sample was loaded onto the Ni-NTA affinity column that was equilibrated
with buffer A which contained 50 mM Tris•HCl, pH 8.0, 150 mM NaCl. His-tagged ClyA
proteins were eluted under a gradient with buffer A and buffer B which contained the
same Tris buffer and NaCl but included 0.5 M imidazole. The ClyA protein eluted in
around 30% buffer B or ~150 mM imidazole. ClyA was then further purified to remove
aggregates and the excess imidazole by Superdex 200 10/300 gel filtration column (GE
Healthcare) that was equilibrated with 25mM Tris•HCl, pH 8.0, 150 mM NaCl. The mon-
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omeric ClyA proteins were collected and stored at -80°C at a concentration of 0.7 mg/ml
or less. The purity of the protein (>95%) was verified by 15% SDS-PAGE (Figure 5.1).

Figure 5.1. SDS-PAGE of nickel affinity purified ClyAwt protein. The ClyA protein eluted
in 150 mM imidazole from the nickel affinity column and was then run through gel filtration as
a further purification step. The protein purity is > 95%.

5.3.3 Gel filtration analysis of ClyA oligomerization
Gel filtration chromatography (GFC) analysis of proteins was performed at room
temperature (22-23°C) using an analytical Superdex 200 10/300 gel filtration column
(GE healthcare). For detergent-triggered oligomerization of ClyA, samples were incubated in 0.1% DDM at the indicated temperature and time. The proteins were then injected onto the column equilibrated in buffer 50 mM Tris•HCl, pH 8.0, 150 mM NaCl,
0.01% (w/v) n-Dodecyl β-D-maltoside (DDM) at room temperature. For detergent independent oligomerization, samples were incubated with buffer containing no DDM at the
indicated temperature for 2 hours prior to GFC analysis. The buffer used to analyze and
collect the soluble oligomers from GFC was 50 mM Tris•HCl, pH 8.0, 150 mM NaCl.
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5.3.4 Intrinsic fluorescence studies
ClyA proteins contained two tryptophan residues (W37 and W85) and were analyzed at a concentration of ~3 μM at 25°C. For intrinsic fluorescence measurements the
excitation wavelength was 280 nm and emission spectra were collected at 290–410 nm
using a Fluorolog-3 spectrofluorimeter. The fluorescence emission spectra of corresponding buffers were subtracted from the emission spectrum of each ClyA sample. For
DDM-induced oligomerization studies, 15 µl of DDM stock solution (10% w/v) was added
to 1.5 ml ClyA monomer at a final concentration of 0.1% (w/v). Subsequently, the emission fluorescence spectra were recorded at 3 minute intervals. The resulting spectra
after DDM was added to the sample were adjusted according to the dilution factor as
well as the buffer blank.

5.3.5 Liposome preparations
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL). E. coli total
extract lipids or pig brain total extract lipids in chloroform at 25 mg/ml was dried at 20–
23°C under dry nitrogen and then kept under vacuum for at least 3 hours. Lipids were
re-hydrated in buffer 50 mM Tris•HCl, pH 8.0, 150 mM NaCl to a 25 mg/ml final concentration of total lipids, and incubated for 30 minutes at 20–23°C with vortexing at 5 minute
intervals. The re-suspended lipid mixture was flash frozen in liquid nitrogen and thawed
at 37°C for a total of three freeze-thaw cycles to reduce the number of multi-lamellar liposomes. Hydrated lipids were extruded 21 times through a 0.4 μm pore size polycarbonate filter (Whatman) using an Avanti Mini-Extruder (Alabaster, AL). The resultant
liposomes were stored at 4°C and used within 2 weeks of production.
Tb(DPA)33- loaded liposomes were prepared as above, except that HBS buffer
(50 mM HEPES, 100 mM NaCl pH 7.5) including 3 mM TbCl3, 9 mM 2,6pyridinedicarboxylic acid (DPA) was added to rehydrate 6.4 mg dried lipids to yield a fi-
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nal total lipid concentration of approximately 30 mM (final volume, 0.30 ml). The resulting liposomes loaded with Tb(DPA)33- were separated from non-encapsulated
Tb(DPA)33- by gravity mediated gel filtration (Sepharose CL-6B-200, 0.7 cm inner diameter X50 cm) in HBS buffer and the resulting concentration (~2 mM) was estimated
by measuring the absorbance (light scattering) at 400 nm .

5.3.6 Analysis of pore forming activity by hemolytic activity
The liquid hemolysis assay with sheep defibrinated blood cells was used to
measure the hemolytic activity of the ClyA proteins.28 Briefly, Remel sheep defibrinated
blood (Thermo Scientific) was washed with HyClone Dulbecco’s phosphate-buffered saline (DPBS) buffer (Thermo Scientific) and diluted four fold in DPBS buffer. ClyA proteins (7 µg) were added to 250 µl of blood cells and incubated at 37°C for 15 minutes.
Samples were then centrifuged at 22,000 x g at 4°C for 8 minutes. The absorbance of
the supernatant at 540 nm was measured to estimate the concentration of released hemoglobin. The total hemolysis (100%) positive control was defined by incubation of red
blood cells in MilliQ water, in place of buffer.

5.3.7 Analysis of pore-forming activity by fluorescence quenching
The pore-forming activity of ClyA proteins was also assessed by using a
Tb(DPA) fluorescence quenching assay. Tb(DPA)33- loaded liposomes (6 µL of ~ 2 mM
giving a final concentration of ~12.5 µM total lipids) were added to 994 µL of quenching
buffer (100 mM NaCl, 50 mM HEPES, 5 mM EDTA pH 7.5) containing 250 nM protein
just before the measurement. Samples were excited at 278 nm and the net initial emission intensity (F0) at 544 nm was determined after equilibration of the sample at 25 °C
for 2 minutes.

The samples were then incubated for 1 hour at 37°C.

After re-

equilibration at 25°C for 10 minutes, the final net emission intensity (Ff) of the sample
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was determined and the fraction of quenched fluorophore was calculated using 1- Ff/F0.
Measurements were repeated 4 times for each condition.

5.3.8 Oxidation of ClyA proteins
The formation of intramolecular disulfide bonds were catalyzed using the oxidizing reagent Cu(phenanthroline)2 following a previous protocol.29 ClyA proteins were incubated with 1.5 mM Cu(phenanthroline)2 at room temperature for 30 minutes with gentle shaking. EDTA (5 mM, final concentration) was then added to quench the oxidation
reaction. All the chemicals were then diluted to a negligible level by buffer exchange using a Centricon (Millipore) with a 3kDa cut-off. To reduce the sample, oxidized proteins
were incubated with 20 mM reducing agent dithiothreitol (DTT) for 60 min at room temperature with continuous gentle agitation. DTT was then removed by buffer exchange
before the analysis of hemolytic activity.

5.3.9 Single channel study of ClyA
Planar lipid bilayer experiments were performed in an apparatus partitioned into
two chambers with a 25 µm-thick Teflon film. An aperture of approximately 100-µm diameter had been made near the center of the film with an electric arc. About 2 µl of 10%
v/v hexadecane dissolved in pentane was added to both sides of the Teflon film and the
pentane was allowed to evaporate for 2 minutes. Each chamber was filled with 900 µl of
25 mM Tris•HCl, pH 8.0, 1.0 M KCl. An Ag/AgCl electrode was immersed into each
chamber with the cis chamber grounded. A positive potential indicates a higher potential
in the trans chamber. 20-30 µl of 1,2-diphytanoyl-sn-glycerol-3-phosphocholine at a
concentration of 10 mg/ml (Avanti Polar Lipids, USA) dissolved in pentane was deposited on the surface of the buffer in both chambers and monolayers formed after the pentane evaporated. The lipid bilayer was formed by raising the liquid level up and down
across the aperture, which had been pretreated with a hexadecane/pentane (1:10 v/v)
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solution to prevent buffer solution exchange between the chambers. The current was
amplified with an Axopatch 200B integrating patch clamp amplifier (Axon Instruments,
Foster City, CA). A voltage potential of about 10 mV was applied for ClyA pore insertion
unless otherwise stated. Signals were filtered with a Bessel filter at 2 kHz (unless otherwise stated) and then acquired by a computer (sampling at 50 µs) after digitization with a
Digidata 1320A/D board (Axon Instruments). Data were analyzed with Clampex 10.0
software.

5.4 Results

5.4.1 Assembly of ClyA in the absence of detergent
It is often observed that PFT monomers assemble to form the oligomeric transmembrane pores upon contacting with detergents or lipid vesicles.30–32 Similar to these
previous findings, the retention volume of ClyA monomers shifted from 15 ml to 10 ml by
gel filtration chromatography (GFC) after incubation with 0.1% (w/v) DDM overnight at
4ºC (Figure 5.2a).12,33 This high molecular weight oligomer was previously shown to represent the transmembrane pore structure and is termed ClyATM here.12,33 During the purification, we noticed that the ClyA protein showed a tendency to form high molecular
weight oligomers even in the absence of detergent or lipids. We therefore explored the
oligomerization of ClyA in the absence of detergent or membranes using GFC. Two
peaks with retention volumes of 8.5 ml and 9.5 ml appeared in chromatograms after incubation of the ClyA monomer at 37°C in buffer containing 50 mM Tris•HCl, pH 8.0, 150
mM NaCl for 2 hours (Figure 5.2b). Fractions corresponding to the two peaks were
named oligomer 8 (ClyAO8) and oligomer 9 (ClyAO9) based on their respective retention
volumes. Notably, these two fractions migrated faster in the GFC column than ClyATM
(Figure 5.2a, 5.2b). The ClyAO8 and ClyAO9 were pooled separately and re-analyzed by
GFC. The two proteins still eluted at their original retention volumes of 8.5 ml and 9.5
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ml, respectively (Figure 5.2c, 5.2d). No monomer was observed in the chromatogram,
suggesting that ClyAO8 and ClyAO9 did not dissociate under our conditions tested. Because the ClyAwt monomer contains two cysteines, it is possible that ClyA could have
formed oligomers through disulfide bond formation during the incubation at 37°C.

Figure 5.2. Gel filtration chromatography of ClyA proteins. (a) Oligomerization of the ClyA
proteins in the presence of DDM. ClyA monomers were incubated with 0.1% (w/v) DDM overnight at 4°C and then analyzed by GFC with a running buffer 50 mM Tris•HCl, pH 8.0, 150 mM
NaCl and 0.01% DDM. (b) Oligomerization of the ClyA protein in the absence of DDM. ClyA
monomer was incubated at 37°C for 2 hrs. The running buffer of GFC was 50 mM Tris•HCl, pH
8.5, 150 mM NaCl. Figure 3: GFC of ClyAO8 and ClyAO9 oligomers. Running buffer used was
50 mM Tris•HCl pH 8.0, 150 mM NaCl.
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To assess this, the same experiment was repeated in buffers containing freshly
prepared 10 mM DTT at 37°C. The presence of DTT did not modify the elution profile of
ClyA oligomers, excluding the involvement of disulfide bridges (Figure 5.3). Thus, we
conclude that ClyA was able to oligomerize in the absence of detergents/membranes
and that the isolated oligomers were stable in solution.

Figure 5.3. ClyA oligomerization under reducing conditions. Purified ClyA protein was
incubated at 42°C for 2 hrs in the presence of 10 mM DTT and subjected to GFC analysis.
The running buffer was 50 mM Tris•HCl, pH 8.0, 150 mM NaCl, 10 mM DTT.

5.4.2 Conversion of oligomer 8 and oligomer 9 to the transmembrane pore
To investigate whether ClyAO8 and ClyAO9 can convert to the transmembrane
pore, we incubated them with 0.1% DDM overnight at 4°C. The ClyAO8 shifted to a peak
eluted at 15ml, corresponding to the monomer, and a peak at 10ml, corresponding to the
fully-assembled transmembrane pore (Figure 5.4a, 5.4b). The ClyAO9 also shifted to
peak at 10ml but little monomer is observed during this process (Figure 5.4c). These
results indicate that ClyAO8 may contain loosely packed monomers that can be solubilized by DDM. By contrast, ClyAO9 had a more stable structure that did not disassemble
in detergent solution. Rather, DDM triggered a conformational change in ClyAO9 that
transformed it into the transmembrane pore. Because a portion of ClyAO8 also appeared
to have converted to ClyATM, it may contain a mixture of ClyAO9-like oligomers with a
stable structure and loosely packed monomers.
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Figure 5.4. Conversion of ClyAO8 and ClyAO9 to transmembrane pore. The purified ClyA
protein (a) ClyAO8 (b) and ClyAO9 (c) were incubated with 0.1% (w/v) DDM overnight at 4°C
and then analyzed by GFC with a running buffer 50 mM Tris•HCl, pH 8.0, 150 mM NaCl and
0.01% DDM.

Many assembled β-toxin oligomers have shown tolerance to sodium dodecyl sulfate (SDS) treatment and remain as oligomers on SDS-PAGE.31,34–36 We were interested
to see if ClyA oligomers would have different stabilities in SDS and migrate differently in
the SDS-PAGE. We found that all three oligomeric forms of ClyA dissociated to monomer on SDS-PAGE (Figure 5.5). This result suggests that the interaction in the oligomeric interface of ClyA is not as strong as those in β-PFTs.
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Figure 5.5. SDS-PAGE analysis of ClyA monomer and oligomers. ClyA oligomers
ClyAO9, ClyAO8 ClyATM and ClyA monomer all run with the same MW in SDS-PAGE indicating that the ClyA oligomers are not SDS-resistant.

5.4.3 Hemolytic activities of the ClyA proteins
The cytolytic activity of the oligomeric forms, ClyAO8 and ClyAO9 was determined
using a hemolytic assay. We also quantitatively compared its functionality to the ClyA
monomer. Sheep blood cells were incubated with ClyA proteins of the same weight concentration at 37°C for 15 min. The release of the hemoglobin associated with cell lysis
was then measured. As a negative control, a denatured ClyA sample, which were preheated at 95°C for 30min prior to the hemolytic assay, was tested. A sample of PBS
buffer was included to define zero activity. Results show that thermally-denatured ClyA
has no hemolytic activity while the monomer has the highest activity (Figure 5.6). ClyAO9
and ClyAO8 exhibited 65% and 30% of the monomer activity, respectively. The transmembrane pore (collected as peak 10 from GFC) only exhibited a background level of
hemoglobin release, supporting the notion that this population had lost its ability to lyse
cells. This result is in agreement with previous observations that transmembrane ClyA
pores formed in detergent octyl-glucoside solution showed no pore-forming activity on
cell membranes.37 Because both ClyAO9 and ClyAO8 were still functional in forming pores
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on erythrocyte membranes, we concluded that they might be oligomeric states with an
ordered structure instead of disordered aggregates.

Figure 5.6. Hemolytic activity of ClyA proteins. Sheep blood cells were incubated with 7 µg
of ClyA at 37°C for 15 min. The hemolytic activity was determined by measuring the absorbance of the released hemoglobin at 540 nm. The plotted values are the average of three independent samples and bars show the standard deviation.

5.4.4 Conductance of ClyA pores
Since ClyA can form transmembrane pores by converting the monomer or oligomer ClyAO9 in the presence of detergents, we asked if the stoichiometry of the transmembrane pores formed from these two pathways are the same. Because the ion conductance of a membrane channel is proportional to the pore size, which, in turn, is determined by the number of protomers in the transmembrane pore,38 we could address
this question by comparing the conductance of ClyA channels formed in two different
pathways. Here, single channel insertion of ClyA proteins into planar lipid bilayers was
monitored by bilayer current recording experiments (Figure 5.7a). Similar to the results
of the electrophysiological studies of E. coli ClyA and its homologs from Salmonella
typhi,6,39,40 the ClyA channels formed by monomer show a broad distribution from 5-15
nS with a major peak at around 11 nS (Figure 5.7b), suggesting that ClyA might create
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pores of variable size. The broad distribution of conductance observed by electrophysiology agrees with the cryo-EM data showing ClyA pores of variable size in detergent solution.12 The ClyA channels formed by ClyAO9 and ClyAO8 exhibited similar conductance
distribution patterns with the majority of ClyAO8 pores exhibiting a conductance between
6-10 nS and ClyAO9 pores a conductance between 9-16 ns (Figure 5.7c, 5.7d). The
population of ClyAO9 channels shifted to slightly larger pores than those formed directly
from monomer while ClyAO8 pores appeared smaller. So far, it is unclear why the conductance of the ClyAO8, ClyAO9 and ClyATM pores are different considering that they migrate at the similar retention volume by GFC (Figure 5.4). Further detailed structural
studies will be carried out to address this issue in future.

Figure 5.7. Single channel conductance of ClyA pores. (a) Single channel insertion of ClyA
proteins. After overnight incubation with 0.1% (w/v) DDM, ClyA proteins (~0.5 μg/ml, final concentration) were added to the cis chamber. A voltage of 10 mV was applied to monitor the single channel insertion events, manifested as stepwise increases of ionic current with time in 25
mM Tris•HCl, pH8.0, 1M KCl. (b, c, d) Histogram of the conductance of ClyA pores. Samples
analyzed were monomer ClyA (b) (105 single channel insertion steps) or ClyAO8 (c) (118 steps)
or ClyAO9 (d) (76 steps) after overnight incubation with 0.1% (w/v) DDM at 4°C. In (e), the sample contained monomer ClyA (112 steps) after incubation with 0.1% (w/v) DDM at 4°C for 7
days.
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Interestingly, when we measured the conductance of the ClyA monomer sample
after seven days of incubation at 4°C in 0.1% DDM, the histogram of conductance
showed almost a single population of 11 nS pores (Figure 5.7e). This suggests that the
11 nS pore is the most stable form, since it survives a long-time incubation in detergent.
By contrast, many other forms of ClyA lose the ability to insert into the lipid bilayer, probably due to aggregation or degradation. The dodecameric structure of the transmembrane pore determined by x-ray crystallography was also obtained from a DDM sample
which contained a large variety of ClyA pores of different sizes.12 We suggest that the
ClyA transmembrane pore with dodecameric structure might correspond to the 11 nS
pores observed in the electrophysiology recordings.

5.4.5 Temperature and concentration dependent oligomerization
We were interested in how the temperature and the protein concentration affect
ClyA assembly in solution. ClyA monomer was incubated at temperatures ranging from
4-42ºC for 2 hrs. At a temperature lower than 37°C, little ClyA oligomerization was observed (Figure 5.8). Unlike the assembly in the detergent micelles which proceeded to
completion at 4°C for 30 min, the detergent-independent assembly was strictly temperature-dependent and was a much slower process relative to the former.

Figure 5.8. Effect of temperature on ClyA assembly. ClyA (0.3 mg/ml) was incubated at
different temperatures for 2 hrs and subjected to GFC analysis. The running buffer was 50
mM Tris•HCl, pH 8.0, 150 mM NaCl.
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To see if oligomerization was also concentration dependent, we incubated 0.1
mg ClyA protein at concentrations ranging from 1 µg/ml to 0.1 mg/ml at 42°C for 2 hours
and samples were then analyzed by GFC. In order to load enough protein sample to the
GFC column for detection, the two lower concentration samples, 10 µg/ml and 1 µg/ml,
were concentrated to 1 ml using an Amicon centrifuge concentrator at 4°C. To eliminate
the possibility that oligomerization or aggregation might also be induced during the centrifugation concentrating procedure, we incubated 100 ml of 1 µg/ml at 4°C for 2 hrs and
concentrated the sample to 1 ml and loaded it to the GFC column as a control. We
found that ClyA remained mainly as a monomer and a small amount of protein was eluted at around 8 to 9 ml retention volume demonstrating the concentration step does not
significantly induce oligomer formation (Figure 5.9).

Figure 5.9. Effect of continuous concentration of ClyA on its oligomerization. ClyA
(100 ml of 1 ug/ml) was incubated at 4°C for 2 hrs and then concentrated to 1 ml on a centricon. Thereafter the protein was subjected to GFC analysis. The running buffer was 50 mM
Tris•HCl, pH 8.0, 150 mM NaCl.

The percentage of each population (ClyAO8, ClyAO9 and monomer) was calculated from the area under the peaks eluted at 8.5ml, 9.5ml and 15ml in the chromatogram
that were analyzed by the Unicorn software (GE) and are summarized in Figure 5.10.
Even at the lowest concentration (1 µg/ml, ~30 nM), the ratio of the oligomer to monomer was not reduced compared those of the higher concentrations, suggesting the oli-
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gomerization was independent of the protein concentration (Figure 5.10). Due to the
detection limit of GFC, we were not able to investigate lower concentrations. This result
demonstrates that ClyA has a strong tendency to oligomerize even at a low concentration (1 µg/ml) at physiological temperature.

Figure 5.10. Effect of protein concentration on ClyA assembly. ClyA at concentrations
ranging from 1µg/ml to 0.1 mg/ml were incubated at 42°C for 2 hours and then analyzed by
GFC. The percentage of each population (ClyAO8, ClyAO9 and monomer) was calculated from
the area of the peaks eluted at 8.5ml, 9.5ml and 15ml in the chromatogram. The error bars
indicate the standard deviation of three independent trials.

5.4.6 Probing the structural arrangement of oligomers by fluorescence
To understand the structural arrangement of ClyAO8 and ClyAO9, we measured
their intrinsic fluorescence spectra. The ClyA monomer contains two tryptophan and 13
tyrosine residues. As shown in Figure 5.7a, the monomer had a fluorescence maximum
at 315 nm while the fully assembled pore ClyATM had a red-shifted emission maximum at
340 nm. The fluorescence emission spectra of the ClyAO8 and ClyAO9 were very similar
to each other with the fluorescence maxima also at 340 nm, close to that of the ClyA detergent-induced transmembrane pore. The spectra of the ClyAO8 and ClyAO9 samples
from 345-400 nm overlapped well with that of the transmembrane pore while there is a
blue shift of 2 nm in the spectra from 300-340 nm (Figure 5.11a). Because the spectra
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of ClyAO8 and ClyAO9 appeared to be in between that of the monomer and transmembrane pore, we suspected they might be an intermediate state. To test this, we studied
a series of intermediate states of ClyA proteins during the DDM-triggered transition to
transmembrane pores. Here, DDM was added to ClyA monomer to a final concentration
of 0.1% (w/v) of DDM at 23°C to trigger the pore formation. The spectrum was taken
every 3 minutes until the spectra stabilized at around 30 minutes. Figure 5.11b shows
that the fluorescence intensity rose sharply immediately after the addition of detergent
and the wavelength of the peak maximum shifted from 315 to 340 within the first 3
minutes of measurement. After the initial fluorescence jump, the fluorescence intensity
gradually decreased and became stable after 30 min. The normalized spectra of these
intermediates revealed the peak maxima undergo subtle blue-shift during the transition
(Figure 5.11c). Interestingly, the spectrum taken 9 min after the addition of the DDM
overlaid well with the spectrum of ClyAO8 and ClyAO9 (Figure 5.11d), indicating that the
structure of ClyAO8 and ClyAO9 might mimic an intermediate state of the oligomerization
process.
We also investigated how the composition of the lipid membrane could affect the
assembly of a ClyA oligomer. To avoid the occurrence of oligomerization in solution that
would contribute to fluorescence spectrum, the ClyA monomers were incubated with liposomes prepared from porcine brain lipids or E. coli lipids extract at room temperature in
an approximate 1:50 protein to lipid molar ratio. The spectrum of the brain lipid liposomes sample overlapped very well with the spectrum of ClyATM (Figure 5.11e), which
demonstrated that ClyA proteins have transformed into transmembrane pores on the
brain lipid liposomes. In contrast, the spectrum of the ClyA incubated with E. coli liposomes did not resemble the DDM treated sample (Figure 5.11f). Instead, it was located
in between the monomer and the spectrum of the ClyAO9, suggesting that ClyA does not
form the transmembrane pore on E. coli lipid membranes.
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Figure 5.11. Intrinsic fluorescence of ClyA monomer and oligomers. (a) Normalized fluorescence emission spectra of monomer, ClyAO8, ClyAO9 and ClyATM. (b) DDM-triggered assembly of ClyA monitored by fluorescence. DDM (0.1% w/v, final concentration) was added to
ClyA monomer (1μM) solution and the fluorescence spectra were recorded every 3 min for 60
min. (c) Normalized spectra from Figure 6b. (d) Comparison of the spectra of ClyAO8, ClyAO9
and the intermediate state taken at 9 min after the addition of DDM. (e, f) Normalized fluorescence spectra of monomer, transmembrane pore and ClyA proteins after incubation with liposomes. ClyA was incubated with liposomes prepared from porcine brain lipids (e) and E. coli
lipids (f) at room temperature for overnight.

5.4.7 Effect of lipid composition on pore-forming activity
To further examine the pore-forming activity of ClyA proteins on liposomes, we
used a fluorescence quenching assay. The liposomes with Tb(DPA)3-3 encapsulated inside were added to buffers containing the fluorescence quencher EDTA. EDTA can diffuse into the liposome through ClyA pores on the liposome membrane and quench the
fluorescence. Figure 5.12 shows that ClyA monomer caused a significant fluorescence
decrease in the brain lipid liposomes. Consistent with our hemolytic assay, ClyAO9 and
ClyAO8 also induced fluorescence quenching but with reduced activity. On the contrary,
no fluorescence quenching was observed with any of the ClyA protein samples incubated with E. coli liposomes. This experiment confirms that ClyA proteins do not form
transmembrane pores on E. coli lipid membranes.
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Figure 5.12. Effect of lipid composition on the pore-forming activity of ClyA. ClyA proteins (0.034mg/ml, final concentration) were added to liposomes (5 μM) containing 3 mM encapsulated Tb(DPA)33-. The buffer used was 50 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM
EDTA. Fluorescence quenching occurred when EDTA diffused across the liposome membrane
through transmembrane pores formed by ClyA. Data shows the percentage of the quenched
fluorescence signal that was an average of quadruplet measurements with the error bar indicating the standard deviation.

5.4.8 Direct conversion of ClyAO8 and ClyAO9 to transmembrane pores
The data above revealed that ClyO8 and ClyO9 can convert to the transmembrane
pore when in contact with detergent micelles or lipid membranes. This could be achieved
through two possible pathways: (i) ClyAO8 and ClyAO9 dissociate into monomers then reassemble in the micelles/ lipid membrane or, (ii) ClyAO8 and ClyAO9 directly convert to
the transmembrane pore without undergoing the dissociation step. To distinguish between these pathways, we monitored the conversion of ClyAO8 and ClyAO9 in the presence of brain lipid membranes by intrinsic fluorescence. Liposomes were added to
monomer and the fluorescence was recorded (Figure 5.13a). After 5 min, the spectrum
showed two peak maxima at 314 nm and 340 nm indicating there was still monomer remaining in the sample. This result suggests the association process of the ClyA monomers to oligomers on the lipid membrane occurs on the time scale of minutes, which is
much slower than the αHL toxin (<5ms).41 If ClyAO8 and ClyAO9 dissociate into monomers, we expect to observe the spectrum of the monomeric species due to the relatively
slow association process of ClyA monomers.
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Adding liposomes to ClyAO8 and ClyAO9

induced a slight change at the 300-340 nm range (Figure 5.13b, 5.13c), however we did
not observe a significant shift of the spectrum towards the monomer peaks. Thus, this
experiment suggests that ClyAO8 and ClyAO9 directly convert to the transmembrane pore
on the lipid membrane without first dissociating to monomers.

Figure 5.13. Examining the pathway of ClyO8 and ClyO9 conversion. Brain lipid liposomes
(0.025 mg/ml, final concentration) were added to ClyA proteins (0.025 mg/ml): monomer (a),
ClyO8 (b) and ClyO9 (c) solution at 25 ºC. The fluorescence spectra were recorded at the indicated time intervals.
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5.4.9 Effect of the redox environment on the activity of ClyA
ClyA monomer contains two cysteines (C87, C285). The structure of ClyA monomer revealed that these cysteines were located within 5.2 Å (Cα to Cα), a distance that
would allow a disulfide bond to form. In the transmembrane pore structure, the cysteines move away from each other to be about 6.8 Å apart, which is the longest possible
distance for a disulfide bond could form between two cysteine residues.42 This raised
the question that a possible disulfide bond formed between the cysteine residues might
act as a redox switch to control ClyA oligomerization and cytolytic activity on its target
cell in vivo.
To test this theory, we induced the disulfide bond formation of the two cysteine
residues in ClyA wild type proteins by incubating the proteins with Cu(phenanthroline)2
for 0.5 hours at room temperature (22-23°C). GFC analysis of the oxidized sample
showed ClyA proteins remained monomeric, indicating that the protein did not form any
inter-molecular disufide bonds during the oxidation reaction (Figure 5.14). The oxidized
ClyA was subjected to the hemolytic activity assay. Figure 5.15 shows that the oxidized
ClyA (dark grey) lost around 90% of its hemolytic activity compared to that of the untreated control (black). Incubation in 20 mM DTT for an hour could recover about 60%
the hemolytic activity. The incomplete recovery of the activity could be likely due to the
close packing of the alpha helix bundles of ClyA that may occlude the disulfide bond
from the reducing chemical DTT. As a control, the double cysteine knock out mutant
ClyA ΔCys exhibited no response to the oxidation/reduction procedure. These results
indicated that formation of the intra-molecular disulfide bond could inhibit the poreforming activity presumably by preventing the occurrence of conformational change necessary for the formation of oligomeric transmembrane pore. The periplasm of E. coli is
an oxidizing environment and thus an oxidized ClyA protein could exist in this environment preventing ClyA from oligomerizing before being secreted in OMVs.
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Figure 5.14. GFC analysis of oxidized ClyA. ClyA (30 μg) was oxidized with 1.5 mM
Cu(phenanthroline)2 for 30 min at room temperature. Reaction was quenched with 5 mM (final
concentration) EDTA. Sample was analyzed by GFC without prior desalting. Running buffer
used was 50 mM Tris•HCl pH 8.0, 150 mM NaCl.

Figure 5.15. Regulation of the ClyA pore forming activity by redox change. The poreforming activity of various proteins was examined by hemolytic assay. The oxidized sample
contained wild type ClyA (ClyAwt) and ClyA double cysteine mutant C87S, C285S (ClyA
ΔCys) incubated with Cu(phenanthroline)2. The reduced samples were obtained by DTT
treatment of oxidized proteins. Blank samples were phosphate buffer saline.

5.5 Discussion
Previous work on ClyA has also shown that ClyA oligomerizes in solution without
detergent at 37°C.43 In this example, monomer, dimers and high molecule-weight oligomers (8-10mers as speculated by the authors) were observed by GFC.43 The 8-10mer
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fraction lacked hemolytic activity. However, our data clearly demonstrated that both
ClyAO8 and ClyAO9 lysed blood cells while the thermally denatured ClyA did not.
Because ClyAO8 and ClyAO9 retains both a stable structure and hemolytic activity,
we expect that they are not a disordered aggregate but rather an active oligomeric form
of ClyA proteins. In addition, the intrinsic fluorescence of these soluble oligomers
matched that of an intermediate state. This suggests the detergent-independent oligomer resembles an intermediate state between the monomer and fully assembled transmembrane pore. Since ClyAO8 and ClyAO9 were formed in solution, it is unlikely that the
α-helical transmembrane barrel has formed, as this would expose the hydrophobic outer
surface of the barrel to aqueous solution. Therefore, we believe that ClyAO8 and ClyAO9
could be oligomeric forms without the hydrophobic transmembrane barrel domain, i.e.
the prepore structure. Also, we have shown that ClyO8 and ClyAO9 can convert directly to
transmembrane pore. In summary, we propose that ClyAO8 and ClyAO9 are intermediate
states between the monomer and transmembrane ClyA channel. Since these two populations were eluted earlier than transmembrane pores in GFC, it might have a less compact structure than the transmembrane pore.
Although many PFTs require detergents or lipid bilayers for assembly to oligomeric prepore, the protective antigen of anthrax toxin also oligomerizes to a prepore
structure in the absence of detergents or lipid membranes.35,44 In fact, the water-soluble
prepore was formed by the oligomerization of protective antigen 63 which derives from
the proteolytic removal of a 20 kDa fragment from the full length anthrax monomer. Similarly, Monalysin, a PFT from the Drosophila pathogen Pseudomonas entomophila, forms
a multimeric structure in solution after proteoactivation.45 Therefore, not all PFTs require
lipid membranes or similar environments to form prepore structures. Although in vitro the
PA63 and Monalysin undergo oligomerization in solution after protease treatment, in na-
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ture the oligomerization of the PA63 and Monalysin is triggered by the proteases expressed on the host plasma membrane, where they subsequently assemble.
The activation of ClyA may be regulated by the change of its redox status during
the secretion of ClyA into OMVs.10,21,43 ClyA in the periplasm contains a C87–C285 disulfide bond,6,21,46 whereas ClyA within OMV is reduced.21 The disulfide bond may prevent
assembly of functional pore complexes, as oxidized ClyA showed a decreased hemolytic
activity than compared to reduced ClyA, which is consistent with previous studies.10,21,43
This notion is further supported by the observation that ClyA expressed in an E. coli
(dsbA- and dsbB-) strain, which is deficient in periplasmic disulfide bond formation, displays a significant hemolytic activity on blood agar plates, an effect that is not detectable
for ClyA expressed in wild-type strain.21 Therefore, the secretion of ClyA to OMVs where
DsbA and DsbB are absent may reduce the intracellular disulfide bonds and activate the
toxin for oligomerization21.
Some speculate that ClyA forms transmembrane pores upon interaction with the
membrane of the OMV.21 However, this contradicts two observations: i) the pre-formed
ClyA transmembrane pore lacks hemolytic activity as demonstrated by our study and
previous data.37 A transmembrane ClyA pore embedded in the OMV membrane loses
functionality for further attack. ii) the pore-forming activity of ClyA is strongly dependent
on cholesterol in the membrane, which suggests that cholesterol may facilitate the
transmembrane domain insertion.46 Since bacterial outer membranes contain no cholesterol, the transformation of ClyA into the transmembrane pore inside of the OMV should
be very slow. Our intrinsic fluorescence analysis supports this notion: the spectra of ClyA
with liposomes reveal transmembrane pores in brain lipids but ClyA cannot transform in
the presence of E. coli liposomes. The Tb fluorescence quenching assay further confirmed that ClyA cannot form transmembrane pores on E. coli lipid membranes. Thus, it
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is reasonable to believe the oligomeric structure of ClyA in the OMV may not be the
transmembrane pore.
The average expression level of a protein in E. coli is approximately 1000 copies,
roughly 1μM in the cytosol.47 Our data demonstrated that ClyA forms oligomers at 37°C
at concentrations as low as 30 nM. Under physiological conditions ClyA can associate
into ClyAO9-like prepore structures once activated in the OMV and this process can occur
independently of lipid membrane. Taken together, these data strongly suggest that the
secreted ClyA proteins oligomerize to a prepore structure instead of the transmembrane
pore inside the OMV before they reach the target cell membrane.
We propose that ClyA adopts a non-classical assembly pathway including the following steps (Figure 5.16): (i) ClyA is expressed as a monomer in the cytosol and exported to the periplasmic space where it remains inactive in an oxidized form; (ii) ClyA is
secreted in outer membrane vesicles in monomer form; (iii) Cleavage of the disulfide
bond in the OMV activates ClyA monomers which subsequently oligomerize to the prepore structure. How the OMV then delivers the active ClyA prepore to the host cell remains unknown. One plausible mechanism involves internalization of the vesicle and
subsequent release of the cargo proteins to the cytoplasm of the target cells25. Further
studies are underway to identify how ClyA is released.
In conclusion, we have shown that ClyA protein assembles into a functional oligomer in the absence of detergents and membranes. The oligomeric form represents a
prepore intermediate state that may resemble the ClyA oligomer structure in the OMVs.
These data provide insight regarding the oligomeric state of ClyA proteins in the OMV,
which represents an important step toward resolving the overall mechanism of ClyA.
High-resolution crystal structures of the prepore might be obtained in the near future and
they will be essential for determining how the prepore becomes the hemolytic pore.
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Figure 5.16. Schematic model showing the proposed assembly pathway for the E. coli
ClyA. The classical PFT attacking mechanism involves the secreted monomer docking to the
host membrane, followed by rapid assembly to the prepore structure. A conformational change
triggers the formation of the transmembrane domain. By contrast, monomeric ClyA is secreted
in OMVs where the redox environment cleaves intramolecular disulfide-bonds and activates
ClyA. ClyA then assembles to a prepore structure in the vesicle. Through an unknown mechanism, OMV release ClyA which then form a transmembrane pore on the host cell.
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CONCLUSIONS AND FUTURE WORK
C.1 What is on the horizon for OmpG?
We could successfully detect biotin binding proteins using the OmpG nanopore
by covalently attaching a chemical ligand onto loop 6 (L6).1–4 We can further extend the
utility of the OmpG nanopore by assessing other analyte targets and chemical ligands.
For example, other strategies we could apply are labeling the OmpG with (i) an
oligonucleotide to detect complimentary nucleic acids or nucleic acid binding proteins (ii)
engineer high affinity peptide sequences into loop 6 of OmpG to detect specific protein
analytes.
Thus far, we have exploited the dynamics of L6 to detect target proteins. We
found that some targets can interact with the OmpG through electrostatic interactions i.e.
through a sampling mechanism.2 Another area we can explore is determining whether
proteins that can sample OmpG can be detected using loops other than L6. The
findings of this exploration would be useful in engineering a new generation of high
affinity OmpG sensors that have multiple binding sites engineered into several loops.
We successfully exploited OmpG’s intrinsic ionic properties based on loop 6 to
develop a sensitive nanopore sensor, however, the underlying mechanisms for OmpG’s
gating behavior is also of interest to us. It has been shown in previous studies and in
our work, that the gating behavior of OmpG is highly altered by conditions of pH and to a
lower extent the applied voltage.5–9 To further develop the OmpG platform, we need
more than just a basic understanding of L6 dynamics. Probing the molecular
mechanisms contributing to OmpG’s ionic behavior will be essential in designing the
appropriate mutations and alterations to its structure so that function is not
compromised.
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C.2 What is in the future for ClyA?
Many aspects of pore forming toxin (PFT) oligomerization and assembly kinetics
remain a puzzle.10,11 Recent work on ClyA from Benjamin Schuler’s lab has
characterized the assembly dynamics of various ClyA proteins when triggered by
detergent DDM.12,13 Since detergent is not the biological relevant membrane target of
ClyA, assembly studies on biological membranes could give more insight into the native
assembly mechanism of pore-forming toxins that are secreted as soluble monomers.
In addition, the Schuler group revealed that the soluble ClyA oligomers that we
observed in chapter 5 are in fact intermediates of an off-pathway assembly
mechanism.14 We also found, through electron microscopy characterization that ClyAO8
and ClyAO9 do not form pre-pore structures but instead fibril like structures (Figure F.1).
We believe these structures could dissociate in the presence of detergent or membrane
to re-associate and form active transmembrane pores (Figure F.2). Thus, we
characterized a stable misfolded intermediate in the protein folding funnel for ClyA. The
motivation for the study of ClyAO8 and ClyAO9 was due to the evidence that ClyA proteins
are secreted in outer membrane vesicles (OMVs). In these OMVs ClyA exists as ring
like structures indicative of oligomeric pores.15 Later studies had engineered OMVs
loaded with ClyA as delivery vehicles into the cell.16,17 However, the mechanism of ClyA
assembly and attack via OMV secretion is still not well understood and is an area for
further investigation in our lab since ClyAO8 and ClyAO9 were found to be non-native
structures.
An area that has not been explored is the study of the stability or dissociation
kinetics of the transmembrane pore. Researchers have found that multimeric protein
complexes can have the ability to exchange subunits.18,19 Currently, protomer
exchange of a PFT has not been studied and is unknown whether it occurs. Very stable
PFTs such as alpha-hemolysin which are SDS stable are unlikely to exchange
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protomers, however, PFTs like ClyA which are not SDS resistant, could undergo such a
mechanism.
A recent study revealed that the C-terminus of ClyA was critical for pore
formation and stability20 which was not apparent or overseen in previous studies.21–24
The b-tongue inn ClyA is a hydrophobic rich region that is solvent exposed and it is still
not quite clear what is its role and thus this can be further investigated.
In conclusion, there are many biochemical and biophysical questions to explore
using these OmpG and ClyA as models.
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Figure C.1. Negative stain electron microscopy of ClyA proteins. Structures of monomer,
ClyAO8 and ClyAO9 in with and without detergent. ClyAO8 and ClyAO9 form fibrillar like
structures in the absence of detergent. However in the presence of DDM the fibrillar like
structures have dissociated and in the case of ClyAO9 some pore structures have formed.
White arrowheads indicate the protein conglomerates while black arrows point to pores.
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Figure C.2. ClyA assembly mechanisms. On-pathway (black arrows) and off-pathway
(grey arrows) oligomerization mechanisms of ClyA revealed by studies of the Schuler and
Chen labs.
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